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Pathological and immunohistochemical analyses of two forms of
human intraocular inflammatory disease, multifocal posterior uveitis and
Behcet's disease, were carried out. Studies of post-mortem eyes from a
patient with multifocal posterior uveitis revealed a focal lymphocytic infiltrate
in the choroid, extending through Bruch's membrane to the retina.
Endothelial cells of choroidal vessels at the inflammatory foci had the
morphological appearance of "high endothelial venules" known to be
involved in the selective trafficking of lymphocytes. Immunohistochemical
analysis of the lymphocytic infiltrate showed that 70-80% were T cells.
Immunohistochemical analysis of enucleated and post-mortem eyes from
Behcet's disease patients showed that the mixed leukocytic infiltrate found in
the retina and uveal tract was composed predominantly of T lymphocytes
and macrophages. The retinal vessels were hyalinised and narrowed in the
post-mortem material and were noted to have IL2 receptor positive CD4
positive T lymphocytes in their walls. Aberrant expression of MHC class II
antigens by organ-resident cells in these studies was minimal.
Experimental work on an animal model of intraocular inflammatory
disease, experimental autoimmune uveoretinitis, was undertaken to
determine the in vivo lymphokine production of T lymphocytes in
inflammatory eye disease. The T lymphocyte infiltrate in active EAU was
identified immunohistochemically as was interferon-y protein and IL2
receptor positive cells. cDNA probes specific for rat interferon-y, IL2,
lymphotoxin and IL4 mRNA were amplified, extracted and radiolabeled.
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These probes were used to identify autoradiographically mRNA for these
lymphokines in the destructive tissue pathology in EAU using the technique
of in situ hybridisation. Localised foci of mRNA for all four lymphokines were
identified over cells in the areas of T lymphocyte infiltrate. Less than 10% of
the infiltrating T cells expressed lymphokine mRNA. The number of positive
cells was generally equal for the four lymphokines throughout the disease
process. These studies confirm the central role of T lymphocytes in
inflammatory eye disease and suggest that production of interferon-y, IL2,
lymphotoxin and IL4 may contribute to the immunopathology.
The findings of these studies are discussed in relation to autoimmunity
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Abbreviations used in the text
ABC Avidin-Biotin-Complex
AEC Amino ethyl carbazole
Ag Antigen
APC Antigen presenting cell
APES 3-Aminopropyltriethylsilane
APMPPE Acute posterior multifocal placoid pigment epitheliopathy
ATP Adenosine triphosphate
bp Base pair
CFA Complete Freund's adjuvant
CNS Central nervous system
CSF Cerebro-spinal fluid




DTH Delayed type hypersensitivity
EAE Experimental autoimmune encephalomyelitis
EAU Experimental autoimmune uveoretinitis
EGF Epidermal growth factor
ELAM Endothelial leukocyte adhesion molecule
EM Electron microscopy
G-CSF Granulocyte colony stimulating factor
GFAP Glial fibrillary acid protein
GM-CSF Granulocyte-macrophage colony stimulating factor
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GTP Guanosine triphosphate
HBVP Hepatitis B virus polymerase
HEV High endothelial venule
HLA Human leukocyte antigen
HSV Herpes simplex virus
ICAM Intercellular adhesion molecule




IRBP Interphotoreceptor retinoid binding protein
LCA Leukocyte common antigen
LFA Lymphocyte function associated antigen
LT Lymphotoxin
MBP Myelin basic protein
MHC Major histocompatibility complex
MS Multiple sclerosis
NK Natural killer
NOD Non obese diabetic
OCT Optimal cutting temperature compound
PAP Peroxidase anti peroxidase
PBS Phosphate buffered saline
PCR Polymerase chain reaction
PDGF Platelet derived growth factor
PMN Polymorphonuclear leukocyte
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RPE Retinal pigment epithelium
RVE Retinal vascular endothelium
SLE Systemic lupus erythematosa
SSC Standard saline citrate solution
TCR T cell receptor
TGF Transforming growth factor
TTP Thymidine triphosphate
TNF Tumour necrosis factor
VKH Vogt Koyanagi Flarada syndrome
VLA Very late activation antigen
VCAM Vascular cell adhesion molecule
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AIMS
The aims of this thesis are:
(a) to describe the processes of immunological tolerance and autoimmunity
and their relationship to inflammatory eye disease.
(b) to undertake immunopathological studies carried out on human eyes
with intraocular inflammation with the aim of characterising the cell types
and mechanisms involved in the disease processes.
(c) to investigate the in vivo lymphokine production by T lymphocytes in
ocular inflammation using an animal model of inflammatory eye disease,
experimental autoimmune uveoretinitis (EAU), with the aim of identifying the
T lymphocyte subsets present and the lymphokine mRNA expressed.
(d) to discuss the significance of the results of this work in relation to current
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1.1 Introduction
This thesis is divided into five chapters. Chapter one is an introduction
which covers background information on clinical uveitis, immunology, in
particular concepts of immune tolerance and autoimmune disease and
clinical and laboratory studies on inflammatory eye disease.
Chapters two and three deal with pathological and
immunohistochemical studies on human eyes with multifocal posterior
uveitis and Behcet's disease. These are the first such studies to be carried
out on these two forms of inflammatory eye disease.
Chapter four covers experimental work using immunohistochemical
and molecular biology (in situ hybridisation) techniques on lymphokine
production and gene expression in experimental autoimmune uveoretinitis
(EAU) an animal model of intraocular inflammation. The work described
represents the first application of in situ hybridisation to the investigation of
inflammatory eye disease.
Chapter five is a discussion of the results of the studies described in the
preceding chapters in the context of immune-mediated inflammatory disease
and the potential implications for future work.
1.2 Intraocular inflammation
In clinical ophthalmology the term intraocular inflammatory disease
covers a range of conditions which vary in location, severity and chronicity.
Since the uveal tract is often centrally involved in these conditions the term
"uveitis" is commonly used clinically to refer to intraocular inflammatory
disorders. The classification of uveitis as anterior or posterior on the basis of
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anatomical location has proven useful since it also divides conditions which
are markedly different in terms of both clinical behaviour and
immunopathology. This thesis deals with posterior uveitis.
Intraocular inflammation can be caused by a local infection with
organisms such as Toxoplasma Gondii (Perkins, 1973); Herpes Zoster,
Herpes Simplex and Epstein-Barr viruses which can cause acute retinal
necrosis (Lightman, 1991) or cytomegalovirus which can produce a retinitis
(Henderley et al.1987). Such infections may in some cases be substantiated
by specific laboratory tests whilst in others the diagnosis remains
presumptive based solely on clinical findings. In the clinical setting,
however, most cases of intraocular inflammatory disease are of unknown
aetiology, can have an uncertain prognosis and may be refractory to therapy.
These idiopathic forms of intraocular inflammation frequently involve the
posterior segment of the eye and the destructive pathology in the choroid,
retinal pigment epithelium (RPE) and retina can result in significant visual
loss.
Idiopathic, non-infectious forms of intraocular inflammation are widely
considered to have an autoimmune basis, a concept which was first
introduced by Elschnig in 1911 in relation to the pathogenesis of
sympathetic ophthalmitis (Elschnig, 1911). The introductory chapter of this
thesis is therefore divided into subsections dealing with the mechanisms of
immune tolerance and autoimmune disease and the relationship of these
processes to ocular inflammatory disease.
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1.3 Immunological tolerance
The ability of an individual to distinguish self from nonself is a
fundamental principle of the immune response. The lack of self reactivity is
achieved through the processes of immunological tolerance. Since animal
populations are outbred, individuals within a population vary substantially in
the self ligands expressed on their cells and there is therefore no simple way
of producing an immune system which does not react with self antigens. The
immune system acquires the knowledge to discriminate self and nonself
during its development (Schwartz, 1989). The processes of tolerance
induction are therefore closely related to those of lymphocyte ontogeny.
1.3.1. T lymphocyte development
T lymphocytes develop in the thymus from bone marrow derived thymic
progenitor cells. Rearrangement of the variable (V), diversity (D) and joining
(J) gene segments encoding the a and p chains of the T cell receptor (TCR)
allows thymic progenitor cells to express a wide diversity of ap T cell
receptors (Blackman et al.1990). It is the interaction of the TCR and the T cell
accessory molecules CD4 and CD8 with MHC molecules expressed on cells
in the thymus which is central to tolerance development.
The ap TCR (the yb TCR is expressed on a separate T cell lineage
making up 5% of peripheral blood T cells which is currently under
investigation) is composed of two transmembrane polypeptide chains.
These a and p chains have constant (C) and variable (V) regions. The
variable regions form combining sites that have contact residues for
antigenic peptide and MHC molecule (Marrack et al.1987). In addition the T
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cell CD4 and CD8 surface molecules bind determinants on class I and class
II MHC respectively to increase the avidity of T cell binding to its target cell
(Sprent et al.1990). The antigen fragment is bound by an MHC molecule in
the groove between two a helices and a (3 pleated sheet. Random
rearrangement of TCR gene segments at a (Va,Ja) and |3 (V|3,Dp,jp) loci
along with N region diversity created by imprecise joining of gene segments
or nucleotide insertion could give rise to a T cell repertoire of 109 different
specificities (Blackman et al.1990). This repertoire is not expressed by any
animal because of the processes of negative and positive selection which
occur in the thymus.
1.3.2 T lymphocyte selection
Although it had previously been proposed that negative selection of T
cell precursors took place in the thymus, the studies of Kappler et al
(Kappler et al. 1987b; Kappler et al. 1987a) provided the first direct evidence
that thymocytes are subject to a process of clonal deletion. These
experiments showed cells which expressed the V|317a gene product in their
TCR (recognised by the monoclonal antibody KJ23a) were a major
subpopulation (9-14%) in mice not expressing the MHC class II molecule I-
E. The V|317a T cell subpopulation was virtually absent in F1 crosses and
other mice strains which did express l-E. Importantly, unchanged numbers of
Vp17a+ cells were present in the subset of immature thymocytes
(CD4+CD8+, "double positive") in the thymuses of l-E positive animals
although the numbers were greatly reduced in CD4+CD8- and CD4-CD8+
subsets. This provided evidence that clonal deletion of thymocytes took
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place at or shortly after the double positive stage of maturation.
TCR transgenic mice have also been used to study negative selection
of thymocytes. Kisielow et al (Kisielow et al. 1988a) constructed transgenic
mice expressing in a large fraction of their T cells an apTCR specific for an
antigen (H-Y) present on male but not female cells. Very few lymph node
cells of male mice proliferated in response to H-Y although one in seven
CD4-CD8+ lymph node cells in female mice responded. The peripheral T
cells of male mice expressed the transgenic TCR at normal frequency
however they expressed very low levels of CD8. The thymuses of male mice
had 10 fold fewer cells than females mainly due to loss of double positive
cells. These studies provided further evidence that deletion occured at the
double positive stage of thymocyte maturation and also suggested that CD4
and CD8 molecules are involved in the deletional process. Sha et al (Sha et
al.1988) used a different transgenic model to demonstrate that deletion
takes place at the double positive thymocyte stage.
Developing thymocytes undergo a second selective process termed
positive selection. It has been established that T cells recognise antigen
exclusively in the context of self MHC and that thymocytes "learn" this self
MHC recognition during maturation (Blackman et al.1990). Experiments
using TCR transgenic mice (Kisielow et al. 1988a; Sha et al.1988) have
demonstrated that mature thymocytes and peripheral T cells only develop in
mice with the same MHC haplotype as the original clone from which the
transgenic TCR was isolated. In contrast large percentages of immature
thymocytes are found to express the MHC disparate TCR. Most of these
thymocytes are found to be CD4+CD8+ demonstrating that positive selection
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takes place at this stage of development.
In thymus repopulation experiments (Kisielow et al. 1988b) it was
demonstrated that thymocytes preferentially differentiate towards a
CD4:CD8 ratio determined by the MHC expression in the thymic
environment. This observation shows that the CD4/CD8 phenotype of T cells
is directed by MHC molecule expression in the thymus and the TCR
specificity in immature thymocytes and that the CD4/CD8 accessory
molecules are involved in positive selection.
1.3.3. Mechanisms of T lymphocyte selection
These thymic selective events are of fundamental importance to the
development of the T cell repertoire and further investigations have been
carried out in an attempt to elucidate the mechanisms involved. Experiments
have demonstrated that different thymic cell types are involved in negative
and positive selection (Blackman et al.1990). Marrack and associates
(Marrack et al.1988) used transgenic and bone-marrow chimeric mice to
investigate the cell types involved in deletion of Vpi7a+ thymocytes. These
experiments showed that bone-marrow derived cells are responsible for
tolerance induction due to thymocyte deletion and that expression of
peptides by thymic epithelium alone was not sufficient to produce tolerance
induction.
Experimental work has in addition indicated that it is the interaction of
the thymic epithelial cell population with developing thymocytes that is
responsible for positive selection (Blackman et al.1990; von Boehmer et
al.1990). It has been argued that this interaction produces positive selection
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by preventing programmed cell death (apoptosis) (Sprent et al.1990).
Since the events leading to the positive and negative selection of
thymocytes appear to occur at a similar stage of ontogeny the factors which
differentiate a positive (selective) response from a negative (deletional)
response brought about by the TCR-self MHC/antigen interaction are central
to the process of selection of the T cell repertoire. Two theories have been
proposed to account for the different thymocyte response in this interaction.
The first model is based on receptor affinity and implies that quantitative
differences in TCR-MHC interaction and binding determine thymocyte fate
(Schwartz, 1989; Blackman et al.1990). This model proposes that
thymocytes whose TCRs recognise MHC with high affinity are eliminated by
negative selection whereas low affinity TCR-MHC interactions produce
positive selection. This theory is supported by recent transgenic experiments
carried out by Robey and associates (Robey et al.1992) which demonstrated
that a two fold increase in expression of a CD8 transgene in mice
expressing a 2C TCR transgene causes a change from positive to negative
selection indicating that a quantitative difference in TCR-MHC binding can
alter T cell selection.
A second theory on the differentiation of positive and negative selective
processes referred to as the "peptide" model argues that qualitative
differences in the interaction of thymocyte TCR with MHC on thymic
epithelial cells or bone marrow derived cells in the thymus is responsible for
the difference in thymocyte response (Marrack et al.1987; Schwartz, 1989;
Blackman et al.1990). This model proposes that thymic epithelial cells
present a set of peptides on their MHC molecules some of which are unique
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and some of which are ubiquitous. Positive selection would occur when a
thymocyte recognises a unique peptide on a thymic epithelial cell and
recieves a signal for survival. Negative selection would result from
thymocyte interaction with an MHC ubiquitous peptide. The data of Marrack
and associates (Marrack et al.1988) provide some evidence that the affinity
model mechanism was not the only process of selection occuring in
transgenic mice where negative selection of transgenic TCR thymocytes was
limited yet there was no overselection of these thymocytes as would be
predicted by the affinity hypothesis. In addition there is evidence that the
MHC molecules on thymic epithelium are not the same as MHC found
elsewhere (Marrack et al.1989). An additional possibility is that the stage of
thymocyte maturation when it interacts with self MHC may influence its
selective response (Blackman et al.1990; Robey et al. 1992). Further
investigation of the mechanisms mediating the processes of thymocyte
selection will be necessary before definitive statements on the molecular
events involved can be made.
There is evidence that in addition to clonal deletion there is a
mechanism of thymic tolerance induction leading to a functional non-
responsiveness, this is termed clonal anergy. Chimeric and transgenic
experiments have shown that in animals where specific T cell clones are not
deleted there is nevertheless a reduction in responsiveness of these cells
(Ramsdell et al.1990). In vitro work by Schwartz and colleagues has
characterised the critical change in anergic T cells as a dramatic reduction in
the ability of the T cell to produce IL2 on subsequent antigen stimulation
(Schwartz, 1990).
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It has been proposed that the intrathymic induction of clonal anergy
may be the result of the interaction of the TCR on immature thymocytes with
self MHC in the absence of a co-stimulatory signal. Presentation of antigen
would occur on the thymic epithelium which is unable to provide a "second
signal". Alternatively the affinity of the TCR-MHC interaction may determine
the type of thymus induced unresponsiveness (Sprent et al. 1990). The
experimental data to support these theories is at present not available.
1.4 Extrathvmic tolerance
1.4.1 Peripheral T lymphocytes
Evidence also exists that mature T lymphocytes can be tolerised. Using
a transgenic mouse model which expresses a class II molecule on
pancreatic beta cells Lo and co-workers (Lo et al.1988) demonstrated that T
lymphocytes were tolerant to this molecule although it was not expressed on
thymic or peripheral lymph tissue. In this model there was no immune-
mediated attack on the pancreatic beta cells although interestingly the
animals did develop diabetes suggesting that an alternative mechanism
may act to produce this presumed "autoimmune" phenomenon. Subsequent
work has investigated the possible mechanisms of peripherally induced
tolerance.
It has been shown that peripheral T cells can be subject to deletion
(Rocha et al. 1991) and that this deletional process is a consequence of
antigen binding to the TCR and occurs as a gradual process in contrast to
thymic tolerance where deletion is relatively sudden (Rocha et al. 1991). In
addition to deletion experimental evidence suggests that peripheral T cells
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can be rendered non-responsive or anergic. In the model used by Lo et al
(Lo et al.1988) T cells, although not deleted, were rendered unresponsive to
class II antigen. In the transgenic experiments of Morahan et al (Morahan et
al.1989) peripheral T cells were found to be unresponsive to upregulated
MHC class I in vivo although these cells could produce in vitro cytotoxic
responses to this antigen suggesting that the unresponsiveness is not due to
deletion or permanent clonal anergy. In contrast to this finding Burkly et al
(Burkly et al.1989) used a transgenic mouse model with Vpi7a TCR T cells
responsive to l-E to demonstrate that clonal anergy could be induced in
peripheral T cells (without clonal deletion).
Investigation of the molecular basis for peripheral tolerance has
suggested that receptor downregulation on T cells may be of importance.
Rocha and von Boehmer (Rocha et al. 1991) demonstrated that the
progressive peripheral tolerance found in their transgenic mouse model
correlated with downregulation of the a(3 TCR and CD8 in T cells. Using a
different transgenic model Schonrich et al (Schonrich et al. 1991) were able
to demonstrate a similar result with regard to downregulation of the TCR and
CD8. These results are also of importance since they demonstrate that the
loss of T cell surface markers is not always correlated with physical deletion
of the cell.
1.4.2 B lymphocyte tolerance
It has been demonstrated that B lymphocytes may also be tolerised and
that B cell tolerance is not solely due to the absence of autoreactive T cell
help (although this may play a significant role) (Goodnow et al.1990).
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Studies have shown that tolerance induction occurs in B cells by processes
which differ from those inducing T cell tolerance. In vivo experimental work
carried out in transgenic mice (Goodnow, 1992) has demonstrated that B
cell tolerance may result from both clonal deletion and clonal anergy. It has
been proposed that these two tolerising mechanisms may be related to the
biphasic nature of B cell development. This consists of an initial phase of
immunoglobulin gene recombination in the bone marrow and liver and a
later somatic hypermutation producing selective expansion of individual B
cell clones and high affinity antibodies. The second phase of B cell
maturation necessitates effective peripheral tolerising controls (Goodnow et
al.1990). Various factors are thought to play a role in the production of B cell
tolerance including the stage of B cell development on encountering
antigen, receptor affinty and downregulation and the absence of
costimulatory signals although the exact nature of these mechanisms
remains to be elucidated.
1.4.3. Tolerance breakdown
The establishment and maintenance of immune tolerance therefore
appears to be mediated by several thymic and extrathymic mechanisms
based on the processes of clonal deletion and clonal anergy. These
mechanisms could act in series to protect an individual from the
consequences of an autoaggressive response. Breakdown of self tolerance
and subsequent autoimmune disease would therefore require a number of
pathological events occuring together or in an ordered sequence. It has
been demonstrated that autoreactive T and B lymphocytes are present in
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healthy individuals who do not have autoimmune disease (Guilbert et
al.1982; Cohen et al.1977). A series of tolerising mechanisms would allow
such self reactive lymphocytes to exist without the development of overt
autoimmune pathology.
The term autoimmune disease is applied to those situations where the
immune system contributes to the pathogenesis of the disease. The events
causing tolerance breakdown are central to the pathogenesis of
autoimmunity. A critical step in this process is the interaction of the T
lymphocyte receptor with antigen in relation to the costimulatory signals
applied to the T cell.
1.5 Costimulation of T lymphocytes
1.5.1 Antigen presentation
Class I MHC antigens (encoded by the HLA-A, HLA-B and HLA-C
regions) are normally expressed on all nucleated cells. The expression of
MHC class II antigens (encoded by the HLA-D locus) is restricted to cells
such as macrophages, B lymphocytes and dendritic cells which function as
antigen presenting cells (APC).The restricted number of cell types
expressing class II antigens serves to limit the situations in which antigen is
presented to CD4 positive T cells. Antigen presentation normally involves
ingestion of antigen by a professional APC, such as a macrophage,
degradation of the antigen by lysosymal enzymes and re-expression on the
APC surface (Unanue et al.1984). Alternative, non-lysosomal dependent
mechanisms of intracellular proteolysis and antigen presentation have also
been documented (Mills, 1986) and these may be sufficient to promote
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protein antigen presentation to class II restricted T cells. APCs
simultaneously secrete cytokines such as IL1 which activate T lymphocytes.
Cells which do not normally present antigen can be induced to express
class II MHC antigens by exposure to interferon y. However this class II
expression does not by itself produce the ability to effectively present
antigen to T lymphocytes as shown by the experiments of Geppert and
Lipsky (Morahan et al.1989) which additionally demonstrated that class II
positive endothelial cells and fibroblasts had different abilities to present
antigen to T cells despite comparible levels of class II expression. These and
similar findings have led to investigations on the role of costimulatory signals
in the process of antigen presentation to T cells.
1.5.2. Costimulatorv signals
Experiments carried out on transgenic mice have demonstrated that
potentially reactive T lymphocytes may remain unresponsive despite the
presence of specfic peripheral tissue antigens (Schonrich et al. 1991) and
that this tolerance can be overcome by viral infection of the appropriate
tissue (Oshashi et al. 1991; Oldstone et al. 1991). It has been proposed that
the tolerance seen in these model systems is due to the presence or
absence of costimulatory signals. A discovery of fundamental importance
has been that the interaction of antigen with TCR in the absence of a
costimulatory signal is not a neutral event and can lead to T cell anergy
(Schwartz, 1990). Gaspari and coworkers used an in vitro system to
demonstrate that class II positive keratinocytes induced in T cells a state of
unresponsiveness to subsequent stimulation with specific antigen (Gaspari
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et al.1988). The in vivo relevance of such findings remains uncertain at
present, however, it is possible that antigen presentation by non¬
professional APCs leading to tolerance could be a mechanism of
maintaining self-nonself discrimination in the periphery and limiting
autoaggressive responses.
The molecular mechanisms by which costimulatory signals determine
the outcome of TCR-antigen interaction have not yet been fully elucidated.
Schwartz has defined three possible systems (Schwartz, 1990): a) a direct
interaction of the costimulatory signal receptor with the antigen specfic TOR
and subsequent enhancement of signal transduction; b) an interaction with
molecules which increase the avidity of the TCR-antigen binding; and c) the
costimulatory signal-receptor interaction initiates its own second messenger
cascade which synergises with the antigen-TCR signals distally or at the
level of gene activation. The nature of the costimulatory signals themselves
may involve cell to cell contact or soluble messengers and is also yet to be
defined. The possible candidates for costimulatory function have recently
been reviewed by Liu and Linsley (Liu et al.1992): a) The CD28 molecule on
T cells has been shown to interact with the B7/BB1 molecule on antigen
presenting cells to produce co-stimulation by a signal transduction pathway
that is completely independent of early events in antigen specific receptor
signaling (Schwartz, 1992). Furthermore, it has been demonstrated that
CD28 induced signaling blocks the development of anergy in T cells
(Harding et al.1992). The T cell activation molecule CTLA-4 also interacts
with B7/BB1 on APCs to produce co-stimulation and experiments using
soluble CTLA-4 receptor suggest that blocking this interaction may provide
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therapeutic immunosuppression (Schwartz, 1992). b) The interactions of the
adhesion molecules LFA3 with CD2, ICAM1/2 with LFA1 and VLA4 with
VCAM1 also have the potential to play a costimulatory role. Liu and Linsley
also argue that costimulation and T cell activation are linked since differing
APCs preferentially stimulate Th1 or Th2 cells.
The further investigation of the nature and role of T cell costimulatory
signals is of importance not only to the elucidation of the processes of
peripheral T cell tolerance but are also potential sites of immune intervention
since the ligands/receptors involved in costimulation are likely to be less
polymorphic than MHC or TCR.
1.6 Autoimmune disease
Aspects of human autoimmune disease give valuable clues to the
pathogenic mechanisms involved in tolerance breakdown (Sinha et
al.1990). Certain clinical conditions thought to be autoimmune in nature
have MHC class II associations. These conditions may be either organ
specific such as insulin dependent diabetes mellitus (IDDM) and Graves'
disease or non organ specific as with systemic lupus erythematosa (SLE).
Other presumed autoimmune conditions such as ankylosing spondylitis and
psoriasis are associated with specific MHC class I antigens. Although a
genetic association may predispose an individual to an autoimmune
condition the aetiology is multifactorial since studies of monozygotic twins
reveal a substantial discordance (concordance is less than 5% for multiple
sclerosis and approximately 30% for IDDM). These findings imply that
environmental factors also play a role in disease development and many
34
autoimmune diseases are known to be associated with preceding infection
(Bottazzo et al.1986; Rose et al.1988). Human autoimmune conditions tend
to run a chronic course with spontaneous exacerbations and remissions
implying a balance between positive and negative regulatory factors.
1.6.1 Autoantibodies
In many organ specific and non-organ specific autoimmune conditions
circulating autoantibodies have been demonstrated (Bottazzo et al.1986).
Such autoantibodies may interact with cell receptors to produce stimulatory
effects, for example thyroid stimulating immunoglobulin in Graves'
hyperthyroidism, or to block receptor action such as the anti-acetylcholine
receptor antibody in myasthenia gravis. In SLE autoantibodies are
generated to several nuclear components and the deposition of immune
complexes is thought to play a role in the immunopathology of the condition.
However, since B cell responses need T cell help, and there is evidence that
T cells are central to the disease processes seen in autoimmunity, it would
appear that the humoral immune response may be secondary to cellular
mechanisms. Autoantibodies may nevertheless provide useful markers for
disease development and progression in human autoimmune conditions
(Sinha et al.1990).
1.6.2. Autoreactive T lymphocytes
Studies carried out on organ-specific and non organ-specific
autoimmune disease have defined the involvement of T lymphocytes in the
disease processes. Autoimmune thyroid disease includes both Graves'
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disease and Hashimoto's thyroiditis which has a more destructive course.
Surgical specimens of thyroid from Graves' disease patients have an
infiltrate of T lymphocytes either scattered throughout the gland or
concentrated in small or large foci (Hanafusa et al.1983). These cells were
not found to be distributed in relation to the MHC class II positive thyroid
follicular cells. In vitro work has shown that MHC class II positive thyroid
follicular cells from patients with Graves' disease are capable of presenting
influenza virus peptide antigen to cloned human T cells although they could
not present whole virus implying that they are incapable of processing
complex antigens (Londei et al.1984). This would suggest that aberrant
expression of MHC class II antigen by thyroid follicular cells can have a
functional role in antigen presentation to infiltrating CD4 positive T
lymphocytes.
Cloned T cells from Graves' disease surgical specimens are
predominantly of the CD4 phenotype and have been shown to be capable of
specifically recognizing autologous thyroid cells (Londei et al.1985). In
contrast cloned T cells from Hashimoto's thyroiditis glands are mostly of the
CD8 phenotype and have increased in vitro cytotoxicity in comparison to
cloned T cells from Graves' disease thyroids (Feldmann et al.1989) implying
a difference in the composition of the T cell infiltrate in these two types of
autoimmune thyroid disease. This is in keeping with the more destructive
disease process seen in Hashimoto's thyroiditis.
Autoimmune liver disease may take several forms. In primary biliary
cirrhosis there is a destructive process involving the intrahepatic bileducts. In
liver biopsy specimens from primary biliary cirrhosis patients infiltration of
36
predominantly CD4 positive T lymphocytes has been demonstrated in the
areas of tissue destruction surrounding bileducts which show aberrant
expression of MHC class II antigens (Ballardini et al.1984). T cell clones
have been generated from patients with another form of autoimmune liver
disease, chronic active hepatitis (Wen et al.1990). These T cell clones were
found to be predominantly CD4 positive and reacted specifically against
liver-membrane antigen implying a role for these cells in the destructive
immunopathology.
In insulin dependent diabetes mellitus there is an autoimmune attack
on the p cells of the pancreatic islets. These cells aberrantly express MHC
class II antigens and in the acute stage of the disease there is a T
lymphocyte infiltrate (predominantly CD8 positive) in the area of tissue
destruction (Bottazzo et al.1985). The T cells were found to be HLA DR and
IL2 receptor positive.
Moore et al (Moore et al.1988) examined the phenotype of lymphocytes
present in the active tissue lesions of rheumatoid arthritis and Crohn's
disease, two diseases thought to have an autoimmune aetiology. In both
diseases they found a predominance of CD4 positive T lymphocytes (with a
CD4:CD8 ratio of 2.4 in the samples from the rheumatoid synovium).
The studies outlined above demonstrate that T lymphocytes, in most
cases of the CD4 positive subset, are the predominant cell at the sites of
autoimmune pathology. T cells may also be involved in tissue damage
through lymphokine release. This effect may be direct or indirect. Release of
IFNy, TNF or lymphotoxin could produce direct tissue damage (Tite et
al.1985; Tite, 1990b). Activation of other cells such as macrophages, which
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are also found at the sites of autoimmune tissue pathology, by T cell
lymphokines such as IFNy, could indirectly contribute to local autoimmune
pathology.
1.7 Mechanisms of tolerance breakdown
1.7.1 T cell receptor - antigen - MHC interaction
Tolerance breakdown and subsequent autoimmune disease appears to
be the result of several events in predisposed individuals although the exact
mechanism involved is not known for any condition (Sinha et al.1990). The
interaction of the T cell receptor with antigen and MHC is again central to
this process. The target antigens involved are mostly not yet identified in
human disease (and animal models) and it is possible that the antigens
responsible for initiation of a condition may be different for those involved in
perpetuation and effector mechanisms. Where target antigens are
sequestered (not subject to the normal immune system surveillance) they
must first be exposed to the immune system in a context where they are
recognised and can subsequently be immunogenic. This effectively means
presentation to a T cell by a suitable antigen presenting cell. It has been
demonstrated that there is aberrant expression of MHC class II by tissue
resident cells at the sites of autoimmune tissue pathology. For example in
autoimmune thyroiditis class II expression has been demonstrated on
thyrocytes (Hanafusa et al.1983) and in primary biliary cirrhosis aberrant
class II expression has been shown on bile duct epithelium (Ballardini et
al.1984). It has been proposed that such aberrant expression of class II
could lead to auto-antigen presentation to T cells (Bottazzo et al.1983) and
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in vitro it has been shown that thyrocytes can present antigen to T cells but
that they cannot process complex antigens (Bottazzo et al.1986). However
there is no evidence that such antigen presentation takes place in vivo and it
is equally possible that presentation by tissue resident cells (in the absence
of costimulation) maintains peripheral tolerance as discussed above
(Schwartz, 1990).
Self reactive T cells are a prerequisite for an autoimmune response, but
as already discussed these can exist in normal individuals without overt
autoimmune disease (Guilbert et al.1982; Cohen et al.1977) and hence are
not sufficient by themselves to produce autoimmunity. Recent work has
focussed on the TCR involved in autoimmunity. In multiple sclerosis (MS)
there appears to be restricted usage of TCRs by the T cells involved in the
central nervous system pathology seen in the disease although it is still
unclear as to whether this is true also of peripheral T cells (Hafler et al.1988;
Cooke, 1991; Wucherpfennig et al.1990). In experimental autoimmune
encephalomyelitis (EAE), an experimental model of MS induced by
immunisation with myelin basic protein (MBP), encephalitogenic T cell
clones specific for residues 1-11 of MBP show extensive TCR homology
(both a and p chains) although the T cell clones specific for residues 89-
100/101 show extensive V|3 TCR diversity (Sinha et al.1990). It therefore
remains uncertain whether there is restriction of TCR gene expression in
autoimmune disease since the picture is likely to be complicated by non¬
specific recruitment of T cells to sites of autoimmune pathology and changes
in the profile of target antigens involved which may occur with progression of
the disease process. If restricted TCR usage is demonstrated in human
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autoimmune disease blocking a specific TCR has the potential to provide a
valuable form of treatment.
Studies of human autoimmunity have demonstrated MHC associations.
The MHC susceptiblity allelles are considered to be those which are
capable of binding and presenting self (or cross-reactive foreign) antigens
and selecting anti-self T cells. In addition there appears to be non-MHC
genetic associations althought the nature of these at present remains
uncertain.
The local presence of lymphokines or other costimulatory signals at the
sites of autoimmune pathology is necessary for T cell activation (Schonrich
et al. 1991; Oshashi et al. 1991). It therefore appears that the presence of
costimulatory signals is a prerequisite for an autoimmune response since
antigen presentation in their absence would lead to tolerance (Schwartz,
1990).
1.7.2. Exogenous stimuli
The initiating event which triggers the processes described above is
likely to be some form of environmental insult. Tissue damage following a
bacterial or viral infection could allow for the release of sequestered
antigens from immunologically priveleged sites and a concomitant non¬
specific inflammatory response would generate the costimulatory signals
necessary for MHC class II expression and effective antigen presentation.
There is also evidence that cross-reaction with certain foreign antigens may
lead to anti-self responses.
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1.7.3. Molecular mimicry
Many exogenous microbial pathogens share common antigenic sites
with self components and this phenomenon has been termed molecular
mimicry (Oldstone, 1987). Experiments have suggested that molecular
mimicry may play a role in the initiation of autoimmune disease. A sequence
homology between myelin basic protein and hepatitis B virus polymerase
(HBVP) has been documented and it was subsequently found that
immunisation with a HBVP peptide could produce humoral and cellular
immune responses and tissue pathology similar to immunisation with MBP
(Fujinami et al.1985). These findings led to the hypothesis that an immune
cross-reaction of a microbial protein with a self component could initiate an
autoimmune response. According to this theory the pathogen may no longer
be present when the autoimmune pathology becomes manifest as ongoing
tissue destruction will generate further autoantigen release and continuing
immune-mediated inflammation. In addition the initial insult may be remote
from the site of autoimmune attack as seen in rheumatic heart disease
where a streptococcal skin or nasopharyngeal infection is though to trigger
the autoimmune response.The theory of molecular mimicry has been
supported by the finding of potentially cross-reactive self components to
epidemiologically associated pathogens in coeliac disease and ankylosing
spondylitis (Oldstone, 1987), diseases which are thought to be of
autoimmune aetiology.
Autoimmune disease appears therefore to develop in genetically
predisposed individuals as a consequence of an environmental agent
causing an event which leads to tissue damage and non-specific
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inflammation or molecular mimicry or both. The sum of these genetic and
environmental factors must be sufficient to override the mechanisms of self
tolerance. In relation to inflammatory eye disease studies of the clinical
features of these conditions provide background information important to the
understanding of the immunopathology involved.
1.8. Intraocular inflammatory disease
As discussed in section 1.2 the term intraocular inflammatory disease
covers a range of conditions. The inflammatory processes may be confined
to the eye or be part of a systemic inflammatory disorder. Clinical studies of
these conditions have attempted to define the immunopathological
processes on the basis of the systemic manifestations of the conditions.
1.8.1. Humoral immune responses
Initial clinical studies of immune mechanisms focussed on the humoral
immune response. Studies on peripheral blood of Behcet's disease patients
with intraocular inflammation showed circulating immune complexes and
alterations in serum complement component levels in some patients
(Williams et al.1977; Kasp et al.1986). Immune complexes were also found
in retinal vasculitis (Dumonde et al.1985; Dumonde et al.1982). High levels
of circulating antibodies to Herpes Simplex virus have also been
documented in Behcet's disease (Hamzaoui et al. 1990a). Humoral immune
responses to retinal S antigen have also been investigated in uveitis
patients. Although some studies have shown an increase in circulating anti
S antigen antibody in clinical uveitis (Gregerson et al. 1981), subsequent
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longitudinal studies, in which healthy controls were shown to have similar
levels of circulating anti S antigen antibody to uveitis patients, have failed to
support this (Abrahams et al. 1983; Doekes et al.1987; Froebel et al. 1989;
Forrester et al.1989; Chan et al. 1985b).A study of Vogt-Koyanagi-Harada
(VKH) syndrome, Behcet's disease and sympathetic ophthalmia (Chan et
al. 1985b) has suggested that there are circulating antibodies to
photoreceptor outer segments and Muller cells in these conditions although
only small numbers of patients were investigated. In diabetic patients a
significant increase in anti S antigen antibodies was documented after
panretinal photocoagulation (Gregerson et al.1982), suggesting that retinal
tissue damage may produce these antibodies as an epiphenomenon. Taken
together the variability of these studies of peripheral humoral immune
responses in uveitis patients and the similarities found in control data have
implied that humoral immunity may play a secondary role in the disease
processes and have led to investigations on the nature of cellular immune
responses in uveitis.
1.8.2. Cellular immune responses
Lymphocyte subpopulations in peripheral blood samples of patients
with intraocular inflammation have been analysed in an attempt to elucidate
alterations in immune function. Alterations in the CD4:CD8 T lymphocyte
ratio have been described in active posterior uveitis (Nussenblatt et
al. 1983b) although some reports have failed to find this change (Deschenes
et al.1986). In Behcet's disease a decrease in CD8 T cell function together
with altered CD4:CD8 ratios has been documented in the preactive phase of
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the disease (Sakane et al.1982).
Results of studies of T cell activation markers in uveitis patients have
been easier to interpret (Deschenes et al.1988). Overall there is an increase
in T cells bearing the Interleukin 2 receptor (IL2R) compared to healthy
controls, the percentage of IL2R positive T cells (in peripheral blood and
intraocular fluids) correlates with disease activity and IL2R expression
correlates with HLA DR antigen expression. Exclusion of uveitis associated
with systemic disease did not affect these findings. It has also been
demonstrated that there is an increased frequency of peripheral blood
lymphocytes capable of producing IL2 in response to S antigen in uveitis
patients (Opremcak et al. 1991). These results suggest that there is a T cell
mediated systemic immune response in ocular inflammatory disease without
overt systemic involvement.
Cellular immune responsiveness to retinal S antigen has been
documented in some peripheral blood studies on uveitis patients
(Nussenblatt et al.1980; Nussenblatt et al.1982; Doekes et al.1987) although
other investigations have failed to confirm this (Froebel et al.1989) or have
given equivocal results (de Smet et al.1990). The recent detailed study of
DeSmet and coworkers analysed cellular proliferation in response to S
antigen, IRBP and peptide fragments of these proteins in patients with a
variety of intraocular inflammatory conditions. In general the proliferative
responses were at very low levels and reached statistical significance in
only three subgroups (P<0.05 in Behcets disease, pars planitis and birdshot
chorioretinopathy) each of which contained patients with no proliferative
response at all. T cell responses in peripheral blood of uveitis patients are
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therefore by no means consistent. Responsiveness to interphotoreceptor
retinoid binding protein (IRBP) and uveitogenic fragments of these antigens
appears to parallel S antigen (Hirose et al. 1988; de Smet et al. 1990). An
increased lymphocyte proliferative response to S antigen (and its
uveitogenic peptide fragments) has been found in diabetic patients following
panretinal photocoagulation suggesting that chorioretinal tissue trauma may
stimulate a cellular immune response without the development of an
ongoing intraocular inflammatory process (Vrabec et al.1990). The
significance of the decreased T cell proliferation (Young et al.1988) and
increased cytotoxicity (Hamzaoui et al. 1990b) to Herpes Simplex virus
which have been documented in Behcet's disease remains uncertain.
Results of these studies on cell -mediated immunity in intraocular
inflammatory disease imply that the current tests of immune function carried
out on peripheral blood lack the sensitivity and specificity necessary to
dissect and analyse localised immune-mediated pathology in the eye.
1.8.3. Genetic background of uveitis patients
Investigation of the genetic makeup of patients with ocular inflammatory
disease have also been carried out. Studies of patients with birdshot
chorioretinopathy have revealed a strong association between this disease
and the HLA A29 antigen (Nussenblatt et al.1982; Priem et al.1988).
Nussenblatt and coworkers found HLA A29 to be present in 80% of birdshot
chorioretinopathy patients compared to 7.4% of controls, Priem and
Oosterhuis found a prevalence of 95.8% in patients compared to 7.2% of
controls. These results give a relative risk of developing the disease of 49.9
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and 224.4 for individuals with the HLA A29 antigen and this association is
amongst the highest of any disease entity.
Sympathetic ophthalmia has been found to be associated with the HLA
A11 antigen (Reynard et al. 1983). Behcets disease is associated with HLA
B5 (in particular the HLA BW 51 split antigen which shows a relative disease
risk of 6.1) and VKH syndrome is associated with HLA BW54, DWa, DR4 and
MT3 (which has a relative disease risk of 74.5) although these associations
only apply to Japanese patients with VKH syndrome (Ohno, 1981).
Investigation of the systemic manifestations of immune responses in
intraocular inflammatory disease indicates that T cell mediated immune
mechanisms play a role in the pathogenesis of these conditions. The
favourable clinical response of many cases to the T cell specific
immunosuppressive agent cyclosporin (Nussenblatt et al. 1983a;
Nussenblatt et al.1985; Graham et al. 1985; de Vries et al.1990; Masuda et
al.1989) supports this view. Present methods of investigating systemic
immune mechanisms are not, however, sensitive enough to be of use in
diagnosis and treatment of intraocular inflammation or to give us useful
information on the pathogenesis of the ocular disease. Studies of the local
immunopathology are necessary to define the detailed disease
mechanisms.
1.9 Immunopatholoqy of intraocular inflammation
The development of increasingly accurate and specific peripheral
blood tests in the future will depend on a greater understanding of the local
immunopathology of intraocular inflammatory disease. Investigation of active
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clinical disease is at present possible using the technique of chorioretinal
biopsy (Peyman et al. 1981). This technique is invasive and has potential
severe complications (Peyman et al.1986; Peyman et al.1987). Careful
patient selection is therefore critical for this procedure (Foulds et al.1985;
Chan et al. 1991). This is illustrated by the report of two cases of
inflammatory eye disease investigated by chorioretinal biopsy where the
findings of the immunopathologic studies of the tissue obtained directed the
therapeutic approach (Chan et al. 1991). An obvious application of the
technique is in the differentiation of immune-mediated inflammatory eye
disease, neoplastic disease and intraocular infection.
Pathological and immunopathological studies have been carried out on
eyes from patients suffering from various forms of intraocular inflammatory
disease. These studies must be interpreted with the caveat that in general
they represent eyes that have been enucleated following prolonged
intraocular inflammation often complicated by conditions such as
neovascular glaucoma which will produce further pathological changes.
Such eyes have also usually been subject to extensive local and systemic
medication. Although the findings of such investigations may represent end-
stage pathology which may differ from the pathology of active disease, they
nevertheless provide information on the immunopathology in these
conditions. Previous studies have characterised the local immunopathology
in four forms of intraocular inflammatory disease: sympathetic ophthalmitis,
pars planitis, VKH syndrome and sarcoidosis.
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1.9.1. Sympathetic ophthalmitis
Studies of eyes enucleated because of sympathetic ophthalmitis
(Green, 1986a; Lubin et al.1980) have demonstrated a marked
granulomatous inflammation primarily affecting the uveal tract. The choroid
is infiltrated by lymphocytes, macrophages, epithelioid cells and giant cells
in both the inciting and the sympathizing eyes. Dalen-Fuchs nodules are
seen to be at the level of the RPE and are composed mainly of epithelioid
cells. Immunohistochemical analysis of sympathetic ophthalmitis eyes
(Jakobiec et al.1983; Chan et al. 1986c) has shown that the choroidal
infiltrate consists mainly of T lymphocytes which are predominantly of the
CD4 phenotype although the relative number of CD8 positive T cells tends
to increase as the disease progresses. 60-90% of these T cells are IL2
receptor positive (although in one described patient who was on heavy
immunosuppression including cyclosporin A only 1% of T cells were IL2R
positive). B lymphocytes are generally less than 20% of cells in the choroidal
infiltrate. Choroidal granulomas consist predominantly of MHC class II
positive cells of monocyte/macrophage lineage. Dalen-Fuchs nodules are
composed mainly of MHC class II positive monocyte/ macrophage derived
cells along with T lymphocytes, depigmented RPE cells and very few B
lymphocytes.
1.9.2. Pars olanitis
Pathological studies of pars planitis (Green et al. 1981) have shown that
the exudative "snowbank" covering the pars plana and anterior retina is
composed of condensed vitreous, hyperplastic non-pigmented ciliary body
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epithelium and fibrous astrocytes in end-stage enucleation specimens.
Retinal neovascularisation has been demonstrated extending into this
tissue. Vitreous aspirates obtained during active disease are composed of
lymphocytes, plasma cells, macrophages, fibroblasts, epithelioid cells and
giant cells (Green et al. 1981). Immunohistochemical analysis of an eye with
pars planitis (Wetzig et al.1988) showed the inflammatory infiltrate in the
snowbank consisted mainly of T lymphocytes in a CD4:CD8 ratio of 10:1
(although the patient had normal peripheral blood T cell populations). T cells
were also prominent in retinal vasculitic infiltrates. B lymphocytes were
found in the iris and ciliary body infiltrates. Most of the inflammatory cells
were HLA DR positive however very few of the T cells were IL2R positive.
Within the snowbank most cells were GFAP (glial fibrillary acid protein)
positive, stained positively with an anti- Muller cell monoclonal antibody and
were HLA DR positive. In vitro it has been shown that Muller cells proliferate
in response to lymphocyte derived products (Roberge et al.1985) and can
present antigen to T lymphocytes (Roberge et al.1988) when stimulated
(although only after non-physiological modification by trypsinisation and
glutaraldehyde fixation). Other in vitro studies have shown that Muller cells
inhibit T lymphocyte proliferation to antigen presentation by conventional
antigen presenting cells and T cell clonal expansion to IL2 as well as
reducing IL2 production and IL2R expression (Caspi et al.1987). It is
therefore possible that in response to the intraocular inflammation Muller
cells play an active role in the ongoing immunopathology in pars planitis
although whether this role is in upregulation or downregulation of the
immune response is at present uncertain. The degree of glial response seen
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in pars planitis is not seen in other forms of intraocular inflammation.
1.9.3. VKH syndrome
In VKH syndrome, histopathological examination of enucleated eyes
has shown a panuveitis which may be granulomatous or non¬
granulomatous (Perry et al.1977). Infiltrating lymphocytes and plasma cells,
and proliferating RPE cells were noted in these eyes. Immunohistochemical
study of an eye from a patient with long-standing disease (Chan et al. 1988b)
showed a T lymphocyte infiltrate in the uvea but in contrast to other forms of
intraocular inflammation which have been studied, foci of B lymphocytes
were also found. Together with the finding of plasma cells within ocular
tissue in VKH (Perry et al.1977) this would suggest that the role of humoral
immunity may be greater in the intraocular immunopathology in VKH
syndrome than in other forms of inflammatory eye disease.
1.9.4. Sarcoidosis
The characteristic tissue pathology in sarcoidosis is a non-caseating
granuloma (Daniele et al.1980) which has macrophages, epithelioid cells
and giant cells centrally, surrounded by a ring of T and B lymphocytes.
Examination of an eye enucleated because of ocular inflammation
secondary to sarcoidosis revealed widespread granulomatous tissue
consisting of lymphocytes, epithelioid cells and multinucleate giant cells
(Chan et al.1987). Immunohistochemistry showed the lymphocytes were
mainly CD4 positive T cells (with a CD4:CD8 ratio of 10:1) many of which
stained positively for IL2 receptors and interferon y. Numerous cells positive
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for macrophage markers were also present and many cells were found to be
positive for MHC class II antigens. This is similar to the findings in other
tissue foci in sarcoidosis and it is notable that, in contrast to this, the number
of T cells and the proportion of CD4 positive cells declines in peripheral
blood in active disease (Daniele et al.1980) suggesting that there is
recruitment of these cells to the tissues.
1.9.5. MHC expression
Expression of the MHC class II antigen HLA DR has been noted on
various cells in eyes with intraocular inflammation. T and B lymphocytes and
cells of monocyte/ macrophage lineage have been shown to be class II
positive in many types of intraocular inflammation (Jakobiec et al. 1983;
Chan et al. 1986c; Chan et al.1987; Kim et al. 1987; Wetzig et al. 1988; Hooks
et al.1986). Organ resident cells have also been demonstrated to be class II
positive in enucleated eyes. RPE cells (Chan et al.1986a; Chan et al.1987;
Kim et al.1987; Hooks et al.1986), ciliary body epithelium (Chan et al.1987),
retinal vascular endothelium (RVE) (Chan et al.1987; Kim et al.1987), Muller
cells (Kim et al.1987; Wetzig et al.1988), fibroblasts (Kim et al.1987),
keratocytes and corneal epithelial cells (Chan et al.1987) have all been
shown to express class II in immunohistochemical studies of ocular
inflammatory disease. RPE cells have also been shown to express class II
antigens in retinitis pigmentosa, a group of genetically determined
degenerative retinal conditions (Detrick et al.1986).
The lymphokines interferon-y and IL2 have been demonstrated
immunohistochemically to be present in enucleated eyes with intraocular
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inflammation (Hooks et al.1986). These were found to be present on
infiltrating cells in the choroid and retina related to HLA DR positive
infiltrating cells and RPE. In vitro studies have shown that human RPE cells
can express class II antigens in response to stimulation by interferon-y
(Liversidge et al. 1988a). This combined evidence would suggest that
lymphokines, and interferon-y in particular, are responsible for the in vivo
class II expression seen in various organ resident cells in human intraocular
inflammation.
1.9.6. Adhesion molecules
The posterior segment of the eye does not contain lymphatics and
therefore lymphocytic interactions with retinal antigens must occur at the
blood-retinal barrier. The cells constituting this are the RPE (and the
adjacent Bruchs' membrane) and the RVE (retinal vascular endothelium).
Adhesion molecules are considered to play an important role in T
lymphocyte interactions in immune recognition. The role of the LFA-1/ICAM-
1 and LFA-3/CD2 adhesion pathways at the blood-retinal barrier has been
investigated in vitro (Liversidge et al.1990). Results indicate that the RPE-T
cell interaction is LFA-1/ICAM-1 dependent in the absence of lymphokine
pretreatment and that the RVE-T cell interaction has both LFA-1/ICAM-1 and
LFA-3/CD2 dependent systems.
The studies of local immunopathology in intraocular inflammation
outlined above demonstrate that cell-mediated immunity is central to the
pathogenesis of these conditions. CD4 positive T lymphocytes are
consistently found in high numbers within the eyes implying that they play a
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major role in the tissue pathology. These studies, however, cannot address
questions on the aetiology and the precise pathogenic mechanisms of
intraocular inflammatory disease and animal models of uveitis have been
employed to investigate further these disease processes.
1.10 Animal models of intraocular inflammation
It was originally thought that the immunogenic autoantigen in ocular
inflammatory disease was related to uveal pigment, and attempts by Woods
to demonstrate immune responses to uveal pigment in patients with
sympathetic ophthalmitis (Woods et al.1933) showed a positive cell
mediated response to intracutaneous injection of crude bovine uveal tissue.
Collins then produced ocular inflammation in an animal model (guinea pig)
by systemic injection of heterologous and homologous uveal preparations in
adjuvant (Collins, 1949). Autoantigenicity was subsequently discovered in
the retina (Wacker et al.1965) and this led to the present experimental
models of immune-mediated intraocular inflammatory disease.
1.10.1. Experimental autoimmune uveoretinitis
Experimental autoimmune uveoretinitis (EAU) has been induced in
rabbit, rat, mouse and primate models using several ocular antigens. A
range of tissue responses is seen in these models which can be altered by
varying the method of immunisation and the species of animal.
Retina was first used as an inducing antigen by Wacker and Lipton
(Wacker et al.1965), this preparation was then separated by
ultracentrifugation into soluble (S) and particulate (P) fractions, with the
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subsequent finding that only the S fraction produced uveitis (Wacker et
al. 1971). Wacker and Donoso extracted and purified "S antigen" from this
fraction and found that it was potentially uveitogenic in partially purified and
purified forms (Wacker et al.1977). S antigen has been characterised as an
intracellular 48 kDa protein which regulates phosphodiesterase activity in
light signal transduction (Pfister et al.1985) and has been localised to rod
outer segments (Rodrigues et al.1987). S antigen is a phylogenetically
conserved molecule which is highly uveitogenic in most species (Faure,
1980; Gery et al. 1986), and is also located in the pineal gland.
Analysis of the structure of the S antigen protein has been carried out
using a combination of enzymatic cleavage, fragment analysis and amino
acid sequencing (Donoso et al.1990). Synthetic peptides have been
constructed to investigate the properties of various domains of the protein.
From these experiments uveitopathogenic sites, T lymphocyte proliferation
sites and adoptive transfer sites have been identified within the protein
(Gregerson et al. 1989). Comparison of these amino acid sequences with
those of other bacterial, viral and fungal proteins from a protein database
showed sequence homology with a yeast histone peptide (Singh et al.1989)
and three viral proteins (Singh et al.1990) which have subsequently proven
to be uveitogenic, and to produce proliferative responses in S antigen
specific T lymphocytes. These findings imply that viral or fungal infection
could sensitize T cells to cross-react with S antigen because of the
molecular mimicry between the proteins and thus initiate an autoimmune
response.
Interphotoreceptor retinoid binding protein (IRBP) is a 140 kDa
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extracellular glycoprotein which functions in Vitamin A transport between
RPE and photoreceptors (Lai et al.1982). IRBP has also been found in the
pineal (Rodrigues et al. 1986). IRBP has induced EAU in rats (Fox et
al. 1987), rabbits (Eisenfeld et al.1987), and primates (Hirose et al.1986) but
is poorly uveitogenic in guinea pigs (Vistica et al.1987). In mice, which are
often refractory to EAU, IRBP has been found to be a more potent uveitogen
than S antigen (Caspi et al. 1988b). The immunopathology produced by
IRBP is similar to that produced by S antigen (Gery et al.1986; Fox et
al.1987). The IRBP molecule has been analysed using a similar approach to
that used for S antigen. From this analysis uveitogenic peptides have been
isolated (Redmond et al.1988).
Other antigens have also been found to be uveitogenic. Although early
preparations of rhodopsin may have been contaminated with S antigen,
highly purified rhodopsin preparations have subsequently been found to
produce EAU (Marak et al.1980). "A" antigen, transducin and cGMP
phosphodiesterase are also considered to produce uveitic changes (Gery et
al.1986) although the properties of these antigens are less well investigated.
The failure to produce models of ocular inflammation by systemic
injection before the 1940s has been attributed to the lack of suitable
adjuvants. Complete Freund's adjuvant (CFA) is a mixture of mycobacteria
and mineral oils which is commonly used in the induction of EAU. It has
been shown that the simultaneous administration of Bordetella pertussis
organisms or pertussis toxin intraperitoneal^ or intravenously further
enhances the induction of EAU (De Kozak et al. 1981b) and it has been
suggested that this effect may be due to the sensitization of vascular
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endothelial cells to vasoactive amines (Mochizuki et al.1984). It is notable
that no disease is induced in animals injected with antigen without proper
adjuvant. In mice, which are resistant to EAU, it is necessary to pre-treat with
low dose cyclophosphamide to reliably produce disease (Caspi et
al. 1988b). This procedure is considered to reduce the numbers of
lymphocytes involved in immune suppression mechanisms.
1.11. Immunopatholoqy of EAU
At present the most widely used EAU model is the Lewis rat. 12 to 16
days following immunisation with S antigen in CFA there is a rapid influx of
inflammatory cells to the vitreous, iris, ciliary body, anterior and posterior
chambers. This is accompanied by an infiltrate of inflammatory cells in the
photoreceptor layer along with patches of retinal oedema and photoreceptor
destruction. 2 to 4 days after onset the choroid becomes heavily infiltrated
with inflammatory cells. There is increasingly heavy inflammatory infiltration
and destruction of the retina which eventually forms a glial scar after
approximately 2 weeks of active inflammation. Polymorphonuclear
leukocytes (PMN) are the predominant cell type in the anterior segment
infiltrate whereas mononuclear cells (lymphocytes and macrophages)
predominate in the posterior segment (Faure, 1980; De Kozak et al. 1981b;
Gery et al.1986). Immunohistochemical analysis of the lymphocytic infiltrate
in EAU has shown that the vast majority of these cells are T lymphocytes and
that the ratio of CD4:CD8 positive T cells (using the W3/25 and 0X8
antibodies) is 5:1-5:2 in the early stages of the disease course and 1:1 to 1:2
in the later stages (Chan et al. 1985a). These findings have been interpreted
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as indicating that CD4 positive T cells are responsible for the acute disease
whereas CD8 cells function to downregulate the disease process (Gery et
al.1986).
Electron microscopic studies of the Lewis rat model of EAU have
recently shown that retinal vascular endothelial cells (but not choroidal
vascular endothelium) at the sites of active inflammation take on the
appearence of high endothelial venules (HEV) (Dua et al. 1991). This
morphological change is associated with biochemical changes resulting in
lymphocyte homing through receptor interactions with endothelial cells
(Duijvestijn et al.1989; Butcher, 1990). These changes may therefore play a
role in recruitment and migration of lymphocytes through the blood-retinal
barrier.
Other species of rat are also susceptible to EAU. In the black hooded
Lister rat immunisation with S antigen produces a mild, chronic form of EAU
which is confined to the posterior segment of the eye (Stanford et al.1987).
Retinal vasculitis is a prominent feature of this model and it may therefore be
a more appropriate model for investigation of intraocular inflammatory
conditions such as Behcets disease in which retinal vasculitis is a marked
clinical feature.
The guinea pig was used for many of the early studies of EAU (Collins,
1949). In this model the pathology is centered on the choroid because of the
lack of a retinal circulation (Forrester et al.1985). The guinea pig model has
also been used to demonstrate the variation in EAU produced by different
doses of S antigen (Rao et al.1979). An acute endophthalmitis was
produced by very high doses, moderate S antigen dose produced a
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granulomatous uveitis and smaller dose levels produced a non¬
granulomatous uveitis composed mainly of mononuclear cells. EAU has
been less well investigated in the rabbit although both S antigen and IRBP
have been shown to produce disease (Rao et al.1986; Eisenfeld et al.1987).
The primate model of EAU is considered to be closest to human
disease. EAU induced by S antigen in the Rhesus monkeys is characterised
by a more delayed onset and a more chronic course than EAU in other
animals (Nussenblatt et al.1981a). Histopathologically there is a retinal
perivasculitis with focal loss of the photoreceptor layer in relation to the
inflamed vessels. There is a subretinal lymphocytic infiltration and relatively
few inflammatory cells in the choroid. Animals also exhibit cell-mediated
responses to S antigen. IRBP induced disease in primates has a greater
degree of choroidal involvement (Hirose et al.1986) suggesting that
immunisation with a retinal antigen can under some cicumstances produce
pathology centered on the choroid. The inflammation in this model was
granulomatous in nature with many giant cells similar to the changes found
in human sympathetic ophthalmia and VKH syndrome.
In general mice are less susceptible to EAU than other animals.
Recently, using S antigen and IRBP with an intensified immunisation
protocol it has been possible to induce disease in several strains of mouse
(Caspi et al. 1988b). In the B10.A strain of mouse EAU is a relatively chronic
disease with focal lesions in the retina and choroid, granuloma formation
and vasculitis. Lesions resembling Dalen-Fuchs nodules and subretinal
neovasculisation have also been found in this model.
Studies of the expression of MHC class II antigens in EAU (Chan et
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al. 1986b; Chan et al. 1988a) have shown that there is class II expression on
RPE cells prior to onset of clinical or histological evidence of disease and
that this persists after the active phase of the disease is over. There is also
widespread expression of class II on infiltrating inflammatory cells.
In all the EAU models outlined above lymphocytes are found in
significant numbers within the inflammatory infiltrates at the sites of
destructive lesions in the posterior segment. Immunohistochemistry has
shown that cells are predominantly T cells and that very few B cells are
present. Treatment of rats with anti-CD4 antibody has been shown to
completely inhibit the development of EAU following active immunisation
(Atalla et al.1990). This is evidence that cell mediated immunity plays a
central role in the tissue pathology in EAU.
1.12. Immune mechanisms in EAU
1.12.1. Adoptive transfer
It has been demonstrated that EAU can be adoptively transferred from
immunised donor animals to genetically identical naive recipients with T
lymphocytes but not with serum (Mochizuki et al.1985). T cells must be of the
CD4 subgroup to have the potential to transfer disease. Furthermore, in the
Lewis rat model, long term T cell lines have been developed which are
capable of transferring EAU (Caspi et al.1986). These T cell lines are CD4
positive, IL2R positive, MHC class II restricted and S antigen specific. The
immunopathology of this form of EAU starts 4-5 days after transfer of disease
and follows a similar pattern to EAU induced by active inflammation (Chan et
al. 1988a). Very small numbers of these S antigen specific T cells can be
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detected in the eyes at the time of disease onset (Lightman et al.1987)
suggesting that they function to recruit other inflammatory cells following
antigen recognition. It is notable that in order to mediate EAU uveitogenic T
cells must be activated with specific antigen or T cell mitogen prior to transfer
(Mochizuki et al.1985). These activated T cells produce lymphokines and it
may be that this is an essential component of the mechanism of induction of
EAU.
Lymphocytes (both CD4+ and CD8+), macrophages and neutrophils
are present in the retinal destructive lesions in EAU, however the identity of
the cells causing the tissue damage is unknown. Since EAU can be
adoptively transferred without a detectible accumulation of antigen specific T
cells in the eye (Lightman et al.1987) the numbers of T cells seen in these
lesions must be produced by clonal expansion of transferred antigen
specific cells, recruitment of non-antigen specific T cells or a combination of
both these processes. Antigen specific T cells must also initiate the
mechanisms of chemotaxis by which macrophages and neutrophils
accumulate in the destructive lesions. Lymphokine secretion is fundamental
to the ability of T lymphocytes to act as cytotoxic effector cells and to exert
effects on other cells, for example migration and induction of cytotoxic action
(Feldmann et al.1989).
1.12.2 Immune modulation
It has been shown that treatment with the specific T cell inhibitor
cyclosporin A from the day of immunisation totally inhibits the development
of EAU (Nussenblatt et al. 1981b). Higher dosage commenced at day 7 post-
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immunisation also inhibited disease. Systemic cell mediated immune
responses to S antigen are altered in animals treated with cyclosporin A in
line with the inhibition of disease (Nussenblatt et al. 1983c). These findings
emphasize the central role of cell mediated immunity in the induction and
development of EAU.
Anti-S antigen and anti-IRBP antibodies can be detected following
immunisation with these antigens but antibody production does not correlate
with a uveitogenic response (De Kozak et al. 1981b; Caspi et al. 1988b). In
adoptive transfer models of EAU, disease can be induced without detectable
antibody levels (Mochizuki et al.1985). Furthermore, it is not possible to
transfer EAU with serum. In cyclosporin A treated animals disease inhibition
occurs without a decrease in systemic antibody levels (Nussenblatt et
al. 1981b). It seems unlikely therefore that humoral immunity plays a major
role in EAU pathogenesis. It may however play an auxiliary role in EAU
regulation through antiidiotype antibody mechanisms whereby antibodies
may form a network following recognition of idiotypes on other antibodies (or
lymphocytes). There is experimental evidence to suggest that EAU can be
modified through manipulation of idiotypic networks (De Kozak, 1990).
1.12.3. Downreaulation of EAU
Several mechanisms may play a role in the downregulation of the
immune response and tissue destruction in EAU. The increase in numbers
of CD8 positive T lymphocytes seen in the later stages of the inflammation in
EAU (Chan et al. 1985a) along with the termination of active disease has led
to speculation that these cells may act to downregulate the immune
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response. Further evidence for a role for cells of the CD8 subtype has come
with the development of a CD8 (OX8) positive T cell line which can inhibit
the proliferation of uveitogenic T cells in vitro and downgrade EAU in vivo
when adoptively transferred to actively immunised animals (Caspi et
al. 1988a).
Non-lymphoid organ resident cells such as Muller cells may act locally
to suppress the immune response. Evidence for this has come from in vitro
experiments showing the negative effect of Muller cells on antigen
presentation to T cells as well as T cell IL2 production and IL2R expression
(Caspi et al.1987). It has also been shown that modified Muller cells can act
as antigen presenting cells to T cells (Roberge et al.1988). Iris and choroidal
cells have the capacity to produce a soluble inhibitor of lymphocyte
proliferation in vitro (Hooper et al. 1991). The in vivo role of such local
immune regulation by organ resident cells remains uncertain.
1.12.4. Genetic influences in EAU development
The genetic background of animals used in the study of EAU appears
to be of importance in disease induction. Studies on the mouse model
suggest that the haplotype of a strain may determine its susceptibility to EAU
(Caspi et al.1990). Only mouse strains carrying the H-2k haplotype in the l-A
region of their MHC are susceptible to EAU induction. Interestingly the
strains studied appeared to respond to either IRBP or S antigen but not to
both.
Strains of rat used in EAU studies can be grouped into high or low
responders on the basis of their genetic makeup. In rats there is a strong
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correlation between the susceptibility to EAU and to EAE. EAE susceptibility
in rats has been linked to the RT1 major histocompatibility gene and this
relationship appears to hold for EAU (Gery et al. 1986). The role of mast cells
in the local release of vasoactive amines has been studied in EAU. It has
been demonstrated that there is a build up of choroidal mast cells following
immunisation and a massive degranulation, which would cause increased
blood vessel permeability, immediately prior to disease onset (De Kozak et
al.1981a). Studies of choroidal mast cells in different strains of rat show that
high numbers of mast cells correlate with disease susceptibility whereas
strains with low numbers are less susceptible (Mochizuki et al.1984). The
extra-MHC genes controlling mechanisms of vasoactive amine action on
blood vessels may therefore be of importance in EAU susceptibility also.
1.13 Relevance of EAU to human intraocular inflammation
1.13.1. Intraocular antigens
Investigation of the immune responses of patients with intraocular
inflammatory disease to S antigen and IRBP, the most commonly used
antigens for the induction of EAU, has shown that while some patients do
have an increase in humoral and cell-mediated responses to these antigens
this is by no means a consistent finding (Williams et al.1977; Kasp et
al. 1986; Dumonde et al. 1985; Doekes et al. 1987; Froebel et al. 1989;
Forrester et al.1989). Furthermore, immune responsiveness to these
antigens is found in patients following retinal trauma (Gregerson et al.1982)
and in healthy individuals (Doekes et al.1987; Froebel et al.1989; Forrester
et al.1989). It is therefore uncertain whether these antigens are involved in
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the induction of human intraocular inflammation. It is notable, however, that
S antigen and IRBP are capable of inducing ocular inflammation in sub¬
human primates (Nussenblatt et al.1981a; Hirose et al.1986) and that this
disease model is closely analogous to human disease suggesting that they
at least have the potential to be uveitogenic in humans. It is possible that
multiple ocular antigens are involved in any particular form of human
disease. Since clinical studies are done on peripheral blood samples and
autoreactive T cells specific for a small organ such as the eye may constitute
only a very small proportion of the total lymphocyte pool, it is likely that our
present clinical tests lack the sensitivity to pick up subtle changes in a T cell
population.
1.13.2. Immunopatholoav
Many of the histological and immunohistological features seen in
human intraocular inflammation are reproduced in the animal models of
EAU (Forrester et al.1990). The marked T cell involvement in
immunohistological studies of human disease is paralleled by the
predominance of T cells in EAU. The retinal vasculitic changes seen in the
more chronic models of EAU, particularly the primate model (Nussenblatt et
al.1981a) is similar to that seen in many forms of clinical disease. Nodules
formed at the chorioretinal interface in EAU (in particular the IRBP primate
model (Hirose et al.1986)) show similarities to the Dalen-Fuchs nodules
seen in sympathetic ophthalmia, VKH and other forms of posterior uveitis.
The widespread MHC class II expression on infiltrating and organ-resident




The genetic predisposition to certain clinical types of intraocular
inflammation such as birdshot chorioretinopathy (Nussenblatt et al.1982;
Priem et al.1988) is also seen in the susceptibility of certain strains of animal
to induction of EAU. The response of EAU to immunosuppressive treatment,
for example cyclosporin A (Nussenblatt et al. 1981b), appears to be similar to
the response seen clinically in intraocular inflammation and is of importance
in the development of new therapies for human disease.
Although it is uncertain if EAU is exactly analogous to any form of
human intraocular inflammation it does provide a range of experimental
models which have proved of value in the investigation of human disease.
1.14 The role of autoimmunity in inflammatory eve disease
Idiopathic intraocular inflammatory disease and in particular
sympathetic ophthalmitis, have for many years been thought to be an organ-
specific autoimmune disease. This theory remains unproven. There are,
however, several lines of evidence which suggest that immune system
mechanisms are centrally involved in the evolution of these conditions and
support the view that they represent autoimmune disease.
Firstly there is a severe inflammatory response, usually localised to
intraocular tissues, in the absence of a demonstrable exogenous stimulus
such as an infective agent or foreign antigen (Forrester, 1991). This is
despite extensive investigations carried out on actively inflammed eyes and
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on systemic studies of patients with inflammatory eye disease. This does not
preclude the possibility of a transient infection providing an initiating event
for ongoing inflammation. Since the subsequent immune-mediated
inflammation is inappropriate in the absence of an infective agent and has a
deleterious effect on the ocular tissues the response could justifiably be
termed autoimmune.
Associations with specific MHC antigens have been demonstrated in
several diseases thought to be of autoimmune nature (Sinha et al. 1990) and
the MHC associations of certain subtypes of inflammatory eye disease
(Nussenblatt et al.1982; Priem et a!.1988; Reynard et al. 1983; Ohno, 1981)
is also suggestive of an autoimmune aetiology.
The central role of T lymphocytes in the immunopathology of
• inflammatory eye disease (sections 1.8 and 1.9) is analogous to the situation
found in many forms of autoimmune disease (section 1.6) and implies that
similar immune-mediated disease mechanisms may be active in these
diverse conditions. Although studies on the immune responsiveness of
uveitis patients to retinal antigens have given inconclusive results (section
1.8) the demonstration that certain patients do react to ocular autoantigens is
suggestive that in at least a proportion of patients these antigens may be
providing an autoimmune stimulus. The inconsistent results found in these
studies may be accounted for by the relative insensitivity of currently
available systemic tests of immune processes ocurring in the eye.
Overall, although there is no conclusive evidence of an autoimmune
aetiology in inflammatory eye disease, aspects of current knowledge gained
from clinical observation and experimental work provide support for the
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theory that this range of conditions represents manifestations of an organ
specific autoimmune disease.
To extend current knowledge on the immune-mediated processes
involved in intraocular inflammatory disease this thesis has investigated the
cellular inflammatory response in two forms of human disease: multifocal
posterior uveitis and Behcet's disease which have not been previously
studied. Subsequent experimental work was undertaken on experimental
autoimmune uveoretinitis to produce the first in situ hybridisation studies of
lymphokine gene expression in intraocular inflammatory disease.
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CHAPTER 2
STUDIES OF HUMAN INTRAOCULAR INFLAMMATORY DISEASE
A: MULTIFOCAL POSTERIOR UVEITIS
2.1 Introduction
2.2 Multifocal posterior uveitis
2.3 Materials and methods
2.3.1. Case report




2.4.2. Light and electron microscopic findings
2.4.2.1. General pathological findings
2.4.2.2. Small non-pigmented lesions
2.4.2.3. Partially pigmented lesions
2.4.2.4. Heavily pigmented lesions




2.5.2. Pathology and immunopathology
68
2.1 Introduction
The previous chapter has outlined studies of the systemic immune
response to intraocular inflammatory disease and its local
immunopathology. These studies demonstrate that although systemic
immune abnormalities can be detected these are often inconsistent and are
not sufficient to allow an understanding of the immunopathologic
mechanisms of intraocular inflammation (or to monitor its clinical course and
response to treatment). Studies of the local human intraocular
immunopathology are therefore essential to provide a basis for clinical and
experimental research. Information from such studies must always be
interpreted with the caveat that it may represent an inactive or end stage of
the disease and may be subject to modification by treatment.
This chapter describes light microscopic, electron microscopic and
immunohistochemical studies carried out on post-mortem material from a
form of human intraocular inflammation: multifocal posterior uveitis. The
general aims of these studies are firstly to describe the ocular pathology and
characterize the infiltrating inflammatory cells in the condition and secondly
to relate these to clinical findings, experimental work and to the pathology
found in other immune-mediated conditions.
2.2 Multifocal posterior uveitis
This term covers forms of posterior uveitis which have multiple inflammatory
foci scattered across the posterior segment of the eye. Within this group of
conditions it may be possible to assign cases to specific diagnostic entities.
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In many cases, however, this is not possible and these are often termed
idiopathic posterior uveitis. The case outlined below highlights some of the
diagnostic difficulties in clinical uveitis.
2.3 Materials and Methods
2.3.1. Case Report
A 50 year old woman who had a one-month history of progressive
blurred vision was noted to have mild anterior uveitis, optic disc oedema and
bilateral total exudative retinal detachments. She had no systemic illness
and was not on any medication. Extensive investigation including viral
serology gave negative results. Following treatment with high-dose systemic
steroids the exudative detachments regressed and multiple round cream-
coloured patches were observed across both optic fundi (Fig. 1). These were
thought to be at the level of the retinal pigment epithelium and a diagnosis of
acute posterior multifocal placoid pigment epitheliopathy (APMPPE) (Gass,
1968) was made. Fluorescein angiography showed characteristic patchy
late hyperfluorescence. There were several recurrences of crops of similar
discrete, pale fundal lesions over the subsequent year against a background
of low-grade inflammation resulting in patchy depigmentary chorioretinal
scarring, with mottled pigmentation of the maculae (Fig. 2). Treatment with
systemic steroids was necessary for a total of five years. After steroids were
withdrawn there was a mild residual posterior uveitis and good preservation
of visual function. The patient died from an acute myocardial infarction nine
years after the original episode of ocular inflammation and the eyes were
obtained for pathological examination. Six weeks prior to death her vision
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was 6/9 right and left, there was a mild bilateral anterior uveitis, and patches
of chorioretinal scarring which did not show any clinical evidence of active
inflammation.
2.3.2. Light and electron microscopy
The eyes were removed approximately 12 hours following death. The
left eye was fixed in 4 % formal saline and the right in 2% cacodylate
buffered glutaraldehyde. Both eyes were of normal dimensions and were
divided horizontally above and below the macula. Paraffin embedded serial
sections 6^m thick, from both eyes were stained with haematoxylin and
eosin, periodic-acid-Schiff, and stains for axons (Bodain), myelin (Loyez),
and iron (Perls) for light microscopic examination. Individual lesions of
varying appearance were selected macroscopically from the glutaraldehyde
fixed eye for electron microscopy. Fifteen blocks were embedded in Araldite
and 1^m thick sections were stained with toluidene blue. Eight of these
blocks were studied by semiserial sectioning (at 50 or 100 |xm steps) and,
where appropriate, ultrathin sections taken and stained conventionally for
examination using a Philips 301 electron microscope.
2.3.3. Immunohistochemistrv
Immunohistochemical staining was done on sections from the formalin
fixed eye using the avidin-biotin-complex (ABC) method. Sections were
dewaxed through toluene and graded alcohols and washed in phosphate
buffered saline (PBS) pH 7.3 for 5 minutes. Endogenous peroxidase activity
was quenched by immersion in 3% hydrogen peroxide in 50% methanol for
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20 minutes. Slides were then washed in PBS for 5 minutes and normal
(horse) serum applied for 20 minutes. The serum was tipped off and the
primary monoclonal antibody applied for 30 minutes followed by washing in
PBS for 5 minutes. Biotinylated secondary antibody was applied for 30
minutes and after a further wash in PBS, avidin-biotin-complex applied for
45 minutes. Slides were then washed in PBS, developed in amino ethyl
carbazole (AEC) to give a red final reaction product and counterstained in
haematoxylin. Coverslips were mounted using an aqueous based mountant
(Dako glycergel). Table 1 (page 99) lists the primary antibodies used and
their specificities. Estimates of numbers of T (UCHL1 antibody) and B
lymphocytes (L26 antibody) were made by counting positive cells
(demonstrating red membrane staining) in ten high power fields.
Control studies for the immunohistochemical staining were carried out
by (a) omitting the primary antibody to provide a negative control and (b) on
known positive tissues (inflammatory eyelid or orbital lesions) to verify the
efficacy of the monoclonal antibodies and immunohistochemical method.




Both globes had similar macroscopic appearances. The anterior
segments were normal and the vitreous was clear. There were meridional
folds at the pars plana but no evidence of "snowball" or "snowbank"
accumulations of leucocytes. Focal lesions, varying in size between 0.5 and
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1.5 mm diameter, were scattered throughout the fundus, predominantly in
the mid-periphery (Figs. 3 & 4). The lesions varied in the degree of their
pigmentation. Smaller lesions in general had less hyperpigmentation while
larger lesions were often heavily pigmented with variable focal areas of
depigmentation. The maculae, peripapillary retina and optic discs appeared
normal for post-mortem material.
2.4.2. Light and electron microscopic findings
2.4.2.1. General pathological findings
The appearances of the conjunctiva, cornea, outflow system and lens
were normal with no evidence of an ongoing inflammatory process.
Histologically there were scattered lymphocytes, occasionally forming
aggregates, in the iris and ciliary body but no evidence of inflammatory cells
in the vitreous. There was non-specific hyperplasia in the epithelial layers of
the pars plana.
In general the retina was well preserved with the nerve fibre layer and
optic nerve containing axons in normal density. Occasional drusen and
degenarative areas of the RPE were noted in the far periphery. Clusters of
lymphocytes were noted in the posterior choroid and in the adventitia of
some of the posterior ciliary vessels and nerves.
Focal destructive lesions involving the retina, RPE and choroid were
found throughout the posterior segment and corresponded to the foci seen
clinically and macroscopically. These lesions were grouped into (a) non-
pigmented - figure 3, lesion b ; figure 4, lesions a, d and e. (b) partially
pigmented - figure 3, lesions a,c,d and f ; figure 4, lesion c, and (c) heavily
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pigmented - figure 3, lesion e ; figure 4, lesion b, on the basis of their
macroscopic appearance.
2.4.2.2. Small non-oiamented lesions
The small, non-pigmented lesions were of variable histological
appearance. Three of the blocks examined individually (Fig 4 lesions a,d &
e) had focal collections of lymphocytes in the choroid (Fig. 5) with infiltration
of lymphocytes and macrophages in the hypopigmented retinal pigment
epithelium. The overlying retina had a minimal degree of photoreceptor
atrophy. Ultrastructural analysis showed the cells within the RPE were
macrophages (Fig.6). Glial scar tissue replaced the RPE and in some foci
penetrated Bruch's membrane causing destruction of the choriocapillaris.
2.4.2.3. Partially pigmented lesions
Partially pigmented lesions also varied in their histologic appearance
(Fig. 3 lesions a,c,d & f; Fig. 4 lesion c). There was a consistent finding of
lymphocytes in the choroid below these foci. The choriocapillaris was either
normal, infiltrated by inflammatory cells or obliterated by collagenous tissue.
In some foci Bruch's membrane had short breaks (Fig. 3 lesions c,d & f; Figs
7 & 8) which in some instances contained inflammatory cells (Fig. 9). The
RPE was multilayered and infiltrated by lymphocytes and macrophages in
some foci (Figs 8,9 & 10) and was destroyed in others. The outer retina was
usually atrophic in these foci and in some cases, where the inflammatory
process was more destructive, Bruch's membrane and the outer retina were
completely lost. In the more advanced lesions there was invasion of the
retina by lymphocytes, macrophages and RPE cells and the extension of
choroidal blood vessels into the retina (Fig. 11).
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2.4.2.4. Heavily pigmented lesions
Lesions which appeared heavily pigmented macroscopically (Fig. 3
lesion e; Fig. 4 lesion b) consisted of atrophic retina over multilayered and
hyperplastic RPE cells infiltrated by macrophages (Fig. 12). There was a
dense choroidal lymphocytic infiltrate in these lesions. At the periphery of
even advanced lesions the photoreceptor architecture was preserved, and
there was evidence of photoreceptor phagocytosis by exogenous
macrophages (Fig. 13)
2.4.2.5. Common pathological features in inflammatory foci
In none of the sections examined at light or ultrastructural level was it
possible to identify structures with protazoal, viral or bacterial characteristics.
Certain features were consistently found in all the inflammatory foci
studied. The lesions were restricted, the adjacent retina being spared and
the choroidal lymphocytic infiltrate being focal (Figs. 5 & 10). Lesions were
often related to a myelinated nerve in the choroid. Retinal glial cells
penetrated Bruch's membrane to extend to the choroid and collections of
RPE cells were often found in the choroid at the site of inflammatory foci
(Figs. 5 & 14) irrespective of degree of destruction. There was evidence of
extension of choroidal vascularisation towards the retinal side of the
destructive focus in some lesions (Fig. 11). Very few plasma cells were
found in any of the tissues examined. There was no hyalinisation of the
intima or media or luminal narrowing in either choroidal or retinal vessels
which would have suggested previous vascular occlusive disease.
The endothelial cells of choroidal capillaries and venules had marked
swelling and cytoplasmic rarefaction irrespective of the degree of
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inflammatory destruction (Figs. 6,7,11,14-18). This change was restricted to
the foci of inflammation and was not seen in the adjacent uninvolved
choroid. Lymphocytes were often noted in relation to the swollen endothelial
cells (Fig. 7). At the ultrastuctural level the junctions between these
endothelial cell were noted to be intact. In some vascular lumina there were
platelet clusters (Fig 8), neither fibrin nor thrombus deposits were identified.
2.4.3. Immunohistochemical findings
Within the choroidal infiltrates an estimated 70 - 80 % of the
lymphocytes were identified as T cells (Fig. 19). B cells constituted 5 - 10 %
of lymphocytes in the choroid. The majority of UCHL1 positive T cells were
also OPD4 positive and these cells were noted to be prominent within the
choriocapillaris (Fig. 20) and in relation to areas of RPE disruption . The
lymphocytes in the iris and ciliary body were also noted to be UCHL1 and
OPD4 positive T cells. Cells which stained positively with the
monocyte/macrophage monoclonal antibody were found in small numbers
scattered throughout the choroid and also in the destructive retinal foci. The
antibody specific for the MHC class II antigen HLA DR a chain was positive
on drusen-like deposits at the level of the RPE and also on occasional cells
in the choroid and ciliary body. No vascular endothelial cells were FILA DR
positive. There were no significant deposits of IgG or IgM.
Studies of normal eyes revealed very occasional OPD4 positive and
UCHL1 positive T cells in the choroid. There was also a very small number




Exudative retinal detachments are not commonly associated with
APMPPE but have been reported (Bird et al.1972). The initial clinical report
of APMPPE described a self-limiting condition (Gass, 1968) but further
studies have stressed that it may be recurrent or chronic (Gass, 1983;
Damato et al.1983; Williams et al.1989). It has also been suggested that
APMPPE may form a continuum of clinical disease with Harada's disease
(Wright et al.1978). Although the initial clinical impression was that this was
a case of APMPPE the presentation with exudative retinal detachments and
subsequent clinical course are more typical of Harada's disease (Ohno et
al.1977; Snyder et al.1980). The condition probably best fits an intermediate
group as defined by Wright, Bird and Hamilton (Wright et al.1978). An
infective aetiology is unlikely in this case as the presentation and
subsequent clinical course was not characteristic of the defined infective
causes of posterior uveitis. Other diagnoses which were considered were (a)
birdshot chorioretinopathy (Ryan et al.1980; Nussenblatt et al.1982; Priem et
al. 1988) however the initial total exudative retinal detachments and
subsequent hyperpigmentation of many of the fundal lesions (Figs. 3 & 4)
are not described in this condition; (b) geographic chorioretinopathy
(Hamilton et al.1974) although the focal, non-progressive nature of the
fundal lesions and the good visual preservation are not seen in this
condition; (c) punctate inner choroiditis (Nozik et al. 1991; Dreyer et al.1984;
Watzke et al.1984; Morgan et al.1986) which usually presents with multiple
small depigmented chorioretinal inflammatory lesions unlike the varied,
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often hyperpigmented, lesions seen in this case (Figs 3 & 4).
This case illustrates some of the diagnostic difficulties common to many
forms of intraocular inflammation. Because of the diagnostic difficulties
outlined, the pathology described above is best considered in the broader
clinical context of multifocal posterior uveitis.
2.5.2. Pathology and immunopatholoqy
The pathological changes reported in this case represent the ongoing
features of the processes involved (nine years after the initial onset) and the
study of the tissue is therefore aimed towards the ongoing pathology rather
than the initial aetiology. Unlike much of the human pathological material
available in inflammatory eye disease the disease has not been complicated
by other pathology and was not subject to medication when it was obtained.
Identifying an aetiological agent is a problem common to many studies of the
immunopathology of human intraocular inflammation since the initiating
insult may be transient and no longer detectable by the time the disease
comes to clinical attention. Some of the observed negative findings are
relevant in this respect. It has been suggested that both pigment
epithelial disease and multifocal choroiditis may be initiated by choroidal
ischaemia (Wright et al.1978; Hayreh, 1975; Deutman et al.1977; Young et
al.1980; Gaudric et al. 1982) but no evidence of concomitant vascular
occlusive disease was found.
The study attempted to correlate the clinical and macroscopic
appearance of the inflammatory foci with their histological appearance.
However, no overall pattern was found in that lesions of similar macroscopic
appearance varied widely in the nature of their pathological change. It was
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notable that in general the lesions were pathologically active yet were
considered to be clinically quiescent.
The restricted, focal nature of the lesions was notable and suggests that
localised stimuli are producing the ongoing inflammation. Finding
inflammatory cells within small breaks in Bruch's membrane suggests that
these cells may gain access to the inflammatory foci by this route.The
demonstration of photoreceptor phagocytosis by exogenous macrophages
is evidence that these cells could form part of the effector cell mechanisms in
this type of intraocular inflammation.
Glial cell migration from the retina to the choroid has been described in
syphilis (Blodi et al.1968) and other chorioretinal inflammatory conditions
(Green, 1985). The occurence of this abnormality in multifocal posterior
uveitis is further evidence of the non-specific nature of the glial cell activity.
Similarly migration of RPE cells into the choroid is regarded as non-specific
(Green, 1985) as is neovasculisation in a glial scar (Green, 1986b).
In VKH syndrome the pathological changes have been described as a
mild, diffuse uveitis consisting of lymphocytes and plasma cells and RPE
atrophy (Perry et al.1977). This is in contrast to the inflammatory infiltrate
described above which although non-granulomatous was severe in discrete
foci and contained very few plasma cells. Immunohistological study of VKH
syndrome (Chan et al. 1988b) has revealed that the majority of infiltrating
cells are T lymphocytes with a high proportion of CD4 positive cells and an
increase of GFAP positive (glial) cells in the retina (although this study was
carried out on end-stage material). The immunohistochemical findings
described above are broadly similar to the results of this study. The
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predominance of T lymphocytes correlates with the findings from studies of
other forms of intraocular inflammation such as sympathetic ophthalmitis
(Jakobiec et al.1983; Chan et al. 1986c), sarcoidosis (Chan et al.1987) and
pars planitis (Wetzig et al.1988) and is further evidence of the central role of
cell-mediated immune responses in intraocular inflammatory disease. The
interpretation of the minimal MHC class II antigen expression found in these
eyes must be made with caution since the HLA DR a chain monoclonal
antibody used on the formalin fixed tissue in this study may be less sensitive
than the anti-class II antibodies used in studies of frozen tissue from other
forms of human intraocular inflammation (Dako: unpublished
communication).
Figure 1
Left fundal appearance at the time of presentation in 1978. Multiple cream
coloured patches are seen across the central retina at the level of the RPE.
Figure 2
Appearance of the left optic fundus one year after initial onset of posterior
uveitis. There is patchy chorioretinal scarring with mottled
hyperpigmentation at the fovea.
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Figure 3
Inferior calotte of the right globe demonstrating the macroscopic appearance
of the lesions. Plastic embedded blocks of the lesions designated a-f were
examined individually. (Non-pigmented - b; partially pigmented - a,c,d, and f
; heavily pigmented - e)
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Figure 4
Superior calotte of right eye showing the variable appearance of the fundal
lesions. Blocks of the lesions designated a-e were examined individually.
(Non-pigmented - a,d and e ; partially pigmented- c ; heavily pigmented - d)
Figure 5
Focal collection of lymphocytes in choroid and choriocapillaris.
The RPE is disorganised (arrows) and there is a cluster of RPE




Electron micrograph demonstrating macrophages (arrows) infiltrating the




Inflammatory focus in which gliotic retina abuts on to Bruchs' membrane
which has small breaks (arrowheads to examples). Inflammatory cells
(arrow) are closely related to HEV in choroidal vessel. x375
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Figure 8
Partially pigmented lesion with multilayered RPE, short breaks in Bruchs'




Fragmentation of photoreceptors over clusters of RPE cells, macrophages




Multilayered RPE (arrow) in a focal area of outer retinal destruction. Bruchs'
membrane shows several breaks (arrowheads) and there is an
accumulation of lymphocytes in the choroid. x325
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Figure 11
Choroidal venule (arrow) and an intraretinal new vessel (arrowhead)
showing endothelial cells of HEV morphology. Bruchs' membrane (white
arrow) is broken and a macrophage (white arrowhead) is in the process of
penetrating through the membrane into the retina, x 1500
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Figure 12
Heavily pigmented lesion (lesion b in figure 4) demonstrating multilayering
of the RPE (arrow) with infiltrating macrophages. Note that choroidal vessel
endothelial cells are swollen (arrowhead). x350
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Figure 13
Macrophages (arrows) phagocytosing photoreceptor outer segments within
an inflammatory focus, x 6000
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Figure 14
Lesion c in figure 4 showing a collection of RPE cells in the choroid (arrow)
adjacent to an area of destruction of the RPE and Bruchs' membrane. The




Swollen endothelial cells (arrow) in the choriocapillaris below intact Bruchs'




HEV like endothelial cells (arrows) in the choriocapillaris below intact




Early endothelial cell swelling in a choroidal venule (arrowhead) in an
inflammatory focus below an intact Bruchs' membrane, x 1500
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Figure 18
High power electron micrograph demonstrating swollen endothelial cells
(arrow) in an inflammatory focus, x 4500
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Figure 19
UCHL1 positive T lymphocytes (arrows to examples) within choroidal
infiltrate at the site of an inflammatory focus, x 450
Figure 20
OPD4 positive T lymphocytes (arrows) in the choriocapillaris below intact
RPE in an area of inflammatory infiltrate, x 450
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TABLE1 MULTIFOCAL POSTERIOR UVEITIS :
PRIMARY MONOCLONAL ANTIBODIES
ANTIBODY SOURCE DILUTION SPECIFICITY
UCHL1 Dako 1:100 T lymphocytes *
OPD4 Dako 1:10 T lymphocytes **
L26 Dako 1:50 B lymphocytes
MAC 387 Dako 1:100 Monocytes/macrophages
HLA DR alpha Dako 1:50 Alpha chain of HLA DR Ag
igG Serotec 1:1000 IgG heavy chain
igM Serotec 1:1000 IgM heavy chain
* Norton et al. 1986, Terry et al. 1988
** Yoshino et al. 1989, Poppema etal. 1991
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CHAPTER 3
STUDIES OF HUMAN INTRAOCULAR INFLAMMATORY DISEASE
B. BEHCET'S DISEASE
3.1 Behcet's disease
3.1.1. Clinical features of Behcet's disease
3.1.2. Systemic immunopathology
3.1.3. Tissue immunopathology














3.4.1. T lymphocytes in Behcet's disease
3.4.2. Cell counts
3.4.3. Localisation of pathological changes in Behcet's disease
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3.4.4. Antigen presentation in ocular Behcet's disease
3.4.5. Treatment of Behcet's disease
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3.1 Behcet's disease
3.1.1. Clinical features of Behcet's disease
Behcet's disease is a multisystem inflammatory disorder. Ocular
manifestations, which occur in 70-85% of patients, are a recurrent
iridocyclitis (classically with a transient hypopyon), choroiditis and retinal
vasculitis. These may be severe and be complicated by macular oedema
and optic atrophy leading to visual loss (Dinning, 1986; Chajek et al. 1975;
BenEzra et al.1986). The underlying disease mechanism for the widespread
manifestations of this condition is an occlusive vasculitis (Michelson et
al.1982), however the aetiology is unknown.
3.1.2. Systemic immunopatholoqy
Studies of aqueous humour (Fenton et al.1964) and peripheral blood
(Williams et al.1977; Shimada et al.1974) showing alterations in levels of
complement components, led to the proposition that immune complex
deposition resulted in the immunopathology of Behcet's disease. Herpes
simplex virus genome has been found in mononuclear cells (Eglin et
al.1982) and in blood samples (Bonass et al. 1991) from Behcet's disease
patients. Likewise, increased levels of anti-HSV antibodies (Hamzaoui et
al. 1990a), reduced proliferative responses of CD4 and CD8 positive T
lymphocytes to HSV (Young et al.1988) and elevated cytotoxic responses by
CD4 and CD8 positive T cells to cells infected with HSV (Hamzaoui et
al. 1990b) have also been found in Behcet's disease in studies carried out
on peripheral blood. Taken together these findings implicate HSV in the
pathogenesis of Behcet's disease.
Streptococcal antigens have been found to induce systemic symptoms
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(The Behcet's disease research committee of Japan., 1989) and to activate T
cells (Niwa et al.1990) in Behcet's patients leading to speculation that
streptococcal infection may play a role in the pathogenesis of the condition.
These theories, however, remain unproven and the aetiology of this disease
is still uncertain.
3.1.3. Tissue immunopatholoav
Immunohistological studies of localised tissue pathology in Behcet's
disease such as erythema nodosum like lesions (Yamana et al. 1986a;
Kaneko et al.1985), oral ulcers (Kaneko et al.1985; Poulter et al. 1986), and
terminal ileum (Yamana et al. 1986b) have revealed infiltrates of
predominantly T lymphocytes suggesting that these cells produce the tissue
damage seen in Behcet's disease. Alterations in peripheral blood T cell
populations have been found (Lim et al.1983) and a decrease in suppressor
T cell activity has been noted in the pre-active stage of Behcet's disease
patients (Sakane et al.1982). These studies are evidence that cell-mediated
immune responses are centrally involved in the tissue pathology seen in
Behcet's disease.
The studies described below were undertaken with the aim of
analysing the local immunopathology of ocular Behcet's disease which is
often the most severe manifestation of the condition. These are the first
published immunopathological investigations of the localised ocular
inflammation found in Behcet's disease and the results of the studies are
considered together.
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3.2 Materials and methods
Initial immunohistochemical analysis was carried out on five
enucleated eyes which were formalin fixed and was directed towards the
characterisation of the infiltrating inflammatory cell types in the chronic
stages of Behcet's disease. Post-mortem eyes then became available which
represented an earlier stage of the condition, one of these eyes was fixed in
glutaraldehyde and the other was frozen allowing a more detailed
immunohistochemical analysis. On the frozen tissue it was possible to
investigate lymphocyte activation using the interleukin 2 receptor




Five eyes, enucleated for the complications of prolonged ocular
inflammation characteristic of Behcet's disease, were obtained from the
archives of the Institute of Ophthalmology. In all cases there was a clear
history of Behcet's disease confirmed by contacting the clinician involved.
Details of the clinical histories are outlined in table 2 (page 131).
3.2.1.2. Frozen tissue
The eyes from a thirty-eight year old male patient who died from
Behcet's disease were obtained post mortem. The patient was twenty-nine
years old when he diagnosed as having Behcet's disease in 1981 on the
basis of a three year history of recurrent retinal vasculitis, anterior uveitis and
oropharyngeal aphthous ulcers. These manifestations were controlled
initially by high dose oral prednisolone. In 1984 he had two episodes of
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deep venous thrombosis and was treated with oral anticoagulants. Between
1985 and 1990 his systemic condition deteriorated with the development of
erythema nodosum, multiple joint symptoms and meningoencephalitis which
resulted in epilepsy. Treatment with chlorambucil, cyclosporin,
cyclophosphamide and azathioprine failed to halt the progression of the
disease. The patient died in October 1990 when central nervous system
involvement resulted in cerebral vascular leakage causing severe cerebral
oedema and raised intracranial pressure which failed to respond to
treatment.
During the period 1981-90 he had recurrent episodes of anterior uveitis
(with hypopyon) and retinal vasculitis in both eyes. This resulted in retinal
ischaemia and visual loss despite systemic immunosuppression and orbital
steroid injections. A dense cataract developed in the left eye early in the
disease process, but cataract extraction was not considered justified
because of the advanced retinal ischaemia. On his last ophthalmic review
three months prior to death he had no light perception in either eye. The
right optic disc was swollen and surrounded by multiple retinal
haemorrhages and retinal oedema (Fig. 21). The retinal vessels in the right
eye were sheathed. There was no view of the left fundus due to the lens
opacity. Anterior uveitis was minimal in both eyes. Intraocular pressures
were normal throughout the course of the disease. Immunosuppressive
treatment at the time of death was high dose systemic prednisolone,
azathioprine and cyclophosphamide.
3.2.2. Tissue fixation
The enucleated eyes were formalin fixed and paraffin embedded.
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Horizontal sections of the whole eye were cut at 6-8 [am thickness. The post¬
mortem material was processed as follows ; after removal the left eye was
frozen in OCT and the right eye was fixed in 4% glutaraldehyde. Horizontal
sections, through the pupil and optic nerve, of both globes were cut at 6 ^m
thickness. Initial staining was carried out using conventional haematoxylin
and eosin.
3.2.3. Immunohistochemistrv
Immunohistochemical staining on the fixed tissue was then carried out
by the peroxidase-anti-peroxidase (PAP) method using a panel of
monoclonal and polyclonal antibodies (Table 3, page 132). Sections were
dewaxed through toluene and graded alcohols then washed in phosphate
buffered saline (PBS) pH 7.3. Endogenous peroxidase activity was
quenched with 0.5% hydrogen peroxide in 50% methanol. The slides were
washed in PBS and background staining blocked with normal serum
appropriate to the secondary antibody at a concentration of 10% in PBS with
2% ovalbumin for 30 minutes. The primary antibody was applied at optimum
concentration (ranging from 1:10 to 1:1500) for 45 minutes. Slides were
washed and secondary antibody applied at a dilution of 1:50 for 30 minutes.
After further washing peroxidase-anti-peroxidase complex was applied for
45 minutes at a dilution of 1:75 in PBS. Slides were washed again and
amino ethyl carbazole (AEC) was used as the reaction substrate to give a
red final reaction product. Sections were counterstained with haematoxylin
and coverslips applied using aqueous based mountant (Dako glycergel).
Negative control sections were processed in identical fashion omitting
primary antibody. Control studies were also carried out on eyes with (a)
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active sympathetic ophthalmitis - to compare the findings in Behcet's
disease with another form of chronic immune-mediated uveitis, and (b)
neovascular glaucoma - to compare the findings to minimally inflamed eyes
with the complications of the type seen in Behcet's disease. Positive control
studies were also carried out on sections known to be positive for each
antibody used.
On the post-mortem material sections of the frozen (left) eye were
stained immunohistochemically using a panel of monoclonal antibodies
(Table 4, page 133) by the avidin-biotin-complex method as described in
section 2.3.3.
Sections from each level examined were stained
immunohistochemically as above with the omission of the primary
monoclonal antibody to provide negative controls. Frozen sections from a
normal eye were stained with each monoclonal antibody to demonstrate the
distribution of each cell type in uninflamed ocular tissue and known positive
tissues (inflammatory eyelid or orbital lesions) were stained with each
antibody used.
3.2.4. Cell counting
To quantify the numbers of cells staining with the monoclonal
antibodies to leukocyte common antigen (LCA), UCHL1 (T lymphocytes),
CD43 (T lymphocytes), OPD4 ( T lymphocytes) and L26 (B lymphocytes) cell
counts were made from twenty randomly selected high power fields in (a)
the choroid and in (b) the retina (and periretinal scar tissue). Cells were
considered positive if they had mononuclear morphology and exhibited a




The five fixed eyes varied in the severity of the intraocular inflammation.
The pathological findings in each eye are summarised in table 2 (page 131).
Total retinal detachment and periretinal fibrovascular tissue (of varying
degrees) were consistent findings in these eyes. Two of the eyes had
evidence of secondary neovascular glaucoma complicating the
inflammation. The retinae were markedly thinned and degenerate in all the
eyes. Inflammatory cell infiltrates were noted around the episcleral vessels,
within the optic nerve, within the iris, ciliary body and choroid, around and
within the walls of the retinal vessels (Fig. 22) and within the fibrovascular
scar tissue. These infiltrates were composed almost entirely of mononuclear
cells, neutrophils being a very infrequent finding. In the sections studied
there was no evidence of thrombus in any of the retinal vessels. In three of
the five eyes there was moderate hyaline thickening of the blood vessel
walls in the iris, ciliary body, retina and periretinal scar tissue associated
with minimal luminal narrowing.
The pathological findings were similar in both the frozen and
glutaraldehyde fixed eyes and represent a less advanced stage of the
inflammatory process than the pathological changes seen in the enucleated
eyes. There was a mild lymphocytic infiltrate of the iris and ciliary body, this
extended to the choroid where there were scattered lymphocytes in all
sections examined. The retinal vessels were patent but showed marked
hyaline thickening of their walls and luminal narrowing (Fig. 23). There were
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infiltrating lymphocytes in this hyaline tissue. There were limited foci of
retinal detachment with underlying patches of subretinal fluid. In the right
eye the optic nerve head was oedematous and there was a lymphocytic
perivasculitis of the central retinal vessels extending into the nerve. The left
optic nerve head was not oedematous but had a perivasculitis and a degree
of loss of neural tissue.
3.3.2. Immunohistochemical findings
3.3.2.1. Fixed tissue
Throughout the fixed eyes the majority of infiltrating cells were positive
for the leucocyte common antigen (LCA) marker. T lymphocytes, identified
by the UCHL1, CD43 and OPD4 markers were a consistent finding in the
infiltrates (Fig. 24) and were prominent in the perivascular infiltrates in the
retina, fibrovascular tissue (Fig. 25) and uveal tract and in the
choriocapillaris below disrupted retinal pigment epithelial cells (Fig. 26).
Markers for IgG and IgM immunoglobulins generally gave a faint stain
of serous fluid in the subretinal space and within vessels. This staining was
observed to be no greater than that in the non-inflamed neovascular
glaucoma control eye. In a total of three areas in two eyes there were small
collections of cells which showed cell membrane staining for
immunoglobulins: two for IgG and one for IgM (Figs. 27 & 28). These cell
aggregates corresponded to the B cell clusters seen with the L26 marker.
There was no evidence of immunoglobulin deposits within blood vessels or
elsewhere within the inflamed tissue. Both the C3c and C1q markers faintly
stained the serous fluid within blood vessels and the subretinal fluid. There
was no evidence of any solid deposition of complement components.
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In the control eye with sympathetic ophthalmitis numerous T and B
lymphocytes were found in the choriodal and retinal cellular infiltrates
consistent with previous reports (Jakobiec et al.1983; Chan et al. 1986c).The
lymphocytic infiltrate in the iris of the eye with neovascular glaucoma
consisted of minimal numbers of T and B lymphocytes but no inflammation
was seen in the retina and choroid demonstrating that the findings in the
retina and choroid in the Behcet's disease eyes did not result from the
secondary neovascular glaucoma which had developed in two of the eyes.
3.3.2.2. Frozen tissue
Positive immunohistochemical staining for T lymphocytes was seen in
cells in the hyalinised retinal vessel walls (Fig. 29) and surrounding the optic
nerve head vessels (Fig. 30). These cells also stained positively with the
CD4 monoclonal antibody however the small number of cells present
precluded cell counts of T cell subset ratios. The perivascular T cells also
stained positively with the IL2 receptor monoclonal antibody. Lymphocytes in
the iris, ciliary body and choroid were also positive for the T lymphocyte
monoclonal antibody although they were generally IL2 receptor negative.
No CD8 positive T lymphocytes or B lymphocytes were found. A few cells in
the hyalinised vessel walls were positive for the macrophage primary
monoclonal antibody. No neutrophils were identified in the vasculitic lesions.
A small number of cells in the optic nerve head and retinal vascular
endothelium were HLA DR positive. There were also numerous HLA DR
positive cells in the retinal pigment epithelium.
In the normal control eye there were very occasional cells in the
choroid which were positive for the T lymphocyte and CD4 monoclonal
111
antibodies. There were also small numbers of cells in the choroid which
were positive for the HLA DR monoclonal antibody.
3.3.2.3. Cell counts
The results of the cell counts are presented in tables 5-8 (pages 134-
137). The cell counts from the choroid, retina and periretinal scar tissue were
analysed together to give an overall picture of the infiltrating cells. T
lymphocytes (CD43 positive) made up a mean of 38% of the LCA positive
cell population in the choroid, retina and periretinal fibrovascular scar tissue.
The OPD4 monoclonal antibody stained a similar number of T cells to the
CD43 antibody.
B lymphocytes were an infrequent and variable finding. Overall in the
LCA positive population less than 1% of cells in the choroid, retina and
epiretinal scar tissue were positive for the B cell marker. In two of the eyes
no B cells were seen in the choroid and in three eyes no B cells were found
in the retina and fibrovascular scar tissue. B cells did occur in small clusters
within the choroidal and perivascular infiltrates (Fig. 31). NK cells, identified
by the Leu7 marker, were absent in three of the globes and were a very
infrequent finding within the leukocyte infiltrates in the other two.
Macrophages were a consistent finding within the T lymphocyte
containing infiltrates being prominent in the fibrovascular scar tissue (Fig.
32) where they constituted an estimated 20-40% of the leucocyte population
in some areas. Numerous lymphocytes and macrophages within the
leucocyte infiltrates showed positive staining for HLA DR a (Fig. 33). In four
of the five eyes small numbers of RPE cells were weakly positive for HLA DR
a however very few vascular endothelial cells in the choroid, retina and
112
periretinal scar tissue were HLA DR a positive.
3.4 Discussion
3.4.1. T lymphocytes in Behcet's disease
These investigations have demonstrated that T lymphocytes are the
principle infiltrating cell type in inflammatory foci in Behcet's disease. B
lymphocytes, neutrophils and NK cells were not prominent findings nor were
there deposits of immunoglobulin or complement components suggestive of
immune complex deposition contributing to the pathology. The high
proportion of T cells implies a central role for these cells in the
immunopathogenic mechanisms responsible for the ocular inflammation in
Behcet's disease and helps to explain the favourable response of ocular
Behcet's to cyclosporin A (Nussenblatt et al. 1983a; Graham et al.1985;
BenEzra et al.1986). The dominance of T cells found in the end stage, fixed
eyes was subsequently supported by the same finding of CD4 positive T
cells in the non-end stage frozen tissue even though the overall cell
numbers were much less in this tissue. This finding is in accordance with the
results of the immunohistochemical study of multifocal posterior uveitis
reported in chapter two and with the results reported by other authors in
various forms of intraocular inflammatory disease (Jakobiec et al.1983;
Chan et al. 1986c; Chan et al.1987; Wetzig et al.1988) it is possible therefore
that while the the clinical manifestations of the various forms of intraocular
inflammation may differ they may share common immunopathologic
mechanisms.
T lymphocytes are also the predominant cell type in other affected
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tissue foci in Behcet's disease (Yamana et al. 1986a; Kaneko et al. 1985;
Poulter et al.1986; Yamana et al. 1986b) and together with the data in this
study this is strongly suggestive that cell mediated immunity is responsible
for the tissue damage in Behcet's disease. It is notable that the findings of
many of the peripheral blood studies in Behcet's disease (Fenton et al.1964;
Williams et al.1977; Shimada et al.1974) do not reflect the tissue
immunopathology. This is a similar situation to the findings in sarcoidosis
(Daniele et al.1980; Chan et al.1987) where normal or low levels of
circulating CD4 positive T cells are found in peripheral blood in contrast to
the large numbers of T cells in the affected tissues.
Examination of the earlier stage pathology seen in the frozen tissue
showed a perivascular and intramural lymphocytic infiltrate in the retinal and
optic nerve vessels together with marked hyaline thickening of the vessel
walls and luminal narrowing. This feature has been reported in pathological
studies of tissue from the eye (Fenton et al.1964; Shikano, 1966) and other
affected foci (Michelson et al.1982) in Behcet's disease. The lymphocytes
were identified in the study of the frozen tissue to be CD4 positive IL2
receptor positive T cells. The perivascular lymphocytes in ocular sarcoidosis
(Chan et al.1987) and pars planitis (Wetzig et al. 1988) have also been
identified as T cells.
3.4.2. Cell counts
Neither UCHL1 nor CD43 are specific for CD3 positive T lymphocytes.
The UCHL1 antibody recognises a peptide of the CD45 family (Terry et
al.1988) which is present on 72% of CD4 positive and 35% of CD8 positive
T cells (Norton et al.1986) although it may stain small numbers of
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macrophages and myeloid cells. The CD43 antibody (Dako DFT1) stains a
high percentage of T cells but also some B cells, neutrophils and
macrophages (Stross et al.1989). Since few B cells were found in the
infiltrates (see results) and neutrophils and macrophages could be
distinguished morphologically the cell counts with the CD43 antibody were
used to represent the T cell population in the assessment of ratios of cell
types. The OPD4 monoclonal antibody reacts against the CD45RO
determinant and selects a similar population of T lymphocytes to the UCHL1
antibody (Poppema et al. 1991) although it does not react against monocytes
or granulocytes, the initial report of this antibody suggested that it was
reactive against a helper/inducer T cell subpopulation (Yoshino et al.1989).
3.4.3. Localisation of pathological changes in Behcet's disease
In Behcet's disease the early stage pathology seen in the post-mortem
frozen tissue is primarily focussed on the retinal and optic nerve vasculature
with associated destruction of related retina and optic nerve tissue. The
choroiditis appears to be a secondary event. In multifocal posterior uveitis,
by comparison, the primary pathological damage is at the level of the RPE
and outer retina and there is a marked, focal choroidal infiltrate. Additionally
the advanced vascular wall thickening and luminal narrowing seen in the
retina and optic nerve in Behcet's disease was not seen in multifocal
posterior uveitis where the vascular changes were found focally in the
choroid. Therefore, although there may be shared immunopathological
processes, the anatomical site of the tissue pathology (and also, by
implication, the inciting antigens) may differ between forms of intraocular
inflammation.
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In experimental autoimmune uveoretinitis there is often marked
pathological change in both the retina and choroid (where there are no
limiting anatomical factors) although "high endothelial venule" changes
have been reported to occur only in the retinal vasculature (Dua et al. 1991)
in the Lewis rat model, implying that these are the sites of lymphocyte
trafficking, and that this model is closest to human intraocular inflammation
where retinal vasculitis is the dominant feature. It would be of interest to
carry out electron microscopic examination on the vasculature of human
eyes with active retinal vasculitis to investigate the morphology of the
vascular endothelial cells.
3.5.3. Antigen presentation in Behcet's disease
The cellular expression of the MHC class II antigen HLA DR was found
to be similar in both the unfixed frozen tissue and the formalin fixed tissue.
Expression of class II by tissue resident cells such as the RPE and vascular
endothelium (which constitute the the blood-retinal barrier where antigen
presentation could potentially happen) was generally at a lower level than
described in other forms of intraocular inflammation (Chan et al. 1986a;
Chan et al.1987; Chan et al.1988b; Wetzig et al.1988). Aberrant expression
of MHC class II antigens has been demonstrated on endogenous tissue
cells in conditions thought to be of autoimmune aetiology (Hanafusa et
al.1983; Ballardini et al.1984) and it has been suggested that these cells
may play a role in antigen presentation to infiltrating CD4 positive T
lymphocytes (Bottazzo et al.1983) such as those demonstrated in these
studies. However as discussed in chapter 1 the expression of MHC class II
antigen does not by itself confer the ability to present antigen (Morahan et
116
al. 1989) and may indeed lead to T cell anergy in the absence of an
appropriate co-stimulatory signal (Schwartz, 1990; Gaspari et al.1988).
Given the low level of aberrant class II expression by tissue resident cells
found in the above studies and the numerous class II positive macrophages
present in the later stages of the disease process it appears likely that
macrophages are the major antigen presenting cells at this stage. The role
of MHC class II positive tissue resident cells, such as RPE and vascular
endothelial cells, in vivo remains uncertain and may be of central
importance to disease progression since these cells have the potential to
induce anergy (and also possibly to activate T cells if the necessary co-
stimulatory signals are present). The balance of the in vivo result of antigen
presentation by macrophages and by tissue resident cells with autoreactive
T cells could therefore determine the outcome of the interaction of such T
cells with self antigen following an initial ocular insult. Macrophage
presentation of antigen to T cells producing upregulation of the anti-self
response and subsequent autoimmune disease whereas antigen
presentation by tissue resident cells leading to down regulation and acting
to limit the autoaggressive response.
3.4.5. Treatment of Behcet's disease
It is notable that despite heavy immunosuppressive therapy the
perivascular T cells in the frozen tissue continued to express IL2 receptors.
This demonstrates the difficulty in adequately treating the severe vasculitis
seen in Behcet's disease. The success of future immunotherapy for Behcet's
disease depends on targetting specific cellular components involved in the
pathogenesis of the tissue destruction. The demonstration of IL2 receptor
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positive, CD4 positive T lymphocytes in the vasculitic lesions in ocular
Behcet's disease suggests that downregulating the effects of these cells
would be beneficial in controlling the severe ocular inflammation.
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Figure 21
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Figure 23
Hyaline thickening and luminal narrowing (arrows) of vessels in
disorganised retina, x 280 H&E
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Figure 24
0PD4 positive T lymphocytes (identified by a ring of cell membrane staining)
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Perivascular distribution of OPD4 positive T lymphocytes (arrowheads,
identified by a circle of cell membrane staining) in fibrovascular tissue in
advanced Behcet's disease, x 250, haematoxylin counterstain.
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Positive staining for IgM immunoglobulin (arrowheads) on cells within an
inflammatory infiltrate, x 250, haematoxylin counterstain.
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Figure 28
Scattered cells positive for IgG immunoglobulin (identified by a circle of cell




T lymphocyte (arrow) in the wall of a hyalinised retinal vessel (T3
monoclonal antibody). x360, haematoxylin counterstain.
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Figure 30
T lymphocytes (arrows) around vessels in optic nerve head, x 360, T3
monoclonal antibody, haematoxylin counterstain.
1
Figure 31
A small cluster of B lymphocytes (arrowhead) related to a vessel in




Numerous macrophages (MAC 387 monoclonal antibody, identified by a




HLA DRa positive inflammatory cells (arrowheads to examples) within

































































































PRIMARY ANTIBODIES USED ON FIXED TISSUE
ANTIBODY Source Dilution Specificity
Leucocyte Common
Antigen (LCA)
Dako 1:50 Leucocytes (CD45)
UCHL1 Dako 1:100 T lymphocytes *
DFT 1 Dako 1:75 T lymphocytes (CD43) **
OPD4 Dako 1:10 T lymphocytes





MAC 387 Dako 1:100 Monocytes/macrophages
HLA DR alpha Dako 1:50 Alpha chain of HLA DR Ag.
igG Serotec 1:1000 IgG heavy chain
IgM Serotec 1:1000 IgM heavy chain
C1q Serotec 1:1500 Complement component C1q
C3c Serotec 1:1500 Complement component C3c
* Norton et al. 1986, Terry et al. 1988
** Stross et al 1989
All mouse monoclonal antibodies except C1q and C3c : sheep polyclonal
TABLE 4
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BEHCET'S DISEASE : PRIMARY MONOCLONAL ANTIBODIES USED ON
FROZEN TISSUE
ANTIBODY SOURCE DILUTION SPECIFICITY
T3 Dako 1:50 Pan T lymphocytes
T4 Dako 1:10 CD4+ T lymphocytes
T8 Dako 1:100 CD8+ T lymphocytes
L 26 Dako 1:50 B lymphocytes
IL2 R Dako 1:100 Interleukin 2 receptor
MAC 3 Dako 1:200 Monocytes/macrophages
HLA DR Dako 1:100 HLA DR antigen expression
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TABLE 5
BEHCET'S DISEASE: (formalin fixed specimens)
Cell counts - Mean positive cell numbers per high power field
(40 fields counted for each antibody per specimen)
Antibody
Specimen LCA UCHL1 CD43 OPD4 L26
1
(1090/89)
55.2 16.7 19.1 26.6 0.5
2
(2100/81)
53.3 14.6 15.2 16.7 0
3
(1974/80)
23.6 3.3 18.5 9.2 0.5
4
(1301/89)
18.0 3.8 3.8 11.0 0.1
5
(1392/89)




Overall mean cell counts per high power field of formalin fixed eyes











* CD43 = 38% of LCA positive cells
** L26 = 1 % of LCA positive cells
T cell : B cell ratio (CD43.L26) = 33:1
Standard error of difference between CD43 and L26 counts = 2.8
(See notes on statistical methods appendix, page 222)




RETINA AND PERIRETINAL SCAR TISSUE
Cell counts - Mean positive cell numbers per high
power field
(20 fields counted for each antibody per specimen)
Antibody
Specimen LCA UCHL1 CD43 OPD4 L26
1
(1090/89)
29.5 7.8 10.4 26.6 0.1
2
(2100/81)
104.6 28.8 29.0 31.0 0
3
(1974/80)
22.8 3.0 13.8 1.4 0
4
(1301/89)
14.7 1.0 1.2 11.0 0.1
5
(1392/89)





Cell counts - Mean positive cell numbers per high
power field
(20 fields counted for each antibody per specimen)
Antibody
Specimen LCA UCHL1 CD43 OPD4 L26
1
(1090/89)
80.8 25.6 27.8 26.5 0.8
2
(2100/81)
2.0 0.5 1.4 1.4 0
3
(1974/80)
24.4 3.7 23.3 17.2 1.0
4
(1301/89)
21.2 6.6 5.5 11.1 0
5
(1392/89)
38.8 2.2 17.8 5.6 1.8
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CHAPTER 4
IN VIVO LYMPHOKINE PRODUCTION IN EXPERIMENTAL AUTOIMMUNE
UVEORETINITIS
4.1 Introduction
4.2 Investigation of effector cells in EAU
4.2.1. Cytokine production by effector cells
4.2.2. Analysis of cytokines
4.2.3. Aims of the investigation of cytokines in EAU
4.3 Materials and methods
4.3.1 Animal model
4.3.1.1. Preparation of tissue sections
4.3.2. Probe preparation
4.3.2.1. Probe amplification
4.3.2.2. Analysis of plasmid DNA
4.3.2.3. Probe extraction (large-scale)
4.3.2.4. Probe labelling


























4.5 Technical aspects of EAU studies
140
4.1 Introduction
Experimental autoimmune uveoretinitis is a well characterised animal
model of intraocular inflammatory disease and is reviewed in chapter 1.
Investigation of the posterior segment inflammatory cellular infiltrate in the
Lewis rat model of EAU has shown that there is a predominance of
mononuclear cells (lymphocytes and macrophages) and that these cells are
mostly T lymphocytes (Faure, 1980; Gery et al. 1986; Chan et al. 1985a). In
this respect the model corresponds to the T cell infiltrate found in the studies
of multifocal posterior uveitis and Behcet's disease described in chapters 2
and 3, and to the findings in other forms of human intraocular inflammatory
disease (Jakobiec et al.1983; Chan et al. 1986c; Chan et al.1987; Wetzig et
al.1988). Furthermore the T cell infiltrate seen in the early stages of EAU in
this model is predominantly of the CD4+ subset (Chan et al. 1985a) a similar
finding to most studies of human disease. The Lewis rat model of EAU
therefore provides a basis for the experimental study of posterior segment
ocular immunopathology which can be considered analogous to the
immunopathology seen in human intraocular inflammatory disease.
4.2 Investigation of effector cells in EAU
Immunohistochemical analysis has demonstrated the presence of
lymphocytes and macrophages in the destructive pathology in EAU and has
also classified the lymphocyte subsets. This information does not, however,
tell us the role that these cells play in the immunopathological processes
responsible for the tissue destruction and in particular which cells are the
effector cells. An understanding of these processes will help us to design
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more specific therapeutic modalities for the treatment of human intraocular
inflammation.
4.2.1. Cytokine production bv effector cells
Cytokines are of major importance in the tissue destruction produced in
immune-mediated disease. Cellular interactions mediated by cytokines can
produce MHC antigen upregulation, cellular chemotaxis and recruitment,
and the activation and proliferation of effector cells, processes central to the
development of immune-mediated tissue pathology. In addition cytokines
may directly produce tissue destruction. The lymphocyte-derived cytokine
lymphotoxin, for example, has a cytotoxic action (Tite et al.1985; Paul et
al.1988; Feldmann et al.1989) and could potentially cause local tissue
damage.
The function of T lymphocytes has been correlated with their
lymphokine production patterns (Mosmann et al. 1986; Powrie et al.1988;
Powrie et al.1989; McKnight et al. 1991; Paliard et al.1988; Salmon et
al.1989; Mason et al.1990). Analysis of the in vivo lymphokine production by
T lymphocytes would therefore help define the functional nature of these
cells. Blocking the action of the effector cells in intraocular inflammation has
the potential to provide a means of controlling the damage produced by
chronic intraocular inflammation.
4.2.2. Analysis of cytokines
Several approaches are available in the analysis of the cytokine action
in vivo. Samples of tissue fluid can be analysed for the presence of bioactive
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cytokine using specific bioassays, this approach is of limited value in the
investigation of ocular disease since samples of such fluid are rarely
available for analysis and are not necessarily representative of the local
tissue effects of cytokines which may act only in the microenvironment of the
secreting cell. Monoclonal antibodies reactive against cytokine protein are
now available for some cytokines which allow the immunohistochemical
analysis of tissue sections for cytokine protein. This approach, however,
does not define the cell of origin of the secreted protein or the number of
cells actively producing a cytokine.
Analysis of cytokine mRNA can be carried out using molecular biology
techniques. Using specific DNA or RNA probes cytokine mRNA can be
localised on tissue sections using in situ hybridisation. The principle of in
situ hybridisation is the use of a labelled, specific DNA or RNA probe to
hybridize with mRNA within a cell (Penschow et al.1987; Penschow et
al.1986). The resulting hybrid is then detected using autoradiography if the
probe is radiolabeled or an enzymatic detection system such as avidin-
biotin or digoxigenin. The tissue section or cell smear can then be analysed
for the presence of signal. This approach has the advantage of detecting
cells which are actively producing cytokine mRNA within tissues. The mRNA
may also be extracted and analysed using the "northern" blotting technique
or can be amplified using the polymerase chain reaction (PCR) (Bell, 1989)
where the mRNA is present in small copy numbers (as is the case for most
cytokines).
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4.2.3. Aims of the investigation of cytokines in EAU
The aim of the experimental work described in this chapter was to
analyse the pattern of expression of mRNA for the lymphokines interferon-y,
IL2, lymphotoxin, and IL4 in vivo in EAU at various time points during the
development of the disease and to relate this to the cellular infiltrate.
Interferon-y, IL2, lymphotoxin and IL4 are well characterised cytokines with
multiple actions (Trinchieri et al.1985; Haworth et al.1989; Paul et al.1988;
Paul et al. 1987). All are produced by T lymphocytes which have been shown
to be the predominant cell type in the destructive tissue pathology of EAU.
These lymphokines were selected for study to produce an overall picture of
the destructive process in EAU. Interferon-y, IL2 and IL4 are important in
cytotoxic T lymphocyte (CTL) differentiation (Chen et al.1986; Haworth et
al.1989) and also in B lymphocyte activation (Haworth et al.1989).
Interferon-y and lymphotoxin appear to be important mediators of CD4+ T
cell cytotoxicity (Tite et al.1985).
The actions of an individual cytokine in a complex cytokine network in
the microenvironment of destructive pathology is difficult to determine. The
cellular secretion pattern of these four cytokines does, however, define the
functional cellular subtype of the infiltrating cells. With regard to murine
CD4+ T cells interferon-y, IL2 and lymphotoxin are produced by the Thi
subset thought to function as effector cells and IL4 is produced by the Th2
subset thought to act as helper cells (Mosmann et al.1986). Although the
subdivision of CD4+ T cells appears to be more complex in rats and humans
(Powrie et al.1988; Powrie et al.1989; McKnight et al. 1991; Paliard et
al.1988; Salmon et al.1989; Mason et al.1990) in the rat the essential
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subdivision appears to be between CD4+ T cells producing IL2 and
interferon-y and those producing IL4 (Powrie et al.1988; Powrie et al.1989;
McKnight et al. 1991).
The pattern of cellular secretion of these four lymphokines will therefore
help identify the functional nature of the T cells involved in the destructive
pathology in EAU. Analysis of lymphokine secretion was carried out using a
combination of (a) immunohistochemistry using primary antibodies to
lymphocytes and, where available, to cytokines and cytokine receptors, and
(b) in-situ-hybridisation using molecular probes to cytokine mRNA. No
previous studies have analysed the localisation of cytokine protein or mRNA
in EAU.
4.3 Materials and methods
4.3.1. Animal model
Female Lewis rats (bred under SPF conditions, St Thomas' Hospital
Medical School), 100-150 grams weight, 6-8 weeks old were used in all
experiments. Rats were immunised subcutaneously in a hind footpad and
base of tail with a total of 50 jug of purified bovine S-antigen (prepared at the
Institute of Ophthalmology, London) (Dorey et al.1982) (Fig. 34) in an
emulsion in complete Freund's adjuvant supplemented with Mycobacterium
tuberculosis organisms to a final concentration of 2.5 mg/ml. Animals were
simultaneously given heat inactivated Bordetella pertussis organisms in 150
}il PBS intraperitoneal^. Animals were killed by cervical dislocation
following ether anaesthesia at days 10,11,12,13,14, 17 and 21 post-
immunisation, the eyes rapidly enucleated, embedded in optimal cutting
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temperature compound (OCT) and snap-frozen in acetone and dry-ice.
Specimens were stored at -70° C until used.
4.3.1.1. Preparation of tissue sections
Horizontal sections of the whole eye were cut on a cryostat, these were
cut as serial sections where technically feasible. For in-situ-hybridisation
sections were cut at 12 thickness and mounted on slides prepared as
follows: washed slides were dipped in a solution of 0.25% gelatin (300
bloom swine) and 0.025% chromium potassium sulphate, dried and dipped
again. For immunohistochemistry 6 pm sections were mounted on slides
coated in 3-Aminopropyltriethylsilane (APES) (2% in methylatred spirit).
Slides were stored at -70°C until used to preserve mRNA.
4.3.2. Probe preparation
Four cDNA probes were used for the in-situ-hybridisation. The rat
interferon y probe consisted of a 528-bp comprising two identical repeats of
a 264-bp sequence corresponding to the last 21 residues of exon 2, all of
exon 3 and the first 60 residues of exon 4 as deduced from the rat I FN y
gene structure (Dijkema et al. 1991). The rat IL2 probe was a full-length 740-
bp fragment corresponding to rat IL2 mRNA (McKnight et al.1989). The rat
IL4 probe consisted of the first 406-bp of the specific rat IL4 gene structure
(McKnight et al. 1991). The lymphotoxin probe was a 1.42 kbp coding
sequence derived from the murine lymphotoxin gene (Li et al.1987).
Lymphotoxin is a highly evolutionary conserved protein (the human
protein (Nedwin et al.1985) has 74% homology to the murine protein (Li et




Probe containing plasmids (with ampicillin resistance gene) were
amplified in E. Coli bacteria (HB 101, ampicillin sensitive) using the
following method. A single colony of E. Coli was grown overnight in 50 ml of
LB medium (1% bactrotryptone, 0.5% yeast extract, 1% NaCI, pH 7.5) at
37°C. These were spun twice at 4500 RPM and resuspended in Tfx solution
(30mM NaCI, 5mM MgCl2, 5mM Tris-CI pH 7.4), spun again and
resuspended in 5 ml Tfx. 200 jul of cells were then aliquoted into eppendorf
tubes and plasmid added at concentrations of 50ng/10ml and 1ng/10ml in
duplicate. These were incubated on ice for 1 hour and heat shocked at 42°C
for two minutes, 0.6 ml LB medium added and incubated for 30 minutes at
37°C. 40[xl from each sample was then plated onto LB agar/ampicillin plates.
The eppendorfs were then centrifuged in a microcentrifuge, the supernatant
discarded and the final 40^1 including the residual pellet plated as above.
These plates were incubated at 37°C overnight and single colonies were
selected and again grown overnight.
4.3.2.2. Analysis of plasmid DNA
To verify the above bacterial transformation a "mini-prep" analysis of
the bacteria was carried out as follows: a single colony was grown in 5ml LB
medium (supplemented with 50|ug/ml ampicillin), 1.5ml was then transferred
to a eppendorf tube and centrifuged for 20 seconds to pellet the bacteria.
The supernatant was removed and the pellet resuspended in 100jnl 50mM
dextrose, 25mM Tris-HCI pH 8.0, 10mM Na4EDTA pH8.0 and left at room
temperature for 7 minutes. To this tube 200j.il of 1% SDS, 0.2N NaOH was
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added and this was incubated on ice for 7 minutes. 150^1 of ice cold 0.1M K
acetate solution was added and this was left on ice for 7 minutes and
centrifuged for 15 minutes. Supernatant was transferred to a fresh eppendorf
tube 0.25ml saturated phenol, 0.25ml CHCl3-isoamylalcohol (24:1) added
and microcentrifuged for 15 seconds at room temperature for phase
separation. The top (aqueous) phase containing plasmid DNA was
removed, 1ml 95% ethanol added, mixed and left for 15 minutes at room
temperature. The tube was then centrifuged for 5 minutes to pellet the DNA
and the alcohol supernatant poured off. The pellet was then rinsed in 70%
ethanol, centrifuged again, the alcohol poured off and the pellet air dried.
This pellet was then resuspended in 50pil TE buffer (10 mM Tris pH 8.0, 0.1M
EDTA pH 8.0). 5j.il of this solution was then used for enzyme digestion.
Plasmid DNA digestion was carried out using restriction endonuclease
enzymes specified for the individual probe/plasmid combination (EcoRI and
BamHI for the interferon gamma, IL2 and lymphotoxin probes, Hind III and
BAM H1 for the IL4 probe) together with the appropriate buffer solution.
Digestions were carried out at 37°C for 2 hours. DNA was then denatured by
heating to 65°C for 2 minutes. Gel loading buffer (glycerol 50%, 1xTAE buffer
with 1 % bromophenol blue, 1 % xylene cyanol) was added to the digest
sample and to controls at 1 /5th of the final volume. Control DNA samples
used were (a) Hind III cut k phage and (b) 123 bp ladder. Samples and
controls were run together on gel electrophoresis apparatus (at approx. 60V)
using 0.9% agarose (typell, medium EEO) gel with 12 jaI ethidium bromide
(10mg/ml). Photographs of the gels were taken using UV transillumination.
By comparison of digest DNA with control DNA it was possible to verify the
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presence of the appropriate bp sequence of the probe within the plasmid
extracted from the transformed bacteria.
4.3.2.3. Probe extraction (large-scale)
Single colonies of plasmid containing E. Coli were grown at 37°C in
100 ml of ampicillin supplemented LB broth overnight. The medium was
then spun at 5000 rpm for 10 minutes, the pellet resuspended in 4 ml ice-
cold TEG buffer (50mM glucose, 25 mM Tris.HCI, 10mM EDTA, pH=8.0) 8 ml
0.2M NaOH, 1% SDS added and left on ice for 5 minutes. 6ml of 3M
NaAcetate pH5.2 was then added, mixed and left on ice 5 minutes and spun
at 15000 rpm for 20 minutes. The supernatant was taken and 18 ml of
isopropanol added, mixed, left at room temperature for 5 minutes and spun
at 7000 rpm for 10 minutes. The supernatant was poured off, the pellet
washed in 70% ethanol and spun again at 7000 rpm for 10 minutes. The
pellet was then redissolved in 0.5 ml TE buffer, 5^1 of 10mg/ml RNAaseA (in
10mM Tris.HCI pH 7.5) and incubated at 37°C for 30 minutes. DNA was
extracted by mixing with 0.25 ml Phenol/Tris, 0.5 ml Phenol/CHCl3 (three
times), 0.5 ml CHCI3 and 0.5 ml ether (twice) and taking the aqueous layer
each time after seperation. 50jmI of 3M NaAcetate pH5.2 was then added
together with an equal volume of isopropanol, left at room temperature for 10
minutes and spun on a microcentrifuge for 10 minutes. The pellet was then
washed in 70% ethanol, spun and resuspended in 200^1 of TE buffer.
The concentration of DNA in solution was measured reading the optical
density using a spectrophotometer. 5jnl of sample with 995|xl of water was
read at a wavelength of 260 nm: the DNA concentration (jig/fxl) is equal to 10
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times the optical density. The purity of the sample was assessed by taking a
second reading at 280 nm. A ratio of the optical densities at 260 nm: 280 nm
equal to 2.0 is due to pure nucleic acids, if the ratio is less than 1.6 then the
sample has significant protein contamination. Where protein contamination
was present in a sample a further extraction with Phenol/CHCta and ethanol
precipitation was performed.
4.3.2.4. Probe labelling
Probes were radiolabeled using the random-primer technique
(Boehringer mannheim). 25-100 ng of probe was used for each labelling.
Probe was initially denatured by heating to 95°C for 10 minutes then cooled
on ice. To the denatured probe 5jal of 35S (=25[iCi, specific activity
>1000CI/mmol) dCTP (CTP was used for initial experiments), 1jnl of dATP,
dGTP and dTTP, 3_tl of reaction mixture (hexanucleotide in 10x concentrated
reaction buffer), Ijul of Klenow enzyme and 8^1 of distilled water were added.
This was incubated at 37°C for 30 minutes and 2jnl of EDTA (0.2mol/l, pH
8.0) was then added to stop the reaction. This was adjusted to 10Ojul with
G50 column buffer (0.1M NaCI, 0.05M Tris-HCI pH8.0, 0.001 M EDTA, 0.02%
SDS). A G50 sepharose column was then prepared by running through 3ml
TE buffer, the probe was then run through the column and collected in a
second aliquot of 400 jal TE buffer. Radioactivity was measured on a
scintillation counter by measuring 1jnl with 99|ul scintillation fluid. Probe
activity was then adjusted to 2x105 CPM/ml in hybridisation buffer (see
below) prior to hybridisation.
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4.3.3. In situ hybridisation
All glassware and solutions were treated with 1% diethylpyrocarbonate
(DEPC) followed by autoclaving to ensure that there was no exogenous
RNAase activity during hybridisation. Slides were warmed to room
temperature and fixed for five minutes in 5% glutaraldehyde in 0.1 M
phosphate buffer pH7.2 (0.1 M Na2HPC>4, 0.1 M KH2PO4) with 20% ethylene
glycol then rinsed twice in hybridisation buffer (600mM NaCI, 50mM NaP04
pH7.0, 5mM EDTA, 0.02% Ficoll, 0.02% bovine serum albumin, 0.02%
polyvinylpyrrolidone, 0.1% DNA (salmon testis) and 50% deionised
formamide). The slides were then soaked in hybridisation buffer for one hour
(found to be the optimal time to prevent background signal) rinsed in ethanol
and air dried. The radiolabeled probe in hybridisation buffer was heated to
90°C for 10 minutes, cooled and 100jil applied under a parafilm coverslip.
Sections were left to hybridize at room temperature for 72 hours in a
humidified chamber. Post hybridisation slides were immersed in 2xSSC
(2xSSC=0.3M NaCI, 0.03M Na citrate) until the coverslips dislodged, rinsed
in 2xSSC and washed at 40°C for 30 minutes inlxSSC. Slides were then
rinsed briefly in distilled water, in 70% ethanol for five minutes, in 95%
ethanol for five minutes and allowed to dry.
4.3.4. Autoradiography
Slides were taped to blotting paper and overlaid with an X-ray film in a
film cassette and exposed for 3-4 days. This film was then developed to
evaluate the strength of the hybridisation signal. Slides were then dipped in
K5 (llford) photographic emulsion diluted 1:1 in 0.5% glycerol and left to
151
expose over silica gel at 4°C for 21-24 days depending on the hybridisation
signal strength on the X-ray plate. The slides were then developed for 3.5
minutes in D19 developer (Kodak) fixed in Unifix (Kodak), washed in
distilled water, counterstained with haematoxylin and coverslips mounted.
4.3.5. Controls
The following control studies were carried out simultaneously with the
in-situ-hybridisation described above.
4.3.5.1. Non-immunised animals
Eyes from non-immunised Lewis rats were processed in the same
manner as above to define the lymphokine gene expression in normal eyes.
4.3.5.2. RNAase
To confirm that positive signal was produced by probe binding to RNA
on the section, slides from each eye studied were treated with RNAase to
abolish specific binding to tissue RNA. Sections were fixed for five minutes
in glutaraldehyde buffer, washed once in 2xSSC with 5% Tween and three
times in 2xSSC. 100^1 of RNAase A 1mg/ml in 2xSSC was applied to each
slide under a parafilm coverslip and incubated at 37°C for 1 hour, slides
were then washed in 2xSSC and hybridisation carried out as above.
4.3.5.3. Irrelevant probe
To determine the specificity of the lymphokine probe hybridisation,
sections from each eye were also hybridised with a 35S labelled probe to the
P53 oncogene which was considered to be irrelevant to the EAU disease




Immunohistochemistry was carried out using the avidin-biotin-complex
method. Slides were warmed to room temperature then fixed for 7 minutes in
acetone and endogenous peroxidase activity blocked by immersion in 3%
hydrogen peroxidase in 50% methanol. Normal serum was then applied for
20 minutes. This was tipped off and primary monoclonal antibodies (Table 9,
page 186) applied in appropriate dilution in PBS for 30 minutes. Slides were
then washed in PBS and rat-adsorbed biotinylated secondary antibody
applied for 30 minutes . Following further washing in PBS, ABC complex
was applied for 45 minutes. The slides were again washed, developed in
AEC to give a red final reaction product and counterstained with
haematoxylin. Coverslips were mounted using aqueous-based mountant.
4.4 Results
There was consistent induction of bilateral intraocular inflammation in
the experimental animals using the immunisation schedule described
above.
4.4.1. EAU Pathology
The description below represents the results of observations made on
the eyes of 35 immunised animals. These findings are summarised in table
10 (page 187).
4.4.1.1. Disease Onset
Clinical observation of the immunised rats revealed conjunctival
hyperaemia in all animals with onset at days 12-13 post-immunisation. In a
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minority of animals onset of hyperaemia varied between the eyes by one
day.
Eyes from animals killed at days 9-11 post-immunisation did not show
any evidence of inflammatory disease. All animals at day 12 showed
evidence of early intraocular inflammatory changes. These changes
consisted of small numbers of mononuclear cells infiltrating the retina (Fig.
35a) and a mixed infiltrate of neutrophils and mononuclear cells in the iris,
ciliary body and anterior chamber (Fig. 35b).
4.4.1.2. Early disease (Day 131
Histopathologically there was a consistent mixed leucocytic infiltrate of
the structures of the anterior segment of all eyes examined. Leucocytes were
numerous in the anterior chamber by day 13 post-immunisation (Fig. 36a)
with only minimal variation in this pattern. The retinas of all eyes examined
contained an infiltrate of predominantly mononuclear leucocytes. In a
majority of eyes examined at day 13 early foci of photoreceptor necrosis and
oedema were observed (Fig. 36b)
4.4.1.3. Intermediate disease (Days 14-17)
Clinically animals had hyperaemic eyes with consistently hazy media.
Most animals also had variable degrees of hypopyon formation in the
anterior chamber. Histopathologically all animals had a mixed leucocytic
infiltrate in the structures of the anterior segment of similar intensity to that
observed at day 13 post-immunisation. All animals had inflammatory
changes observed in the posterior segments although the intensity of the
inflammation varied. Localised foci of outer retinal oedema and necrosis
showed variable degrees of development (Fig. 37a-c) along with localised
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areas of retinal detachment with underlying subretinal serous fluid. A mixed
infiltrate of inflammatory cells was also found in the vitreous. By day 17 the
majority of photoreceptors in most of the animals examined were
degenerate. All eyes had a mononuclear cell infiltrate in the choroid, the
cells being more numerous in eyes where there was more advanced retinal
destruction.
4.4.1.4. Late stage disease (Davs 18-21)
Clinically the eyes were less hyperaemic although most still had
hypopyons. Histopathologically the anterior segment inflammation was in
general less intense. A degree of retinal destruction was seen in all eyes -
this varied fron total loss of retinal architecture with extensive retinal
detachment (Fig. 38) to more focal retinal destruction and oedema with
areas of intact retinal architecture still identifiable. There was a marked
accumulation of mononuclear cells in the choroid at this stage of the disease
process (Fig. 38).
4.4.2. Cellular Immunohistochemistrv
T lymphocytes, identified by the OX 19 monoclonal antibody, were
found in inflammatory infiltrates throughout the extraocular tissues, anterior
chamber, ciliary body, choroid and retina at all stages of the disease
process. Comparison of CD4+ to CD8+ T cells (identified by the W3/25 and
0X8 antibodies respectively) found a predominance of W3/25 positive cells
in the early and intermediate phases of the disease and increasing numbers
of OX8 positive cells as the disease progressed, as has been reported
previously (Chan et al. 1985a). T lymphocytes in the inflammatory infiltrates
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in both the anterior and posterior segments also showed positive staining for
IL2 receptor expression (Fig.39). MHC class II expression (0X6 antibody)
was found on cells from day 10 post-induction onwards, this increased
markedly as the disease progressed and was seen on both organ-resident
and infiltrating cells.
4.4.3. Lvmphokine Immunohistochemistrv
The interferon-y monoclonal antibody gave positive staining of cells
from day 12 post-induction onwards. Mononuclear cells in the extraocular
tissues, anterior chamber, ciliary body, choroid, retina, vitreal cavity and
subretinal fluid all showed positive staining (Fig. 40). The staining intensity
increased as the inflammatory process progressed.
4.4.4. In Situ Hybridisation
Eyes from 24 immunised and 4 control (non-immunised) rats were
studied by in-situ-hybridisation. The time points examined were as follows:
days 10 and 11, two animals from each day, days 12,13,14,17 and 21, four
animals from each day. A total of 398 individual hybridisations were carried
out to determine the pattern and reproducibility of the results. The results of
all hybridisations were integrated to produce an overall analysis of the
findings.
Levels of background signal (the amount of scattered dark grains in the
photographic emulsion) varied on the numerous hybridisation procedures
carried out but in all experiments, for all four probes, discrete collections of
dark grains were identifiable over the background signal. The collections of
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autoradiographic signal were seen in sections from eyes at day 12 post-
immunisation onwards and occured over mononuclear cells in the areas of
the T lymphocyte infiltrate. These foci were interpreted as positive
localisation of expression of lymphokine mRNA by lymphocytes.
The characteristics of the pattern of hybridisation for each probe is
described in the sections below. To provide an estimate of the relative
numbers of cells expressing mRNA for an individual lymphokine at a given
time-point in the disease, the number of positive foci in the retina and
choroid were counted on each eye section and the mean value taken at
each time point. Standard deviations and standard errors of the means of
these counts were calculated. These figures were grouped together as early
disease (days 12 and 13 post-immunisation), established disease (days 14
and17) and advanced disease (day 21) in the tables and graphs used to
illustrate the results for each probe.
4.4.4.1. IFNv Probe
No positive localisation of hybridisation signal was seen in sections of
eyes studied at days 10 and 11 post-hybridisation. Positive hybridisation foci
were observed from day 12 post-immunisation onwards. In the early stages
of the disease process positive cells were seen in the outer retina and
choroid (Fig. 41). These cells were often related to the localised patches of
retinal oedema and destruction which were seen in the model at this stage
(Fig. 42). There were also numbers of positive cells in the anterior
extraocular tissues at the early stage of the disease. As the retinal
destructive process progressed increasing numbers of positive cells were
seen in the choroid (Fig. 43) as well as in accumulations of inflammatory
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cells in the ciliary body and the anterior extraocular region. At the later time
points when there was marked retinal destruction positive foci were a
variable finding in the necrotic retinal tissue and consistently high numbers
of positive foci were found in the choroid .
The relative numbers of positive foci throughout the disease process
are documented in table 11 (page 188) and illustrated in figure 44. This data
demonstrates that there is a significant increase in the numbers of positive
foci in late disease and that this is a reflection of the increase in foci counted
in the choroid. The numbers of positive foci in the retina declined in
established and late disease due to the loss of intact retinal tissue. The
standard deviations and standard errors for the counts of positive foci are
relatively high especially in the early and established phases of the disease
process, this is due to the variation between counts from individual eyes.
It was notable that fewer cells were positive for interferon-y mRNA than
for immunohistochemical localisation of interferon-y protein as demonstrated
using the interferon-y specific monoclonal antibody. Although there was a
heavy infiltrate of mixed inflammatory cells in the anterior chamber no
positive signal was seen over any cells in this area.
4.4.4.2. IL2 Probe
There were no localising foci found in the eyes studied at days 10 and
11 post-immunisation. Positive signal for IL2 mRNA was found from day 12
post-immunisation onwards. In the early phase of the disease there was an
accumulation of positive cells around the areas of retinal oedema and
destruction (Fig. 45). These positive cells were localised to the inner retina
despite the focal necrosis of the photoreceptors. At the early disease stage
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there were also minimal numbers of positive cells in the choroid and
vitreous. In the eyes with established and advanced disease there were
numerous positive cells in the retina and vitreous, and markedly increased
numbers of positive cells scattered throughout the ciliary body and choroid.
The relative numbers of positive cells present within the eyes of
immunised animals are documented in table 12 (page 189) and figure 46.
These results show that the number of positive foci increased in the choroid
as the disease progressed and the difference from early disease reached
statistical significance in the choroid and also in the overall figures. Numbers
of positive foci in the retina showed no significant change. The relatively
high standard deviations and standard errors reflect the variation between
individual sections examinedNo positive signal was seen on cells in the
anterior chamber. Numerous positive cells were seen in the extraocular
inflammatory infiltrates in both anterior and posterior extraocular regions at
all stages of the disease process.
4.4.4.3. Lvmphotoxin Probe
Positive hybridisation signal from the lymphotoxin probe was generally
less strong than the other probes utilised. No positive cells were seen at
days 10 and 11 post-immunisation. In the early phase of the disease
positive cells were most numerous in the extraocular inflammatory cell
infiltrates but a few scattered positive cells were also found in the choroid
and very occasional positive cells in the retina at this stage. Positive foci of
hybridisation signal were prominent in the choroidal infiltrate in the later
phase of the disease. In general very few lymphotoxin mRNA positive cells
were found in the retina. No positive cells were found in the anterior
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chamber.
Numbers of positive cells increased as the disease progressed (Fig.
47), these results are documented in table 13 (page 190) and illustrated in
figure 48. The data presented in this table and figure demonstrates that there
is a significant increase in the number of positive cells in the late phase of
the disease and that this is due to the increased numbers present in the
choroid at this stage. The relatively high standard deviations and standard
errors again reflects the variation between individual sections.
4.4.4.4. IL4 Probe
Hybridisations with the IL4 probe revealed positive cells from day 12
post-immunisation onwards, there were no positive foci at days 10 and 11
post-immunisation. Positive foci of hybridisation were seen in the inflamed
retina (mainly the inner retina, related to patches of retinal necrosis and
destruction), choroid and extraocular infiltrates in the early phase of the
disease. In the established and late stages of the disease (Fig. 49) there was
a marked increase in the numbers of positive cells found in the ciliary body
and choroid. Small numbers of cells in the retina and subretinal fluid were
positive in the later stages of the disease process. Again, no positive signal
was seen on any of the numerous inflammatory cells in the anterior
chamber.
The numbers of positive cells throughout the disease process are
documented in table 14 (page 191) and figure 50. The significant increase
in positive cells in late disease seen with the IL4 probe was a consistent
finding in the uveal tract. In the retina numbers of positive foci decreased in
late disease due to destruction and loss of retinal tissue.
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4.4.4.5. Overall Results of In-situ-hvbridisation
The numbers of positive cells for each probe was generally a small
percentage (less than 10%) of the total T lymphocyte number as defined by
the 0X19 antibody. On the frozen sections examined
immunohistochemically it was not possible to make accurate cell counts of
the T cell numbers because of the difficulty in defining individual cells with
positive immunohistochemical stain in areas where there was a marked
accumulation of infiltrating mononuclear cells. Hence it was not feasible to
calculate the percentage of cells giving positive hybridisation signal within
the T cell population. It was, however, possible to compare the mean overall
number of positive cells for each lymphokine probe within the eyes (in all
areas) throughout the disease process, this is illustrated in figure 51. This
figure shows that the increase in positive cell numbers in late disease was
consistent to all four probes. The increase in cell numbers is also seen in the
established phase of the disease (days 14-17) for the IL4 probe and to a
lesser degree also the IL2 probe. Because the protocol used was not




No autoradiographic signal suggestive of localisation of lymphokine
mRNA was found using any of the probes in any of the four non-immunised
animals studied. Immunohistochemical analysis showed no expression of
MHC class II antigens within the eyes and only very occasional T
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lymphocytes in the anterior extraocular region which were not IL2 receptor
positive.
4.4.5.2. RNAase Pretreatment
Analysis of sections pretreated with RNAase at a concentration of
0.1 mg/ml for 30 minutes revealed faint residual traces of concentrations of
autoradiographic signal at the sites of positive foci found on the non-
pretreated sections. The concentration of RNAase was therefore increased
to 1 mg/ml and the incubation with RNAase increased to one hour, it was
found that this regime abolished all localising signal on the sections of all
the positive eyes for each probe (Figs. 45,47 &49).
4.4.5.3. P53 Probe
Sections hybridised with the P53 oncogene probe revealed a
generalised background signal over areas of inflamed tissue without any
focal cellular localisation.
4.5 Technical aspects of EAU studies
Immunohistochemical staining was carried out on unfixed tissue since the
monoclonal antibodies used do not recognize epitopes on fixed tissue, this
results in morphology which is in general less well preserved. The initial
immunohistochemical staining on the EAU eyes was performed with non-
adsorbed secondary antibody and gave high levels of background stain,
subsequent staining was therfore carried out using a rat-adsorbed
secondary monoclonal antibody which abolished this problem.
Modification of various parts of the techniques used in these studies
would be of benefit in the further development of the investigations. Cutting
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whole eye sections of frozen rat eyes on a cryostat is technically difficult due
to the delicate nature of the tissues and the lack of support provided by the
vitreous cavity to the unfixed retina. Brief fixation of the eyes (for example
with paraformaldehyde) could potentially produce an improvement in
morphology without compromising immunohistochemical staining or mRNA
hybridisation. Sectioning unfixed eyes to allow penetration of fixative was
performed in an earlier study however this resulted in retinal detachment in
all eyes and disruption of intraocular morphology.
Matching lymphokine mRNA expression to individual cells stained
immunohistochemically was not possible in this study although it was
feasible to localize such mRNA expression to areas of T lymphocyte
infiltrate. Serial sectioning of eyes would be desirable to match cells and
tissues on any given slide to an adjacent slide processed using a different
technique. Cutting serial sections of frozen, unfixed ocular tissues is
extremely difficult both because of the delicacy of the tissues themselves
and the variation in section thickness caused by minor fluctuations in
cryostat temperature. A potential solution to this problem would be to use a
double staining immunohistochemical technique (although this would not
have been possible for rat cytokines since IFN-y is the only cytokine to which
monoclonal antibodies are available) or to combine immunohistochemical
staining and in-situ-hybridisation on a single slide, a method which would
involve considerable technical difficulties due to the different requirements of
the two methods.
Beta irradiation from the 35S labelled probe tends to spread within the
photographic emulsion and the resulting signal is therefore not precisely
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localised over a cell. In this investigation the results were not compromised
by this effect however a more accurately localised signal could be obtained
by using a probe radiolabeled with an alternative radioisotope. An
alternative to radiolabelling of the probe is to use an enzymatic detection
system such as digoxigenin which has proven useful in the detection of viral
genomes (Furuta et al.1990). Enzymatic methods provide rapid results by
avoiding prolonged autoradiographic exposures and avoid the constraints
and risks of the use of radioactivity in laboratories, however it is uncertain
whether enzymatic systems are at present sensitive enough to detect low-
copy genes such as those for cytokines. In the investigations it was notable
that radiolabelling the DNA probe with CTP rather than dCTP gave similar
overall results, although its probe incorporation was much reduced this was
compensated by using a more concentrated hybridisation mixture.
Occasional slides were found to be unexpectedly negative when hybridised,
having been positive on previous hybridisations, this can be explained by a
contamination with RNAase during the hybridisation procedure.
Alternative methods could be employed to further investigate the
production of lymphokines by infiltrating cells in EAU. Cells could be
extracted from the eyes and analysed phenotypically on smears (or using
flow cytometry) lymphokine mRNA could then be analysed in a semi¬
quantitative manner using northern blot analysis or the polymerase chain
reaction (Bell, 1989) if only small quantities of mRNA message were found to
be present. Extracted cells could also be cultured as cell lines and the
lymphokine secretion measured by these molecular methods and supported
by assays of biological activity. Experiments involving the in vitro stimulation
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of rat T lymphocytes failed to detect IL4 mRNA by in-situ-hybridisation which
was found only using the polymerase chain reaction technique (McKnight et
al. 1991). The demonstration of IL4 mRNA by in-situ-hybridisation in vivo in
EAU suggests that the in vivo stimulus is more potent and produces a
greater expression of IL4 mRNA.
Photomicrography of autoradiographic slides presents difficulties in
focussing on both the tissue section and the grains in the photographic
emulsion which are on different focal planes. This problem is greatest at
higher powers of magnification where the depth of field of the objective lens
may not be sufficient to compensate. Although in general the best results are
obtained by focussing on the photographic grains it may be necessary to
compromise by focussing midway between focal planes to provide a degree
of morphological definition of the tissue.
Further development of the in-situ-hybridisation technique employed in
these studies could provide a method of quantification of lymphokine mRNA
present. This would involve a standardisation of the probe activity along with
incubation and exposure times used in the experimental protocol and
subsequently counting grains within the photographic emulsion. The liquid
emulsion used does not produce a coating which is even or of a standard
thickness and would therefore make results unreliable. This problem could
be overcome by the use of transparent photographic film of a standard
thickness which could be laid over a slide and would give reproducible
results. As a development of this method the EAU model could be modified




Electrophoretic gel (12.5% agar) demonstrating purified S antigen (arrow,
48kD) and molecular weight ladder (large arrowhead = 66kD, small
arrowhead = 45 kD)
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Figure 35
EAU - disease onset
a) Small numbers of leukocytes (arrowheads) infiltrating the retina which
retains its normal architecture.
b) Mixed leukocytic infiltrate within iris, ciliary body and drainage angle
x 200, H&E.
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Figure 36 (a) EAU - early disease. Numerous mixed leukocytes in the
anterior chamber and infiltrating iris and ciliary body,
x 200, H&E
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Figure 36 (b) Retina in early EAU with a leukocytic infiltrate to the inner
retina (arrowheads) and an early focus of photoreceptor necrosis and outer






EAU - intermediate stage
Examples of areas of outer retinal destruction and oedema (arrowheads),
(a) & (b) x 200 H&E
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Figure 37 (c)
EAU - intermediate stage





EAU - advanced disease
Retinal destruction and loss of architecture with an accumulation of mixed
leukocytes in the choroid (arrows)
a) & b) x 200 H&E
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Figure 39
IL2 receptor positive T lymphocytes (arrowheads) infiltrating ciliary body. IL2
receptor monoclonal antibody, haematoxylin counterstain. x 250.
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Figure 40
Positive immunohistochemical staining for interferon gamma (arrowheads)
over cells in disorganised retina in advanced EAU. x360, haematoxylin
counterstain.
Figure 41
EAU : early stage of the disease process. Hybridisation signal from
interferon-gamma probe over cells in outer retina (arrow) and choroid
(arrowhead), x 450, haematoxylin counterstain.
Figure 42
EAU : established disease. Hybridisation signal from interferon-gamma
probe over cells in retina (arrows) adjacent to an area of retinal oedema
(arrowhead). x450, haematoxylin counterstain.
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Figure 43
EAU : late disease. Multiple foci of hybridisation from interferon-gamma
probe (arrows to examples) in an area of advanced retinal destruction, x
280, haematoxylin counterstain.
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Figure 44 IFN-gamma probe:
Counts of positive foci of probe hybridisation























EAU : early stage of the disease process
Multiple areas of hybridisation to IL2 probe in inner retina (arrows to
examples) around a focus of outer retinal oedema and destruction. The
retina is detached with infiltration of leukocytes to the subretinal space
(arrowheads) and vitreous,
x 180, haematoxylin counterstain.
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Figure 45 (b)
EAU : early stage of the disease process
RNAase treated control on an adjacent section to figure 45 (a) with no
localising signal






EAU : late stage
a) Marked retinal destruction with positive localisation of lymphotoxin mRNA
(arrowheads).
b) RNAase control on adjacent section - no localising signal
x 200, haematoxylin counterstain.
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Figure 48 Lymphotoxin probe:
Counts of positive foci of probe hybridisation
















EAU : late disease
a) hybridisation signal from IL4 probe in choroid and retina
b) adjacent section to a) pretreated with RNAase - no localising signal
x 180, haematoxylin counterstain.
Figure 50 IL4 probe:
Counts of positive foci of probe hybridisation


















Figure 51 Comparison of lymphokine probes:
Counts of positive foci of probe hybridisation









(D 12-13) (D 14-17) (D 21)
Disease Stage









ANTIBODY SOURCE DILUTION SPECIFICITY
OX 19 Serotec 1:100 Pan T cells
W 3/25 Serotec 1:100 CD4 T cell subset
OX 8 Serotec 1:100 CD8 T cell subset
0X39 Serotec 1:75 IL2 receptor





All antibodies are rat specific
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TABLE 10 PATHOLOGICAL CHANGES IN EAU MODEL
Clinical Anterior Uveal tract Retina/
features segment vitreous
Disease Conjunc¬ Mixed PMN and PMN and Small numbers
onset tiva mononuclear mononuclear of lymphocytes
(Day 12) hyper- cells in anterior cells in iris and infiltrating the
aemic chamber ciliary body retina
Early Conjunc¬ Numerous Mixed WBC Early foci of
(Day 13) tiva mixed WBC infiltrate of iris photoreceptor





Inter¬ Hyper- Numerous Mixed WBC Foci of retinal
mediate aemia mixed WBC infiltrate of iris oedema and
(Days 14 Media and ciliary body necrosis with
-17) hazy Infiltrate of subretinal fluid
Hypopyon mononuclear Mixed WBC
in most cells in choroid infiltrate in
eyes vitreous
Late Media Mixed WBC - Marked Retinal
(Days 18 hazy smaller numbers infiltration of destruction:
-21) Hypopyon mononuclear advanced in
cells in choroid most eyes
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TABLE 11
EAU: INTERFERON GAMMA PROBE
Mean positive hybridisation foci per whole eye section
n = sections counted






























































Mean positive hybridisation foci per whole eye section
n = sections counted



















































0.317 > P >
0.1
7.49









Mean positive hybridisation foci per whole eye section
n = sections counted


































































Mean positive hybridisation foci per whole eye section
n = sections counted












































0.317 > P >
0.1
3.65
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5.1 Human intraocular inflammatory disease
The work in this thesis has covered both studies of tissue
immunopathology in clinical intraocular inflammation and experimental work
on an animal model of immune-mediated ocular inflammatory disease.
Certain problems are inherent to the study of the eye specimens obtained
from patients with intraocular inflammatory disease. Firstly the method of
tissue fixation employed on pathological specimens determines the
available investigational techniques. Fixation with glutaraldehyde gives
optimal preservation of morphology and is suitable for electron microscopic
examination. This method was used on one of the eyes available in the
study of multifocal posterior uveitis reported in chapter two and resulted in
the identification of swollen endothelial cells (seen on thin sections), small
breaks in Bruch's membrane, cellular junctional attachments (for example
the junctional complexes of RPE cells in the choroid) and cellular activity
such as the phagocytosis of photoreceptor outer segments by exogenous
macrophages. A limitation of glutaraldehyde fixation is that it makes
immunohistochemical examination impossible because of its effect of cross-
linking cellular proteins causing alterations of oligopeptide epitopes and
exclusion of antibodies from penetrating tissue sections. Formaldehyde
fixation gives good morphological preservation and also allows for
immunohistochemical analysis as was carried out on the other eye in the
study of multifocal posterior uveitis and on five of the eyes used in the study
of Behcet's disease. This combination is useful for immunohistochemical
identification of cell types involved in tissue pathology however the range of
monoclonal antibodies suitable for use on formaldehyde fixed tissue is
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limited (the monoclonal antibody UCHL1 for example is not absolutely
specific for T lymphocytes (Norton et al.1986; Terry et al.1988)). In some
cases antibodies may be less sensitive when used on formalin fixed tissue:
the HLA DR a chain antibody may be less sensitive than other HLA DR
antibodies which are suitable only for use on unfixed material. Unfixed,
frozen material gives the best results when used for immunohistochemical
analysis both in terms of antibody availability and sensitivity, however this is
at the cost of morphological preservation. The optimal approach is to use the
fixation method which will yield the maximal information from an individual
specimen, which in some cases may mean using a combination of all the
methods outlined above on a single specimen. In many cases this approach
is not possible since the specimen may already be fixed when received. In
retrospect it would have been advantageous to have frozen portions of all
the eyes used for the studies of human immunopathology to allow for
immunohistochemical analysis of cellular markers such as the interleukin 2
receptor and for more sensitive analysis of the MHC class II antigen
expression.
A further problem is the end-stage nature of much of the material
obtained for immunopathological analysis. The studies described in
chapters 2 and 3 of this thesis have demonstrated the problems in
determining the aetiology of many forms of intraocular inflammation. The
initiating agent may no longer be present either systemically or locally at the
time of clinical presentation of the ocular condition. This problem is common
to other diseases thought to be of autoimmune aetiology such as insulin
dependent diabetes mellitus where subclinical disease may be present for
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months or even years (Bottazzo et al.1985) before the condition is manifest.
The studies of human material in chapters 2 and 3 therefore primarily deal
with the mechanisms of perpetuation of intraocular inflammation. Indirect
evidence as to the aetiological factors involved may come from studies of
peripheral blood such as those implicating Epstein Barr virus in multifocal
choroiditis (Tiedeman, 1987) and herpes simplex in Behcet's disease (Eglin
et al.1982; Bonass et al. 1991; Hamzaoui et al. 1990a; Young et al.1988;
Hamzaoui et al. 1990b) and it is likely that more information will be produced
by studies of peripheral blood as the sensitivity of the tests available
improves.
Study of ocular tissue does, however, give clues to the aetiology of
these conditions: these may be negative such as the lack of any identifiable
infectious agent (although this is hardly surprising since a transient viral
infection may be sufficient to trigger an autoimmune disease) in any of the
eyes studied or the lack of any evidence of previous vascular occlusion in
multifocal posterior uveitis. Other findings are also relevant such as the
vascular wall hyaline thickening and luminal narrowing seen in the Behcet's
disease eyes (although not seen in all the end stage eyes again highlighting
the need for suitable material) suggestive of previous vascular occlusion.
The search for aetiological agents may be of secondary importance
since present therapies are aimed at a generalised control of the
inflammatory immunopathology and treatment of an initiating factor is not, as
yet, possible. This position may change, however, as newer and more
specific therapies develop and identification of an initiating insult may then
become of therapeutic significance.
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Despite the limitations of studying human material the
immunohistochemical analyses carried out on multifocal posterior uveitis
and Behcet's disease do provide useful information on the infiltrating cells in
the local pathology. These were characterised as predominantly T
lymphocytes (CD4+ in the frozen Behcet's disease specimen) which is in
line with the findings in eyes of other forms of posterior uveitis which have
been examined (Jakobiec et al. 1983; Chan et al. 1986c; Wetzig et al. 1988;
Chan et al. 1988b; Chan et al.1987).
5.2 T lymphocyte involvement in intraocular inflammation
The introductory discussion of EAU has stressed that this animal model
may not be analogous to any one form of human disease. Furthermore,
studies on patients with intraocular inflammation have given equivocal
results as to whether the antigens commonly used in disease induction in
animal models of EAU, that is S antigen and IRBP, are of significance in
human disease (Doekes et al.1987; Froebel et al.1989; Forrester et al. 1989;
Chan et al. 1985b; Froebel et al.1989; de Smet et al.1990). The EAU model
does, however, provide a form of ocular inflammation induced and
perpetuated by CD4 positive T cells.
The results of experimental work must be interpreted with caution in
regard to human disease. In EAE, for example, treatment of actively
immunised animals with cyclosporin A inhibits the development of disease
as does in vitro conditioning of transfer active cells (Hinrichs et al.1983). In
multiple sclerosis, however, the clinical response to cyclosporin therapy has
been disappointing (Rudge et al.1989). In human intraocular inflammatory
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disease there is often a favourable clinical response to therapy with
cyclosporin A (Nussenblatt et al. 1983a; Nussenblatt et al.1985; Graham et
al.1985; de Vries et al. 1990; Masuda et al.1989) similar to the response
found in EAU (Nussenblatt et al. 1981b). This T cell dependent aspect of the
EAU model is therefore analogous to human disease. This finding, however,
cannot necessarily be generalised to the interpretation of other aspects of
the T cell mediated immunopathology found in EAU.
Despite its limitations the EAU model is of relevance to human
intraocular inflammation. The infiltrating inflammatory cells in the posterior
segment destructive foci in the Lewis rat model of EAU have been
characterised as being predominantly T lymphocytes (with a high CD4:CD8
ratio in early disease) in studies from other centres (Chan et al. 1985a) and
in the model used for the experimental work described in chapter 4. This is
analogous to the retinal and choroidal infiltrate of CD4 positive T
lymphocytes found in forms of intraocular inflammatory disease where
immunohistochemical studies have been carried out (Jakobiec et al.1983;
Chan et al. 1986c; Wetzig et al.1988; Chan et al. 1988b; Chan et al.1987) and
our studies of multifocal posterior uveitis and Behcet's disease. This aspect
of the EAU model forms the basis of the experimental work since it is the
lymphokine secretion by the T lymphocytes in the destructive foci in EAU
which is under investigation. The results of the studies on in vivo lymphokine
secretion in EAU may therefore be of significance in relation to human
disease.
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5.3 In vivo production of lymphokines in ocular inflammation
5.3.1. Cytokine mRNA expression
The demonstration by in-situ-hybridisation of cytokine mRNA on a
tissue section indicates that individual cells have been stimulated to express
the cytokine gene but does not necessarily mean that they are actively
producing cytokine protein. This has been demonstrated for IFN-y production
by rat CD4+ T cells (McKnight et al. 1991) where a greater frequency of
CD4+ T cells positive for IFN-y mRNA was found in the 0X22 low group
although the level of secreted IFN-y protein is higher from 0X22 high cells.
This may be due to post transcriptional regulation of translation of IFN-y
mRNA or regulation of secretion of IFN-y protein. Grabstein and coworkers
demonstrated that stimulation of peripheral blood T cells resulted in
expression of mRNA for IL2, IL2 receptor and IFNy which correlated well with
the levels of the respective proteins obrerved (Grabstein et al.1986).
Likewise Carding and colleagues demonstrated good concordance
between IL2 and IL4 mRNA and secreted lymphokine as detected by
bioassay (Carding et al.1989). Recent work by Dallman et. al. (Dallman et
al. 1991) however, has shown that cellular IL2 mRNA expression is not
necessarily reflected by production of bioactive IL2.
In view of these conflicting studies the results of experimental work
demonstrating lymphokine mRNA must be interpreted with caution in regard
to production of bioactive lymphokine. Where possible molecular studies
should be supported by other findings such as the immunohistochemical
localisation of cytokine protein (as with IFN-y in the studies of EAU) or the
presence of cellular cytokine receptors for example the IL2 receptor.
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5.3.2. T cell activation
The expression of lymphokine mRNA by T cells in the inflammatory
infiltrates in EAU implies that the T cells are activated within the eye or
remain in a state of activation within the eye. It is uncertain, however, as to
whether these cells are all S antigen specific arising from clonal expansion
or a mixture of antgenic specificities resulting from T cell recruitment.
At present it is unknown whether the antigenic stimulus which T
lymphocytes are subject to in the EAU model is similar in terms of quality or
quantity to human disease. It has been demonstrated that the activation of
cytokine genes in CD4 positive T cells is stimulus dependent in vitro
(Carding et al.1989) and similar mechanisms may therefore also be
important in vivo. The antigenic and soluble stimuli are likely to differ
between the EAU model and the situation in human disease and may
therefore affect the cytokine gene expression. It is also likely that these
stimuli differ in the various clinical forms of introcular inflammation and may
in part be responsible for the variation in the presentation and behaviour
seen in clinical disease.
The IFN-y, IL2 and IL4 producing cells were notably distributed in
relation to foci of retinal oedema and destruction suggesting that a stimulus
to produce these lymphokines is present in this area and their subsequent
release may contribute to the focal destructive lesions seen in the early
stages of EAU. Antigen contact is one potential stimulus, however it is
notable that these cells were distributed almost entirely within the inner
retina in contrast to the outer retinal distribution of S antigen. The stimulus
for production of these lymphokines may therefore be another antigen or
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inflammatory mediator.
Cells positive for all four lymphokines were also found in the
accumulations of inflammatory cells surrounding the eyes, presumably
trafficking to and from the sites of the intraocular pathology. This evidence
raises the possibility that some T cells may be activated peripherally and
"home" towards the eye. Lymphokine production in these extraocular sites
would potentially be involved in the chemotaxis and local proliferation of
inflammatory cells.
It is notable that despite a heavy mixed inflammatory cell infiltrate in the
anterior chamber no cytokine production was found in this site suggesting
that these lymphocytes in this location are not actively involved in the
intraocular pathology. This may be a reflection of the absence of suitable
antigen in the anterior chamber.
5.3.3. Lvmphokine mRNA expression within the eve in EAU
As stated above expression of lymphokine mRNA is not absolute
evidence of the presence of bioactive lymphokine within a tissue however it
does provide evidence that a given lymphokine is potentially involved in the
ongoing immunopathology being studied.
The finding of IFN-y mRNA in actively inflamed EAU eyes was
supported by the immunohistochemical demonstration of IFN-y protein in
similar locations. These observations can be correlated with the
immunohistochemical finding of IFN-y related to areas of activated T cells in
human posterior uveitis (Hooks et al.1986). It was demonstrated that greater
numbers of T cells had strong immunohistochemical staining for IFN-y than
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had a positive signal for IFN-y mRNA. It is likely that this is due to the
transient expression of mRNA for this lymphokine by T cells (McKnight et
al. 1991) compared to a longer time period when lymphokine protein can be
demonstrated on cells, either localised to cytokine receptors or on cells no
longer expressing cytokine mRNA.
It has been demonstrated that systemically administered IFN-y
downregulates the immune response in the mouse model of EAU (Caspi et
al. 1991). The demonstration of increased mRNA expression for IFN-y at the
later stages of the intraocular destructive process is evidence that its local
production could play a role in the in vivo immune regulation of EAU. IFN-y is
known to induce or upregulate MHC class II antigen on a variety of cell types
(Trinchieri et al.1985). It has been shown that IFN-y can induce MHC class II
expression in vitro in rat, guinea-pig (Liversidge et al. 1988b) and human
(Liversidge et al. 1988a) retinal pigment epithelial (RPE) cells which form
part of the outer blood-retinal barrier. RPE cells are known to express MHC
class II antigens in vivo in human posterior uveitis (Chan et al. 1986a) and in
EAU (Chan et al. 1986b) and it has been proposed that such aberrant
expression of class II MHC may be important in the development of
autoimmunity (Bottazzo et al. 1983) by providing a mechanism of
autoantigen presentation to autoreactive T cells. There is also evidence,
however, that antigen presentation by cells lacking a co-stimulatory signal
(this may apply to tissue resident cells such as RPE) acts to downregulate
the immune response and results in T cell anergy (Schwartz, 1990; Gaspari
et al.1988). In relation to these observations it is notable that iris and ciliary
body cells treated in vivo with IFN-y are able to suppress antigen driven T
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cell responses in vitro (Streilein et al.1992). This suggests that the local IFNy
production found in EAU may be downregulatory to the disease process. In
this context it is notable that IFN-y has been shown to be inhibitory to the Th2
subset of CD4+ T cells (Mosmann et al.1989).
Intraocular injection of recombinant IFN-y has been demonstrated to
induce in vivo MHC class II expression in organ resident cells in the uveal
tract and cornea and also in extraocular conjunctival epithelial cells.
Subretinal injection of recombinant IFN-y produces in vivo class II
expression in rats (Hamel et al.1990). These changes were shown to be
associated with an infiltrate of both neutrophils and monocytes to the iris and
inner retinal layers suggesting that local IFN-y plays an important role in the
induction of autoimmune inflammatory disease.The studies of Lee and
Pepose (Lee et al.1990) demonstrated that both mice and rats had induced
expression of MHC class II antigens on intraocular injection of IFN-y but only
rats demonstrated an related ocular cellular infiltrate. This observation
parallels the known susceptibility of mice and rats to EAU. It has also been
demonstrated that intraperitoneal injection of IFN-y leads to intraocular class
II expression wheras topical administration does not (Kusuda et al.1989).
Local production of IFN-y has the potential to play a role in immune
regulation in inflammatory eye disease although the studies outlined above
demonstrate that the exact nature of this role is yet to be defined.
Interleukin 2 (IL2) is a lymphokine which is produced by helper T cells
following activation by antigenic or mitogenic stimulation, it is required for
the subsequent proliferation of T lymphocytes and therefore plays a key role
in the initiation of an immune response (Smith, 1988). IL2 protein has been
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demonstrated in human eyes with posterior uveitis (Hooks et al.1986) and
an increase in circulating IL2 receptor positive (Deschenes et al.1988) T
lymphocytes has been demonstrated in patients with active uveitis. The
demonstration of IL2 mRNA and IL2 receptor positive lymphocytes in EAU is
further evidence that this mediator is involved in the immunopathology of
intraocular inflammatory disease.
Clinical and experimental studies of autoimmune disease have
indicated abnormalities in the IL2-IL2 receptor system. Increased T
lymphocyte IL2 production and enhanced IL2 responsiveness have been
demonstrated in experimental models of autoimmunity (Kroemer et al. 1989).
IL2 mRNA has been demonstrated at the sites of tissue pathology in
rheumatoid arthritis (Warren et al. 1991) a condition thought to have an
autoimmune aetiology. In vivo expression of IL2 mRNA by activated T cells
at the site of tissue pathology in EAU is additional evidence for its role in
autoimmune disease.
Lymphotoxin is produced by both CD4+ and CD8+ T lymphocytes and
is thought to play a key role in T lymphocyte cytotoxicity (Paul et al.1988).
IFN-y is of importance in the maturation of cytotoxic T lymphocytes (Simon et
al.1986; Chen et al.1986) and secretion of IFN-y along with lymphotoxin
appears to promote CD4+, class II restricted T cell cytotoxicity (Tite et
al.1985). IL2 has also been demonstrated to produce differentiation of
cytotoxic T lymphocytes (Simon et al.1986; Haworth et al.1989). The in vivo
expression of mRNA for these lymphokines at the site of tissue pathology in
EAU is evidence that tissue destruction may be produced by effector T
lymphocytes.
204
T cell cytotoxicity can be mediated by several mechanisms (Tite et
al.1985; Tite, 1990a; Tite, 1990b; Lancki et al. 1991) and the relatively low
numbers of cells in the retinal pathology expressing lymphotoxin mRNA
would suggest that cytotoxic mechanisms other than those involving
lymphotoxin are involved (Jongeneel et al.1988). The widespread cellular
expression of MHC class II antigens in the eye in EAU would provide
suitable target cells for cytotoxic CD4+ T cells which may subsequently
produce more extensive damage through "innocent bystander" killing (Tite et
al.1985). IFN-y, however, also has the potential to activate macrophages
(Nathan et al.1983) and it is possible that macrophages have an effector cell
function at the sites of tissue destruction in EAU .
IL4 produces B lymphocyte activation, MHC class II expression and
immunoglobulin (IgGi and IgE) production. It is also involved in T
lymphocyte activation and growth (Paul et al.1987) and has also been
shown to inhibit the action of certain T cell subsets (Peleman et al.1989).
Although few B cells are present in the intraocular pathology in EAU, in vivo
IL4 production would fascilitate antigen presentation by B cells to the
infiltrating antigen-specific T lymphocytes.
In summary,with regard to the effector mechanisms operative in EAU
the demonstration of in vivo production of IFN-y, IL2, lymphotoxin and IL4
would allow CD4 positive and CD8 positive T lymphocytes and
macrophages to act as effector cells and it may be that all these cell types
are involved in the destructive process. Several issues remain to be
resolved regarding the effector cells in EAU and inflammatory eye disease.
Firstly the relative contributon of the potential effector cells present.
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Secondly the mechanisms employed by these cells in vivo to produce the
tissue pathology. Thirdly whether the T cells present are all antigen specific
arising from local clonal expansion of small numbers of infiltrating cells or
whether local cytokine production causes the attraction and infiltration of
non-antigen specific T cells which may subsequently act as effectors.
5.3.4. T Cell Subsets
Subsets of T lymphocytes have been defined based on their pattern of
lymphokine secretion and these subsets appear to correlate with the
functional properties of the activated T cells. In general these studies have
been carried out in vitro and it is uncertain if these patterns exist also in vivo.
The experiments of Mossman and coworkers divided murine CD4+ T cell
clones into two types on the basis of their lymphokine secretion (Mosmann
et al.1986; Mosmann et al.1989). Th1 cells produce IL2, IFNy and LT and are
thought to function as cytotoxic or inflammatory effector cells and to mediate
delayed type hypersensitivity (DTH) responses (Cher et al.1987). Th2 cells
produce IL4, IL5 and IL6 and are considered to act as helper cells for
example upregulating B cell and antibody responses and mediating many of
the effects of allergic responses. Both cell types produce IL3, GM-CSF and
TNF. In addition murine T cell clones have been described which do not fit
these patterns of lymphokine secretion (Firestein et al. 1993; Yokohama et
al.1989; Mosmann et al. 1991). It has been proposed that these cells, which
in many cases have an unrestricted lymphokine secretion profile, have been
termed TO and it has been proposed that they represent a precursor stage in
the development the restricted Th1 and Th2 patterns.
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Th1 and Th2 helper T cell subsets have been shown to cross-regulate
by the production of of lymphokine which are inhibitory or down-regulatory to
the other subset. IL4 production by Th2 cells has been shown to suppress
the production of IFNy by Th1 cells (Peleman et al.1989) and IL10 (produced
by Th2 cells) acts to inhibit the production of all lymphokines by Th1 cells
(Mosmann et al. 1991). Conversely IFNy has been shown to inhibit the
proliferative response of Th2 clones to IL2 and IL4 (Mosmann et al.1989).
T cell subsets have also been defined on the basis of their cell surface
antigens, in particular the isotypes of the CD45 antigen (Leucocyte common
antigen, LCA) (Mason, 1992). The monoclonal antibody 0X22 binds to the
product of exon C of the LCA gene on rat CD4+ T cells. These "OX22 high"
(by flow cytometry) produce IL2 and IFNy. Following antigen contact these
cells have low 0X22 binding and produce higher levels of IL4 (Powrie et
al.1988; Powrie et al.1989; McKnight et al. 1991). Recent work has
suggested that these OX22 low CD4+ T cells have an inhibitory effect on the
development of autoimmune disease in animal models (Mason et al.1992).
Human and murine CD4+ T cells also appear to have functional properties
defined by the expression of of differing isoforms of CD45, however the data
on these subsets is as yet incomplete (Mason, 1992) and at present it is is
difficult to fit the data relating to the CD45 isotype expression with any simple
model of Th1 and Th2 subsets.
It would appear that the Th1/Th2 dichotomy represents an end-stage in
T cell differentiation and there is now evidence that these stable patterns of
lymphokine secretion may also be found in mice in vivo (Bass et al.1989).
Initial work suggested that human T cell clones produced IL2, IL4 and IFNy
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and therefore did not subdivide as Th1 and Th2 (Paliard et al.1988). Recent
studies have suggested that human T cell clones derived from peripheral
sites of tissue pathology do fall into the Th1/Th2 subsets (Wierenga et
al.1990; Maggi et al. 1991; Kapsenberg et al. 1991). These studies suggested
that long term stimulation of T cells in atopic patients resulted in selection of
Th2 cells. The previous finding of unrestricted lymphokine profiles in human
CD4 positive T cells would therefore represent T cells not yet committed to a
differentiation pathway and the chronically stimulated T cells found in atopic
individuals have differentiated to a stable Th2 secretion pattern (Kapsenberg
et al. 1991). In addition stable antigen-specific clones of Thi and Th2 type
have been derived from peripheral T cells from healthy individuals
(Romagnani, 1991).
The presence of mRNA for the lymphokines IFNy, IL2, lymphotoxin and
IL4 was demonstrated in the areas of T lymphocyte infiltrate in actively
inflamed eyes in EAU. The presence of these four cytokines has implications
with regard to the subsets of CD4+ T cells (the predominant infiltrating cell
type in EAU) present in the rat model used. In relation to the Th1/Th2 CD4+
T cell dichotomy the expression of mRNA for these four lymphokines implies
the presence of a mixed infiltrate of both subsets. Alternatively the CD4+ T
cells could be of the TO subtype, not yet committed to to a Th1 or Th2
lymphokine secretion pattern. It is also possible that the infiltrating CD4+ T
cells are an admixture of all three subsets (and potentially additional subsets
which are as yet not fully defined).
A mixed Th1/Th2 response would result in the interaction of these two
subsets producing mutual inhibition. This may be produced through several
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mechanisms, for example through the action of the Th1 lymphokine IFNy
downregulating the Th2 response (Mosmann et al.1989) and the Th2
lymphokine IL4 acting to downregulate the Th1 response (Peleman et
al.1989). These inhibitory responses may be important in the in vivo
limitation of an immune response to any given antigen. Initial activation of
the Th1 and Th2 subsets is thought to be dependent on the nature of the
antigenic stimulus and the antigen presenting cell (Mosmann et al.1989)
and manipulation of an immune response at this level could potentially
provide a mechanism of downregulating ongoing in vivo immunopathology.
In relation to the CD45 antigen isoform expression of the T cells present
(Powrie et al.1988; Faure, 1980; McKnight et al. 1991; Mason, 1992), the
expression of mRNA for these four lymphokines would imply the presence of
both niave and memory T cells. This would seem logical since any section
of an eye would be likely to contain a mixture of T cells involved in the
dynamic process of trafficking to the eye followed by antigen contact and
subsequent effector or helper function. It is also possible that additional
subgroups of rat CD4+ T cells exist and the position may be
considerably more complex. Analysis of the cytokine secretion by individual
T cells from the inflammatory infiltrates would be necessary to further
investigate the exact nature of the T cells present.
5.3.5. Cytokines in autoimmune disease
Several methods have been employed in the investigation of the
mediators involved in autoimmune disease. Tissue fluids or cell extracts
have been analysed using bioassays but this approach has not been
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productive due to the lack of specificity of the assays used (although this can
potentially be overcome by the use of blocking monoclonal antibodies) and
the short half life of bioactive lymphokines. Immunohistochemical analysis of
affected tissues can be employed but the range of suitable antibodies is at
present limited. Analysis of the lymphokine mRNA by in-situ-hybridisation or
mRNA extraction and estimation provides a further approach to the
assessment of the production of cytokines in vivo. As argued above however
the presence of cytokine mRNA does not necessarily correlate with bioactive
cytokine (Grabstein et al.1986; Carding et al.1989; Dallman et al.1991).
Rheumatoid arthritis (RA) is a chronic destructive inflammatory disease
involving the articular synovium which is thought to have an autoimmune
aetiology. A wide spectrum of cytokines have been demonstrated to be
represent in the destructive inflammatory lesions found in this condition.
Buchan and colleagues have demonstrated the presence of mRNA for IL2,
IL2 receptor, IFN^y, IL1a, IL1(3, LT and TNF in the mononuclear cells derived
from the diseased joints of patients with rheumatoid arthritis (Buchan et
al. 1988a; Buchan et al. 1988b). They also demonstrated increased levels of
these cytokines were produced by mononuclear cells in vitro without
stimulation for up to two weeks following removal from tissue implying a
chronic abnormality in regulation of lymphokine production by these cells in
the rheumatoid joint. In situ hybridisation analysis of the rheumatoid
synovium has shown the in vivo expression of IL2 mRNA in inflammmatory
foci where the majority of cells are CD4 positive, CD45RO positive T
lymphocytes and IL2 protein is localised immunohistochemically (Warren et
al.1991). Turner and coworkers demonstrated that T lymphocyte clones
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derived from the sites of tissue pathology from patients with rheumatoid
arthritis produced TNF, lymphotoxin and IFN7 (Turner et al.1987). They also
demonstrated mRNA for TNF and lymphotoxin in these cells. Feldmann has
reviewed the results of cytokine research on rheumatoid arthritis joints
showing that mRNA for IL1a, IL10, IL2, IL6, IL8, TNF, LT, IFN-y, TGFp,
PDGF(A/B), TGFa, EGF, G-CSF and GM-CSF is present in the joint and in
most cases this correlates with the presence of cytokine protein although the
relative concentration of protein is often lower than would be expected from
the mRNA level (Feldmann et al.1990; Feldmann et al. 1991). In addition
Feldmann has documented that cytokine mRNA expression is not
concordant with the presence of protein and that this is true especially for T
cell derived cytokines. Several explanations have been offered for this
finding including absorption by receptors, degradation by enzymes,
inhibition by antagonists, and translational regulation by other cytokines.
The presence of cytokines at the sites of local tissue pathology in
autoimmune thyroid disease has also been studied. This has demonstrated
the presence of mRNA for IFN-y, TNF, LT, IL6, IL1a and ILip in both Graves'
disease and Hashimoto's thyroiditis (Turner et al.1987; Feldmann et al. 1991;
Zheng et al. 1991). The studies on rheumatoid arthritis and autoimmune
thyroid disease have been supported by in vitro work which has explored
the potential role of these cytokine in disease pathogenesis. For example it
has been demonstrated that TNF and LT are strong inducers of IL1 in RA
joint cell cultures in vitro (Feldmann et al. 1991) and that anti-TNF (but not
anti-LT) abrogated the production of IL1 bioactivity. Similarly in vitro studies
have demonstrated that thyroid epithelial cells can produce IL1 and IL6
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(Feldmann et al. 1991) and this correlates well with previous work showing
that such cells are capable of presenting antigen to cloned human T cells
(Londei et al.1984).
In diabetes mellitus the localised autoimmune events take place in the
pancreatic islets, however this tissue is generally inaccessible to direct
investigation. A study of cytokine levels in the peripheral blood of diabetic
patients at the time of diagnosis showed increased levels of TNF compared
to controls but similar levels of IL1, IL2, IL6 and IFN-y (Cavallo et al. 1991).
This highlights the difficulty in interpreting the results of investigations
carried out on peripheral blood in the context of localised autoimmune
pathology since all these cytokines may reasonably be expected to be
involved in the local immunopathology.
Experimental work has been undertaken in transgenic mice to
determine the potential role of cytokines in the immunopathology of diabetes
mellitus. Sarvetnick and colleagues (Sarvetnick et al.1990) used transgenic
mice in which the expression of IFN-y is directed by the insulin promotor to
demonstrate that development of diabetes with an influx of inflammatory
cells to the pancreas and additionally that lymphocytes from these
transgenic animals are cytotoxic to pancreatic islets in vitro. This implies a
role for IFN-y in the loss of tolerance to pancreatic islet tissue in DM.
In contrast mice expressing the IL2 transgene develop insulitis but not
diabetes (Allison et al.1992). Double transgenic mice which express the
MHC class I molecule FI2-Kb and have specific anti Kb T cells do not develop
diabetes (Heath et al.1992) however if these animals are crossed with the
IL2 transgene mice diabetes does develop suggesting that autoreactive T
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cells require the addition of IL2 to produce an autoimmune response.
Studies of cytokine involvement in multiple sclerosis have been
supported by work carried out on the experimental allergic
encephalomyelitis (EAE) animal model. Analysis of the infiltrating leucocytes
at the sites of demyelinating lesions in the CNS have shown that both CD4+
and CD8+ T lymphocytes are present at the lesion margin and macrophages
are found in the centre of the lesion (Traugott et al.1983). Investigations
have attempted to define the TCR Va and Vp repertoire of the T cells
involved. Initial work suggested that the TCR Va and Vp chain expression
was restricted in both CSF and blood (Hafler et al.1988) however
subsequent work has demonstrated a polyclonal population of TCR Va and
Vp in localised brain lesions in MS (Wucherpfennig et al.1992). This may be
due to non-specific recruitment of T lymphocytes and it is possible that the
autoreactive T cells within these lesions do in fact have limited TCR
heterogeneity (Bernard et al.1992).
Recent studies have also focussed on potential involvement of
cytokines in the destructive CNS pathology in MS. Tumour necrosis factor
and lymphotoxin have been identified immunohistochemically associated
with both lymphocytes and glial cells within the lesions (Hofman et al. 1989;
Selmaj et al. 1991). Wucherpfennig and coworkers demonstrated mRNA for
IL1 in acute and subacute lesions but lower levels of IL2 and IL4 mRNA in
only acute lesions (Wucherpfennig et al.1992). These studies have been
paralleled by investigations on the EAE model which
immunohistochemically demonstrated the presence of IL1, IL2, IL2 receptor,
IL4, IL5, IL6, IFN-y, TNF, LT and TGF-p protein in acute lesions leading to the
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proposition that Th1 CD4+ T cell / macrophage interactions are responsible
for the local acute pathology. This work has been developed by the
demonstration that neutralising antibody to LT and TNF can reduce the
severity of disease in EAE (Ruddle et al.1990).
The experimental work in this thesis has shown the expression of
mRNA for IFN-y, IL2, IL4 and LT in the areas of T cell infiltrate in EAU. This
has been supported by the immunohistochemical demonstration of IFN-y
protein and IL2 receptor on lymphocytes. In common with the other forms of
autoimmunity described above these results suggest that these cytokines
can play a role in the development of intraocular inflammatory disease in the
EAU model and potentially also in human disease. In the case of IFN-y
functional studies also defined an immunoregulatory role in EAU (Caspi et
al. 1991; Hamel et al.1990; Lee et al.1990). Additionally it has been shown
that soluble IL1 receptor inhibits ocular inflammation in an animal model
(Rosenbaum et al. 1991). The results therefore provide a basis for the further
investigation of the biological role these cytokines play in inflammatory eye
disease.
5.4 Future developments in the treatment of intraocular inflammatory
disease
Clinical therapy of intraocular inflammatory disease has been based on the
non-specific suppession of the inflammatory and immune responses
causing tissue damage. The efficacy of such treatment in severe intraocular
inflammatory disease is limited by the non-specific nature of the drugs used,
resulting in a generalised immunosuppression leading to susceptibility to
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infectious disease and other systemic side-effects resulting from the
prolonged high dosage of steroids and cytotoxic agents (Salaman, 1983;
Kinlen et al.1979). The aim in developing new therapies is therefore to
produce agents which will specifically target the elements involved in the
detremental immunopathology found in intraocular inflammation while
sparing the inflammatory and immune response components necessary for
the normal function of systemic defence mechanisms. More specific agents
would also potentially be free from other unwanted systemic side-effects.
A number of potential sites for specific immunotherapy in intraocular
inflammatory disease can be identified. For example the interaction of the
TCR with antigen and MHC, the costimulatory signals involved in antigen
presentation and the interaction of T cells with vascular endothelium.
5.4.1. Anti T lymphocyte therapy
A first step towards selective clinical immunotherapy for inflammatory
eye disease was the introduction of the anti T lymphocyte agent cyclosporin
A (Nussenblatt et al. 1983a; Nussenblatt et al.1985; Graham et al.1985; de
Vries et al.1990; Masuda et al. 1989), this was paralleled by experimental
work demonstrating its anti T cell effect on the EAU model (Nussenblatt et
al. 1981b). Cyclosporin A produces a specific anti T ceil action by inhibiting
production of IL2 and IFN-y and inhibiting expression of the IL2 receptor. FK
506 is a new immunosuppressive agent, at present used only on an
experimental and trial basis, which has a mode of action similar to
cyclosporin A although it is structurally distinct (Thomson, 1989). The
primary immunosuppressive effect of FK 506 is an inhibition of antigen-
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driven production of IL2 and IFN-y, and in experimental models it produces
this effect at much lower molar doses than cyclosporin A. It is hoped
therefore that FK 506 will produce clinical immunosuppression at a lower
dose than cyclosporin A and with fewer side effects. Initial work has
suggested that FK 506 is relatively non-toxic although a vasculitis has been
reported in dogs and further experimental and clinical studies are awaited.
Furthermore, FK 506 appears to have a synergistic effect with cyclosporin A
and combined therapy of low dose FK 506 and cyclosporin A has been
shown to suppress EAU (Mochizuki et al. 1991). Rapamycin is another new
immunosuppressive agent which, although structurally related to FK 506
(both are macrocyclic lactones), appears to act by a different mechanism
(Morris, 1991). Rapamycin blocks Ca2+independent and cytokine-
dependent T cell division and produces synergistic immunosuppression with
FK 506. The clinical usefulness of FK 506 and rapamycin have yet to be
evaluated but specific T cell immunosuppression has the potential to play a
significant role in the future treatment of T cell mediated autoimmune
disease.
5.4.2. Blocking of specific T lymphocyte responses
T lymphocytes have been shown to play a central role in the
immunopathology in both human intraocular inflammation and EAU.
Manipulation of T cell responses could therefore provide an effective means
of suppressing the tissue damage seen in these conditions. Several
approaches to the modification of T cell responses are currently under
investigation and will hopefully prove useful in the treatment of human
216
disease. T cell vaccination involves inoculation with subpathogenic doses of
disease promoting T cells which induce regulatory T cells that downregulate
the immunopathological process (Cohen et al. 1988). This approach has
been shown to be effective in experimental animal models of autoimmune
disease (Cohen, 1986) including EAU (Beraud et al.1990). Major limitations
to its use in humans, however, are the need for antigen specific T cells since
the autoantigen is unknown in most forms of human autoimmune disease
and the need to use T cells specific for each patient. Therapeutic
intervention using monoclonal antibodies specific for T cell surface receptors
involved in antigen recognition may also be possible. In rheumatoid arthritis
patients for example clinical improvement has been demonstrated using
anti-CD4 monoclonal antibody (Kingsley et al. 1991). The use of foreign
immunoglobulins in humans can produce anti-globulin responses which can
interfere with therapy or cause hypersensitivity reactions. To prevent this
human antibodies should be used but it has been difficult to make such
antibodies by hybridoma technology. A solution may be to produce
"chimaeric" antibodies with mouse variable and human constant regions by
the genetic engineering of lymphoid cells (Riechmann et al.1988). These
antibodies have the potential to minimize adverse reactions.
Therapeutic intervention at the level of the interaction of the T cell
receptor(TCR)/CD4 complex with the antigen/MHC complex may also be
possible. Analysis of the restricted TCR and MHC gene expression and the
protein structure of the inducing antigens in autoimmune disease models
has led the development of specific therapies. In EAE a synthetic peptide
analogous to part of the Vp8 TCR gene was found to be effective in
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protecting against, and treating rats with EAE (Offner et al. 1991).
Alternatively antigen which interacts with MHC can be modified to produce a
peptide which will block T cell activation and have enhanced MHC binding
as has been demonstrated in EAE where a MBP peptide analog which binds
to la but does not activate T cells was found to be effective in blocking T cell
responses in vitro and in vivo (Urban et al. 1989).
5.4.3. Blocking cellular interaction with blood vessel endothelium
The term "high endothelial venule" (HEV) is applied to the post¬
capillary venules of lymph nodes and also to vessels in inflamed tissue
which morphologically have an increase in the height of their endothelial
cells associated with an enlarged, ovoid nucleus and abundant cytoplasm
(Freemont et al. 1985; Freemont, 1988). The biological changes associated
with endothelial cell activation such as MHC class I and II expression,
secretion of IL1, increased ICAM-1 expression and increased lymphocyte
adhesion have been shown to be associated with a change to "high
endothelial venule" morphology (Pober, 1988; Duijvestijn et al. 1989;
Butcher, 1990). The binding of recirculating lymphocytes to endothelial cells
plays an important role in the migration of lymphocytes to lymph nodes and
to inflamed tissues. It has been demonstrated that lymphocytes can
discriminate between HEV in different body tissues (Butcher, 1990) and it
appears that these lymphocyte-endothelial interactions are mediated by
tissue-specific homing receptors and non tissue-specific adhesion
molecules (Duijvestijn et al. 1989). The pathology described in the
ultrastructural studies of multifocal posterior uveitis demonstrates that HEV-
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like changes were found in the choroidal vessels (and the
neovascularisation extending through Bruch's membrane to the retina)
specifically related to the inflammatory foci. Interactions between these HEV
and recirculating lymphocytes could result in the selective migration of
lymphocytes to the sites of ongoing inflammation in uveitis.
In the Lewis rat model of experimental autoimmune uveoretinitis HEV
like vessels have been reported to occur in the retinal vasculature but not in
choroidal vessels (Dua et al. 1991) suggesting that this model is similar to
human retinal vasculitis rather than the predominantly choroidal disease
described above.
The eye does not contain lymphatics and hence presentation of retinal
antigens must occur at the sites of the blood-retinal barrier. The inner blood-
retinal barrier is formed by the endothelial cells of the retinal vessels and the
outer blood-retinal barrier is formed by the RPE cells, Bruch's membrane
and the endothelium of the choriocapillaris. It has been demonstrated that
when stimulated (for example by IFN-y) vascular endothelial cells from a
variety of organs can express MHC class II antigen (Pober et al.1986). In
vitro investigations on cerebral vascular endothelial cells have produced
conflicting results as to whether these cells can produce the co-stimulatory
signals necessary for effective antigen presentation (Pryce et al. 1989; Risau
et al.1990; Hughes et al.1990). Endothelial cell activation may therefore be
of importance in vivo for production of the co-stimulatory signals (cytokines
or other mediators) required for effective presentation of antigen by vasular
endothelium. The HEV-like vessels demonstrated above may therefore be
the sites of both lymphocyte trafficking and antigen presentation.
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The HEV-lymphocyte interaction is a further potential site of
intervention in the disease process. Specific therapy aimed at inhibiting the
interaction of T lymphocytes with the suface markers such as ICAM-1, ELAM-
1 and MHO class II known to be present on activated endothelial cells (HEV)
(Pober, 1988) could regulate the influx of T cells to sites of immunopathology
within the eye. Furthermore, since it has been shown that lymphocytes can
discriminate between HEV in different body tissues (Butcher, 1990) the
differentiation markers for HEV in various tissues (although not yet
definitively identified) are a potential target which would provide specificity
for this therapy. ICAM-1 has been demonstrated to be involved in the
pathological processes in asthma and therapy using an anti-ICAM-1
monoclonal antibody in a primate model of asthma produces an inhibition of
the pathological responses (Wegner et al.1990) suggesting that therapy
directed towards the interaction of lymphocytes and adhesion molecules
may find widespread in vivo clinical application.
Although not yet fully identified, the costimulatory signals necessary for
effective antigen presentation are another potential target for intervention.
The demonstration that tolerance may result from antigen presentation
without appropriate costimulation (Schwartz, 1990; Gaspari et al.1988)
suggests the possibility of immunosuppression by blocking costimulatory
signals.
5.4.4. Anti-cvtokine therapy
The experimental work in this thesis has dealt with the in vivo T cell
lymphokine production in EAU. Several strategies have been proposed to
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produce specific anti-cytokine therapies and are currently under
investigation. Monoclonal antibodies reactive with a cytokine or its receptor
can act to interfere with the biological action of a particular cytokine. This
approach has been employed in experimental autoimmune disease. For
example, antibodies reactive with the p55 p chain of the IL2 receptor
suppress the development of experimental autoimmune diabetes mellitus
and systemic lupus erythematosus (Kelley et al.1988). Another method of
interference with the cytokine-receptor interaction is the therapeutic
administration of soluble cytokine receptors which bind to cytokine and
provide a competitive antagonism of the cytokine action (Maliszewski et
al.1990). Administration of soluble IL1 receptor has been shown to be
effective in preventing experimental T cell-mediated graft failure (Fanslow et
al. 1991) and may also have wider applications in the treatment of
autoimmune disease. Specific cytokine inhibitors are also being developed,
for example the IL1 antagonist IL1ra (Ohlsson et al.1990), although the
therapeutic role of these is at present uncertain.
Targetting a specific cytokine receptor could also downregulate an
immune response. Such an approach has been demonstrated to be
successful in the NOD (non-obese diadetic) mouse model of autoimmune
diabetes using a diphtheria toxin related IL2 fusion protein (Pacheco-Silva
et al.1992).
Lymphokines exert their effects in the local microenviroment of the
secreting cell. This may lead to problems in the systemic administration of
anti-lymphokine therapy requiring very high dosage to achieve sufficient
concentrations in the areas of the local immunopathology. A further problem
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is whether immunotherapy aimed at a specific cytokine would be effective in
the complex cytokine networks which mediate severe immunopathology.
and further experimental work will be required to resolve this issue.
5.5 Conclusion
This thesis has for the first time demonstrated the involvement of T
lymphocytes in the intraocular immunopathology in Behcet's disease and
multifocal posterior uveitis. The experimental work in the thesis has shown
the expression of lymphokine mRNA in the active stages of experimental
autoimmune uveoretinitis. Overall these findings are evidence for the central
involvement of T lymphocytes in the immunopathology of ocular
inflammatory disease. The EAU studies are the first published investigations
to address the local ocular immunopathology using in situ hybridisation. The
results of these studies provide the basis for future investigations of human
and experimental intraocular inflammation at the molecular level. The
knowledge gained from such work will contribute to the development of
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A pathological study was performed on the
necropsy eyes of a 59-year old-woman who had
suffered for nine years from multifocal pos¬
terior uveitis. The disease had been controlled
by steroid therapy with good preservation of
visual function. Extensive investigation did not
reveal the aetiology. On macroscopic examin¬
ation numerous focal lesions with various
degrees of pigmentation were observed
scattered across the fundi. These lesions were
studied by light and electron microscopy and
immunohistochemistry. There was ongoing
chorioretinal inflammation in the foci, pro¬
ducing destruction of Bruch's membrane, the
retinal pigment epithelium (RPE), and the
outer retina. The focal scars showedmigration
of RPE and glial cells and neovascularisation.
Capillary and venule endothelial cells were
swollen at the inflammatory sites. Attempts to
establish a cause for this condition were
unsuccessful.
The pathogenesis of many forms of multifocal
chorioretinal inflammatory disease remains
unknown, and a lack of histopathological
material has in many cases prevented an under¬
standing of the aetiology of these conditions. In
this report we describe the unexpectedly active
and destructive inflammatory changes found in a
case of multifocal choroiditis which clinically
was thought to be quiescent.
Case report
In 1978 a 50-year-old woman presented to the
eye casualty department with a one-month
history ofaching pain and blurring vision in both
eyes. Her vision was 6/12 in the right and 6/18 in
the left eye. She had mild iritis and mild optic
disc oedema in both eyes. Two weeks later her
vision deteriorated to counting fingers right and
hand movements left. In addition to moderate
anterior chamber inflammatory activity she had
bilateral total exudative retinal detachments. She
had no systemic illness, was on no medication,
and extensive investigation including viral
serology gave negative results.
Treatment with systemic prednisolone 80 mg/
day resulted in rapid regression of the exudative
detachments; cream coloured round patches
then became evident throughout the whole extent
of both fundi (Fig 1). Fluorescein angiography
showed patchy late hyperfluorescence. The
electro-oculogram (EOG) was reduced to 140%
in the right eye and 120% in the left. A provisional
diagnosis of acute posterior multifocal placoid
pigment epitheliopathy (APMPPE) was made.
The patient's vision gradually improved, and the
steroid dose was reduced, though two transient
episodes of increased activity required tempor¬
ary increases in steroid dosage. One year after
presentation her visual acuity was 6/9 right and
6/6 left, and there was patchy depigmentary
chorioretinal scarring, with mottled pigmen¬
tation of the maculae (Fig 2).
Low dose systemic steroids were continued for
a total of five years. There was mild residual
anterior uveitis following systemic steroid with¬
drawal. The patient died in 1987 from an acute
myocardial infarct. Six weeks prior to death her
vision was 6/9 right and left, there was a mild
bilateral anterior uveitis, and there were patches
of chorioretinal scarring which did not show any
clinical evidence of active inflammation.
Material and methods
The eyes were removed approximately 12 hours
after death. The left eye was fixed in formal
Figure 1 The appearance of the left fundus at the time ofpresentation in 1978. Note the
multiple pale lesions scattered across the central retina.
Multifocalposterior uveitis: clinical andpathologicalfindings 689
semiserial sectioning (at 50 or 100 pm steps),
and, where appropriate, ultrathin sections were
taken and stained conventionally for examination
in a Philips 301 electron microscope.
Results
Figure 2 Leftfundal appearance oneyear later. Note the hyperpigmentation at the macula
and the loss ofpigmentation elsewhere.
saline and the right in 2% cacodylate buffered
glutaraldehyde. Both eyes were of normal
dimensions and were divided horizontally above
and below the macula.
Paraffin-histology. After paraffin embedding
serial sections were taken from both paraffin
blocks and stained with haematoxylin-eosin
(H-E), periodic acid Schiff (PAS), and stains for
axons (Bodain), myelin (Loyez), and iron (Perls).
Additional blocks were taken from the calottes
for immunohistochemistry and electron micro¬
scopy.
Immunohistochemistry. Sections from
the formal saline fixed tissue were stained by the
peroxidase-antiperoxidase (PAP) technique for
B and T lymphocytes, macrophages (mura-
minidase, a-ACT, a-lAT), and immuno¬
globulins (IgA, IgG, IgM, x and X). In-situ
hybridisation was employed for identification of
herpes simplex viral antigen.
Electron microscopy. Macrophotographs were
taken of the superior and inferior calottes from
the right eye, and designated foci of hypo and
hyperpigmentation were excised for study (Figs
3 and 4). Fifteen blocks were embedded in
Araldite and 1 pm sections were stained with
toluidene blue. Eight blocks were studied by
MACROSCOPIC EXAMINATION
The findings in both globes were essentially the
same. The anterior segments appeared normal,
and the vitreous was clear. Thereweremeridional
folds on the pars plana, but no evidence of pars
planitis. Focal lesions, varying in size between
0-5 and T5 mm, were scattered throughout the
fundus, predominantly in the mid periphery.
The smallest lesions were pale and free from
pigmentation, while the more obvious contained
specks and clumps of pigment (Figs 3 and 4).
The largest lesions were heavily pigmented with
lacunae of depigmentation. The appearances of
the maculae, the peripapillary retinae, and the




The conjunctiva, the cornea, the outflow system,
and the lens were of normal architecture. The iris
stroma contained scattered lymphocytes which
formed aggregates at the pupil and at the root.
The ciliary body contained a few clusters of
lymphocytes, and there were non-specific pro¬
liferative changes in the epithelial layers of the
pars plana. The vitreous was free from inflam¬
matory cell infiltration.
At the far periphery the retinal pigment had
non-specific age-related degenerative changes,
and occasional drusen were observed. The inner
retina was well preserved, and the nerve fibre
layer and optic nerve contained axons of normal
density.
At the macula there was depletion of nuclei in
the outer nuclear layer; here the photoreceptors
showed autolytic changes. Clusters of lympho¬
cytes were noted in the posterior choroid and in
the adventitia of some of the posterior ciliary
vessels and nerves. A study of designated rep¬
resentative lesions (Figs 3 and 4) was made from
plastic embedded matrial.
Figure 3 Inferior calotte of the right eye to show the macroscopic appearance of the lesions.
EM blocks were taken from areas designated a-f (letters located below lesions).
Plastic embedded histology
The following description is derived from blocks
taken from the sites designated in Figs 3 and 4.
Where appropriate light microscopy was
supplemented by electron microscopy. The
descriptions relate to the centre of the lesions.
The small non-pigmented lesions were of
variable histological appearance. In three blocks
(Fig 4, lesions P, T, and W) there was a
lymphocytic infiltration in the choroid, with
some cellular infiltration in the hypopigmented
retinal pigment epithelium (Fig 5); the overlying
retina showed minor atrophy of the photo¬
receptor layer. Electron microscopy showed the
cells within the retinal pigment epithelium (RPE)
to be macrophages (Fig 5C) and the outer
segments to be adequately preserved (Fig 5b).
By contrast in a somewhat similar macroscopic
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Figure 4 The appearance ofthe superior calotte to show in more detail the characteristic
lesions. EM blocks were taken from the areas designated P-W.
lesion (Fig 3, lesion b) the RPE was replaced by
glial scar tissue which had penetrated Bruch's
membrane and had destroyed the chorio-
capillaris. Beneath this lesion there was a cluster
of lymphocytes adjacent to a myelinated nerve
bundle. It was noteworthy that in almost every
block examined branches of ciliary nerve were
observed in association with the lymphocytic
clusters within the choroid.
Partially pigmented lesions also varied in their
histological appearance. In three blocks (Fig 3,
lesions a, c, and d) Bruch's membrane was
interrupted by small breaks but was easily
identifiable. In lesion c the photoreceptor layer
was replaced by glial cells which abutted on to
Bruch's membrane (Fig 6a). In lesions a and d
(Fig 3) the RPE was multilayered and infiltrated
by macrophages and lymphocytes (Figs 6b, c).
Over these areas of RPE disturbance there was
outer retinal atrophy of varying degrees. The
choriocapillaris was either normal, infiltrated by
inflammatory cells, or replaced by collagenous
Figure 5 The choroid in small pale lesions, (a) The stroma contains lymphocytes (which are also present in the choriocapillaris) and RPE clusters (RPE). (b)
Outer segments (os) are present on the surface of the RPE. (c)Macrophages (m) are infiltrating the pigment epithelium. The choriocapillaris is partially replacea
by fibrous tissue and elsewhere the endothelial cells are swollen (se). (a, x250. b, X3000. c, xllOO.)
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Figure 6 L ight micrographs of lesions c (top), d(middle),
and a (below) shown in figure 3. Bruch's membrane is intact in
all three examples, (a) Inflammatory cells are sparse and
gliotic retina abuts on to the membrane, (b) There is
multilayering of the RPE but there is some preservation of the
inner segments, (c) The photoreceptors are fragmented over
clusters ofRPE cells, macrophages. and lymphocytes. Note
inflammatory cells in swollen endothelium in (a), a platelet
aggregate in(b), and a macrophage within Bruch's membrane
in (c) (arrow heads). (x37S.)
tissue. Invariably there were clusters of lympho¬
cytes in the choroidal stroma.
In other partially pigmented lesions the
inflammatory process was more destructive (Fig
3, lesion e, Fig 4, lesion s). In these it was
difficult to identify Bruch's membrane. The
outer retina was invaded by lymphocytes,
macrophages, RPE cells, and capillaries (Fig 7).
Swelling and cytoplasmic rarefaction of endo¬
thelial cells in choroidal capillaries and venules
was a constant feature irrespective of the degree
of inflammatory destruction (Figs 5, 6a, and 7).
At the ultrastructural level the junctions between
these endothelial cells were intact, but lympho¬
cytes were often found in close relationship with
the endothelial cells (Fig 6a). In some vascular
lumina there were platelet clusters (Fig 6b), but
neither fibrin, thrombi, nor immune complex
deposits were identified. There was no evidence
of previous choroidal vascular occlusive disease
as shown by hyalinisation of the intima or media.
Migration ofRPE cells into the choroid was seen
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in lesions of varied appearance and degree of
destruction (Figs 5 and 7).
Two heavily pigmented foci were studied (Fig
3, lesion f, and Fig 4, lesion R). These consisted
of atrophic retina in all layers over a band of
multilayered and hyperplastic RPE cells with an
admixture of macrophages. There was a dense
choroidal inflammatory infiltrate. At the peri¬
phery ofeven advanced lesions the photoreceptor
outer segment architecture was preserved, and
evidence of photoreceptor phagocytosis by
exogenous macrophages was obtained (Fig 8).
In none of the sections examined at the light or
ultrastructural level was it possible to identify
structures with protozoal, viral, or bacterial
characteristics.
Immunohistochemistry
Within the choroidal infiltrate 70-80% of the
lymphocytes were identified as T cells, less than
20% were B cells. Small numbers ofmacrophages
were noted in all parts of the inflammatory foci.
There was no significant deposition of immuno¬
globulin. In-situ hybridisation for identification
of herpes simplex virus gave negative results.
Discussion
The case was initially diagnosed as acute posterior
multifocal placoid pigment epitheliopathy
(APMPPE)1 because of the multiple pale
inflammatory lesions seen across the posterior
fundi. Exudative retinal detachments have been
described as an unusual presenting feature of
APMPPE,2 andmore recent reports have stressed
that APMPPE can be chronic or recurrent.3"5
However, the presentation and subsequent
course of the disease are more typical ofHarada's
disease.6-8 Similarities between these two
conditions have been noted, and it has been
suggested that they represent a continuous
spectrum of disease.9 This case has the ocular
picture of Harada's disease without the systemic
manifestations and therefore best fits an inter¬
mediate group as defined by Wright, Bird, and
Hamilton.9 Because of the difficulties in
categorising the case we have elected to refer to it
in the broader clinical context of multifocal
posterior uveitis.
The histopathological characteristics of the
lesions identified in the choroid and retina
include a deep choroidal lymphocytic infiltrate
(usually associated with a myelinated nerve),
with extension to the choriocapillaris and variable
breaks in Bruch's membrane. Thickening of the
RPE was due to proliferation of the native RPE
cells (with and without melanin depletion) and to
infiltration by macrophages and lymphocytes.
The restricted focal nature of the lesions was
impressive, as was the sparing of the adjacent
retina. Indeed it appeared that involvement of
the photoreceptor layer could be regarded as the
destruction of an innocent bystander. The
pattern of cellular infiltration is similar to that
found by Perry and Font in cases of Harada's
disease,7 although we found few plasma cells
within the infiltrate.
It has been suggested that both APMPPE and
multifocal choroiditis may be initiated by
choroidal ischaemia.9-13 With reference to this
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Figure 7 Lesion S in Fig 4. The inflammatory reaction had penetrated Bruch's membrane, (a) The outer retina is destroyed by an infiltrate which contains
lymphocytes, macrophages, and capillaries (arrows), with swollen endothelial cells (se). (b) The choroid adjacent to the focus containsRPE cells (RPE), and the
venule is lined by swollen endothelial cells (se). The capillaries present on both sides ofBruch's membrane are shown in more detail in (c). (d) This demonstrates
the junctional attachments between RPE cells (RPE) within the choroid (arrows), (a, x250. b, x630. c, xlSOO. d, X4300.)
hypothesis we did not find immune complexes or
fibrinoid necrosis in blood vessels, nor was there
any evidence to suggest a previous inflammatory
vasculopathy which had produced choroidal
vascular hyalinisation and luminal narrowing.
There was no evidence of current bacterial,
fungal, viral, or protozoal infection.
The evolution of the destructive process
appeared to depend on the preservation of
Bruch's membrane. If the membrane survived
the initial inflammatory insult, the RPE res¬
ponded by proliferation and formation of layers
of collagen. An intact Bruch's membrane did not
necessarily protect the RPE and photoreceptor
layer. RPE loss and photoreceptor destruction
were seen despite the preservation of the under¬
lying membrane, and we demonstrated that
inflammatory cells may gain access to the outer
retina through small breaks in an otherwise
intact Bruch's membrane (Fig 6).
There was notable photoreceptor survival
despite ongoing inflammation within the foci.
The long term survival of photoreceptors con¬
trasts with the early lysis of rod outer segments
reported in experimental autoimmune uveitis.14
Our evidence suggests that photoreceptor outer
segments are not the primary autoimmune target
in this form of human disease.
Glial cell migration from the retina to the
choroid has been described in syphilis15 and
other inflammatory conditions." The occurrence
of this abnormality in multifocal posterior uveitis
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Figure 8 Electron micrographs to illustrate the preservation of the outer segments of the photoreceptors, which in this example
are phagocytosed by macrophages (m). Some RPE cells contain vacuoles (v). (a, X6000. b, X2480.)
is further evidence of the non-specific nature of
the glial cell activity. Similarly migration of RPE
cells into the choroid is now regarded as non¬
specific," as is neovascularisation in a glial scar.17
Recent work has highlighted the importance
of high endothelial venule (HEV) like vessels in
the recruitment of lymphocytes into inflamed
tissues.'8" The term 'high endothelial venule' is
applied to the post-capillary venules of lymph
nodes and to vessels in inflamed tissue which
morphologically have an increase in the height of
their endothelial cells. These endothelial cells
have histochemical alterations relating to
lymphocyte-endothelial interactions and are
believed to play a role in the uptake of lympho¬
cytes to lymphatic and inflamed tissues. We
frequently found this response to dense focal
accumulations of lymphocytes, and we also
demonstrated the presence of lymphocytes with¬
in the vessel wall. Endothelial cell swelling was
demonstrated in both the choroidal venules and
the choriocapillaris. The presence of such
changes is of added significance in view of the
recently reported association of class II major
histocompatibility complex (MHC) antigen
expression on endothelial cells with lymphocyte
recruitment in experimental ocular inflam¬
mation.20
In conclusion, we have demonstrated that
active, ongoing focal inflammation can occur in a
case of clinically quiescent posterior uveitis.
Despite detailed study we were unable to cor¬
relate the macroscopic appearance of the lesions
with specific patterns of pathological change. No
ischaemic or infective cause of the disorder was
found.
There was migration of glial and RPE cells
within the inflammatory foci and neovascularisa¬
tion of the glial scars; these changes are seen in
other forms of posterior uveitis. We believe that
this is the first study to demonstrate the presence
ofhigh endothelial venule-like vessels at the sites
of inflammation in human ocular tissue.
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CD4+ LYMPHOCYTE INVOLVEMENT IN OCULAR BEHCET'S
DISEASE
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Despite extensive study, the pathogenic mechanisms of Behcet's disease remain uncertain. The ocular inflam¬
mation caused by this disease is severe, often causing significant visual loss and, although the nature of the
cellular infiltrate has been examined in many of the involved organs, the infiltrating cells in inflamed eyes
have not.
To investigate the mechanisms involved in perpetuating the ocular inflammation, five enucleated eyes from
patients with Behcet's disease were examined by immunohistochemical staining using a panel of monoclonal
and polyclonal antibodies. Control eyes from patients with chronic intraocular inflammation from other
causes were also examined.
Cellular infiltrates were a consistent finding in choroid and periretinal scar tissue, formed almost entirely
by mononuclear cells. T lymphocytes were found to predominate (largely the CD4+ subset). B lymphocytes
and NK cells were infrequent findings but macrophages were present in significant numbers. No complement
or immunoglobulin deposits were found. Infiltrating lymphocytes and macrophages were HLA DR positive.
Retinal vacular and retinal pigment epithelium were only occasionally positive.
Our findings suggest that cell mediated immunity, rather than immune complex deposition is responsible
for the perpetuation of the ocular inflammation in Behcet's disease and that CD4+ T lymphocytes play a cen¬
tral role in this.
KEY WORDS: CD4+ T lymphocytes, Behcet's disease, uveitis, MHC class II antigens.
INTRODUCTION
Behcet's disease is a multisystem disorder character¬
ised by aphthous mouth ulcers, genital ulcers and ocu¬
lar inflammation. Other manifestations are erythema
nodosum, cutaneous thrombophlebitis, arthropathy,
gastrointestinal disturbances and less commonly cen¬
tral nervous system involvement and major vessel
thrombosis. The underlying pathological mechanism
is thought to be an immune-mediated occlusive
vasculitis'.
The ocular manifestations of Behcet's disease,
which occur in 70-85% of patients are recurrent
inflammation of the iris, ciliary body and choroid with
occlusive retinal vasculitis. These may be complicated
by oedema of the central retina, ischaemic atrophy of
the optic nerve and visual loss. The visual prognosis is
poor for untreated disease but systemic steroids and
cyclosporin have been used successfully to control the
inflammation2,3.
Studies of aqueous humour4 and peripheral blood5,6
showing alterations in levels of complement com¬
ponents, led to the proposition that immune complex
deposition resulted in the immunopathology of ocular
Behget's disease. Herpes simplex virus7 and strepto-
Correspondence: K. Barton, Professorial Unit, Moorfields Eye
Hospital, City Road, London, EC IV 2PD.
coccal infections8,9 have been implicated in the
initiation of the pathogenic mechanism of Behcet's
disease. These theories, however, remain unproven
and the aetiology of this disease is still uncertain.
Immunohistological studies of erythema nodosum
like lesions10", oral ulcers11,12 and terminal ileum13
have revealed infiltrates of predominantly T lympho¬
cytes suggesting a central role for cell mediated
immunity in the pathogenesis of these lesions in
Behcet's disease. Alterations in peripheral blood T
cell populations have been found14 and decreased sup¬
pressor activity noted in the pre-active stage of
Behcet's disease patients15.
The beneficial effect of cyclosporin in systemic and
ocular Behget's disease emphasizes the importance of
T cells in this condition2,3.
Histological examination of enucleated eyes from
Behcet's disease patients reveals a non-granulomatous
uveitis, retinal vasculitis and infarction associated
with retinal detachment16,17. Immunohistological
studies from ocular tissue from patients with other
forms of chronic immune-mediated uveitis such as
sympathetic ophthalmia18 and sarcoidosis19 demon¬
strate that the predominant infiltrating cells in the ret¬
ina and choroid are T lymphocytes and that the
majority of these T cells are of the CD4 positive sub¬
set. The aim of this study was to examine eyes, enu¬
cleated from patients with Behget's disease in which
active inflammatory foci were present, to determine
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Five eyes, enucleated for the complications of ocular
inflammation characteristic of Behcet's disease, were
obtained from the archives of the Institute of Ophthal¬
mology. All cases fulfilled the major diagnostic cri¬
teria for Behcet's disease confirmed by contacting the
clinician involved in 4 of the 5 cases. The average age
of the patients at enucleation was 27 years (range
18-37 years). All had severe panuveitis, 2 with recur¬
rent hypopyon. Three eyes were enucleated after
recurrent aggressive episodes of acute panuveitis
within 3 years of developing symptoms, all of which
were still active at enucleation. The other 2 eyes were
enucleated after more chronic disease with persistent
activity, 13 years after symptoms developed in one
case.
The indication for enucleation in each case was that
the eye was blind and painful. In 3 cases this was due
to glaucoma (1 chronic closed angle and 2 rubeotic).
All the patients had been treated with systemic ster¬
oids and one with additional azathioprine. None had
received cyclosporin or chlorambucil.
The eyes were formalin fixed and paraffin embed¬
ded. Horizontal sections of the whole eye were cut at
6-8 //m thickness. Initial examination was made using
haematoxylin and eosin stained sections. Sections
were then examined immunohistochemically using a
panel of antibodies (Table 1). Control studies were
made on eyes with: (a) active sympathetic
ophthalmia—to compare the findings in Behcet's dis¬
ease with another form of chronic immune mediated
uveitis, and (b) neovascular glaucoma—these cases
have minimal inflammation and secondary compli¬
cations of the type seen in Behcet's eyes but are due
to non-inflammatory causes.
Immunohistochemistry
The immunohistochemical staining was carried out as
follows: Sections were dewaxed through toluene and
graded alcohols and washed in phosphate buffered
saline (PBS) pH 7.3. Endogenous peroxidase activity
was quenched with 0.5% hydrogen peroxide in 50%
methanol. The slides were washed in PBS and back¬
ground staining blocked with serum appropriate to the
secondary antibody at a concentration of 10% in PBS
with 2% ovalbumin for 30 min. The primary antibody
was applied at optimum concentration ranging from
1:10 to 1:1500 for 45 min. Slides were washed and
secondary antibody applied at a dilution of 1:50 for
30 min. After further washing peroxidase antiperoxi-
dase complex (PAP) (Dako, High Wycombe, UK) was
applied for 45 min at a dilution of 1:75 in PBS. After
washing again, amino ethyl carbazole (BDH, Poole,
UK) was used as the reaction substrate. Sections were
counterstained with haematoxylin and coverslips
applied using aqueous mountant—Glycergel (Dako,
High Wycombe, UK). Negative control sections were
processed in identical fashion omitting primary anti¬
body. Known positive control slides were also stained
using each monoclonal antibody.
Cell counting
To quantify numbers of cells staining with the mono¬
clonal antibodies to leucocyte common antigen, CD43
(T lymphocytes), OPD4 (CD4 positive T lym¬
phocytes)20 and L26 (B lymphocytes) cell counts were
made from twenty high power fields (x400) in (a) the
choroid and in (b) the retina (and periretinal scar
t able I
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tissue). Cells were considered positive if they exhib¬
ited a ring of pink to red stain around their cellular
membrane.
Neither UCHL1 nor CD43 are specific for CD3
positive lymphocytes. The UCHL1 antibody recog¬
nises a peptide of the CD45 family21 which is present
on 72% of CD4 positive and 35% of CD8 positive T
cells22 although it may stain small numbers of macro¬
phages and myeloid cells. The CD43 antibody (Dako
DFT1) stains a high percentage of T cells but also
some B cells, neutrophils and macrophages25. Since
we found very few B lymphocytes (see Results) and
since neutrophils and macrophages could be dis¬
tinguished morphologically, we used counts of the
CD43 positive cells to represent the T cell population.
RESULTS
Pathology
The five eyes varied in spectrum and severity of intra¬
ocular inflammation but all had typical pathological
features of Behcet's disease with retinal detachments
and periretinal fibrovascular tissue of varying degrees.
Two of the eyes had evidence of neovascular glau¬
coma complicating the inflammation. The retinae
were markedly thinned and degenerate. Inflammatory
cell infiltrates were noted and around the episcleral
vessels, within the optic nerve, within the iris, ciliary
body and choroid, around and within the walls of the
retinal vessels (Figure 1) and within the fibrovascular
scar tissue. These infiltrates were composed almost
entirely of mononuclear cells. Neutrophils were
infrequent within the infiltrates. In the sections stud¬
ied there was no evidence of thrombus in any of the
retinal vessels.
The eye enucleated for sympathetic ophthalmia,
another cause of chronic intraocular inflammation
(used as a positive control), had moderate inflam¬
mation in the iris and ciliary body and marked mono¬
nuclear cell infiltrate in the choroid, retina and pre-
retinal scar tissue. The eyes with neovascular
glaucoma from a non-inflammatory cause had a mod¬
erate lymphocytic infiltrate in the iris but no detect¬
able inflammation in the choroid or atrophic retina.
Immunohistochemistry
Throughout the eyes, the majority of infiltrating cells
were positive for the leucocyte common antigen
(LCA) marker. T lymphocytes, identified by the
UCHL1 and CD43 markers were a consistent finding
within the infiltrates. T lymphocytes (CD43+
sensitive) formed 26-95% of the LCA+ cell population
in the choroid (mean 53.8%) and 9-60% in the retina
and periretinal fibrovascular scar tissue (mean 30%).
T cells were prominent in the perivascular infiltrates
in the retina, fibrovascular scar tissue and uveal tract
and in the choriocapillaris below disrupted retinal pig¬
ment epithelial cells (Figure 2). CD4+ T cells, ident¬
ified by the OPD4 monoclonal antibody, constituted
33-90% (mean 77%) of the T cell populations (Figure
3). ■
B lymphocytes were an infrequent and variable
finding. In the LCA positive population between 0
and 5% of cells in the choroid and less than 1% of
cells in the retina and epiretinal scar tissue were posi¬
tive for the B cell marker. In two of the eyes no B
cells were seen in the choroid and in three eyes no B
cells were found in the retina and fibrovascular scar
tissue. B cells did occur in small clusters within the
choroidal and perivascular infiltrates. NK cells, ident¬
ified by the Leu 7 marker, were absent in three of the
globes and were a very infrequent finding within the
leucocyte infiltrates in the other two.
Macrophages were a consistent finding within the T
lymphocyte containing infiltrates being prominent in
the fibrovascular scar tissue where they constituted
20-40% of the leucocyte population in some areas.
Significant numbers of lymphocytes and macrophages
within the leucocyte infiltrates showed positive stain¬
ing for HLA DRa chain. In four of the five eyes small
numbers of retinal pigment epithelial cells (separating
the choroid and retina) were weakly positive for HLA
DRa but minimal numbers of vascular endothelial
cells in the choroid, retina and periretinal scar tissue
also showed positive HLA DRa staining.
Figure 1 Perivascular infiltrate of lymphocytes in the retina. H&E.
x360.
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Markers for IgG and IgM immunoglobulins gener¬
ally gave a faint stain of the serous fluid within the
subretinal space and within vessels. This staining was
observed to be no greater than the non-inflamed neo-
vascular glaucoma control eye. In a total of three
areas in two eyes there were small collections of cells
which showed cell membrane staining for immuno¬
globulins; two for IgG and one for IgM. These cell
collections were closely related to the small B cell
clusters seen with the L26 marker. There was no evi¬
dence of immunoglobulin deposits within blood ves¬
sels or elsewhere within the inflamed tissue. Both the
C3c and Clq markers gave a faint stain of the serous
fluid within blood vessels and in the subretinal fluid.
Figure 2 CD43 positive T lymphocytes (arrow) infiltrating
choriocapillaris below pigment granules released from disorganised
retinal pigment epithelium (arrowheads). Haematoxylin
counterstain, x450.
There was no evidence of any solid deposition of
complement components. Within the choriocapillaris
of the inflamed eyes the C3c and Clq staining of
serous fluid was more prominent suggesting some
concentration of complement components in this
region.
In the control eye with sympathetic ophthalmia
numerous T and B lymphocytes were found in the
choroidal and retinal cellular infiltrates consistent
with previous reports18. The lymphocytic infiltrate in
the iris of the eye with neovascular glaucoma con¬
sisted of minimal numbers of T and B lymphocytes
but no inflammation was seen in the retina or choroid
demonstrating that our findings in the retina and cho¬
roid in the Behcet's eyes are not secondary to the
complicating pathology which has developed.
DISCUSSION
This investigation demonstrates that T lymphocytes
are the principal infiltrating cell type in inflammatory
foci in ocular Behcet's disease. B Lymphocytes, neu¬
trophils, and NK cells were not a prominent finding.
There were no deposits of immunoglobulin or comp¬
lement components suggesting that deposition of
immune complexes do not contribute to the pathology.
The high proportion of CD4 positive T cells implies a
central role for these cells in the perpetuation mechan¬
ism and helps explain the favourable response of ocu¬
lar Behcet's disease to cyclosporin2'3. It should be
emphasised that these results do not provide any
information on the mechanism of initiation of the
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Figure 3 Infiltrate of CD4 positive T
cells in epiretinal scar tissue. (OPD 4
monoclonal antibody). Hacmatoxylin
counterstain, x385.
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The implication that cell mediated immunity is
responsible for the tissue damage within the eye in
Behcet's disease is in accordance with the findings in
tissue from other affected organs"1-'3. It is notable that
the findings of many of the peripheral blood studies in
Behcet's disease do not reflect the tissue immuno-
pathology. This is a similar situation to the findings in
sarcoidosis'1'24 where normal or low levels of circu¬
lating CD4+ T cells are found in peripheral blood in
contrast to the large numbers of T cells in the affected
tissues.
Aberrant expression of HLA class II by endogenous
tissue cells in vivo may be important in the develop¬
ment and perpetuation of autoimmunity25 and may
play a role in the recruitment of antigen specific CD4
positive T lymphocytes from the blood to inflamed
tissues26. This study has demonstrated that minimal
aberrant HLA Class II expression is present on the
retinal pigment epithelium and retinal vascular endo¬
thelium, cells which constitute the tight blood-retinal
barrier and which are in contact with circulating lym¬
phocytes. This is in contrast to the marked HLA Class
II expression found in retinal pigment epithelial cells
(RPE) and retinal vascular endothelial cells (RVE) in
other forms of human posterior uveitis27. It may be
that early class II expression does not persist during
late disease. However, in the animal model exper¬
imental allergic encephalomyelitis, cerebral vascular
endothelial cells which demonstrate aberrant
expression of HLA class II antigens lack the co-stimu¬
latory signal required to activate myelin basic protein
(MBP) autoreactive T cells in vitro28 and are thought
to result in T cell anergy. Some of the infiltrating T
cells in our specimens were also HLA DR positive but
whether these cells are able to present antigen to each
other in vivo is unclear.
One proviso to this argument is that we have used
paraffin sections for immunohistochemistry whereas
studies carried out on other inflamed eyes were per¬
formed using frozen sections. It is possible that
aberrantly expressed class II antigens are better pre¬
served in frozen tissue or that the monoclonal anti¬
bodies to HLA DR used on frozen sections are more
sensitive than those we used. Some of the infiltrating
T cells in our specimens were also HLA DR positive
but whether these cells were able to present antigen to
each other in vivo is unclear. With the large number of
macrophages present with the T cells in the inflamma¬
tory infiltrate, it is likely that these are the major cells
presenting antigen to the CD4+ T cells.
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A 38-year-old man who died from systemic
Behcet's disease had previously suffered
from severe, recurrent bilateral retinal
vasculitis, and anterior uveitis for 10 years.
Immunopathological examination of the eyes
postmortem revealed marked hyaline
thickening of the retinal and optic nerve
vessels. The vessels had an intramural and
perivascular infiltrate of T lymphocytes which
stained positively for CD4 and IL2 receptor
surface markers. Small numbers of cells in the
optic nerve head, retinal vascular endothelium,
and retinal pigment epithelium were HLA DR
positive.
(BrJ Ophthalmol 1992; 76: 499-501)
Behcet's disease is a multisystem inflammatory
disorder mediated by an occlusive vasculitis.'
The disease is characterised by aphthous mouth
ulcers, genital ulcers, and ocular inflammation.
Ocularmanifestations ofBehcet's disease, which
occur in 70-85% of cases, are a recurrent irido¬
cyclitis, retinal vasculitis, and retinal ischaemia.
These frequently lead to cystoid macular oedema
and optic atrophy resulting in profound visual
loss.
Alterations in complement components in
aqueous humour2 and peripheral blood14 led to
the theory that immune complex deposition
caused the immunopathology in Behcet's disease.
Studies of tissues involved in the disease
process5-8 have however shown that it is pre¬
dominantly T lymphocytes which infiltrate the
affected tissues. This suggests a central role for
cell-mediated immunity in the disease process.
Histopathological examination of enucleated
eyes from patients with Behcet's disease reveals a
non-granulomatous uveitis, retinal vasculitis,
and infarction.910 This paper documents the
findings of a pathological and immunohisto-
chemical study on eyes obtained postmortem
from a patient who died from Behcet's disease.
Figure I Right optic
fundus 3 months prior to
death. The optic disc is
oedematous with
surrounding retinal
haemorrhages and patches of
retinal oedema.
Case report
A 29-year-old man was diagnosed as having
Behcet's disease in 1981 on the basis of a 3 year
history of recurrent retinal vasculitis, anterior
uveitis, and oropharyngeal aphthous ulcers.
These manifestations were controlled initially by
high dose oral prednisolone. Between 1985 and
1990 his systemic condition deteriorated with the
development of erythema nodosum, multiple
joint symptoms, and meningoencephalitis which
resulted in epilepsy. Treatment with chloram¬
bucil, cyclosporin, cyclophosphamide, and
azathioprine failed to halt the progression of the
disease. The patient died in October 1990 from
pneumonia secondary to raised intracranial
pressure due to central nervous system involve¬
ment which failed to respond to treatment.
From 1981 until his death he had recurrent
episodes of anterior uveitis (with hypopyon) and
retinal vasculitis in both eyes. This resulted in
retinal ischaemia and visual loss despite systemic
immunosuppression and orbital steroid
injections. A dense cataract developed in the left
eye early in the disease process, but cataract
extraction was not considered justified because
of the advanced retinal ischaemia. At his last
ophthalmic review 3 months prior to death he
had no light perception in either eye. The right
optic disc was swollen and surrounded by
multiple retinal haemorrhages and retinal
oedema (Fig 1). The retinal vessels in the right
eye were sheathed. There was no view of the left
fundus due to the lens opacity. Anterior uveitis
was minimal in both eyes. Intraocular pressures
were normal throughout the course of the disease.
Immunosuppressive treatment at the time of
death was high dose systemic prednisolone,
azathioprine, and cyclophosphamide.
Materials and methods
Consent was obtained for full postmortem
examination including examination of the eyes.
Both eyes were removed, the right globe was
fixed in 4% glutaraldehyde and the left globe
was frozen in OCT (Shandon, Runcorn).
Horizontal sections, through the pupil and optic
nerve, of both globes were cut at 6 pm thickness.
Initial staining was carried out using haema-
toxylin and eosin. Sections of the frozen (left) eye
were stained immunohistochemically using the
avidin-biotin-complex (ABC) method (Vector,
Peterborough). Briefly, slides were fixed in
acetone, endogenous peroxidase activity
quenched and blocked using normal serum.
Primary monoclonal antibodies (Table 1) were
applied for 30 minutes at appropriate concen¬
tration, biotinylated secondary antibody and
ABC complex were subsequently applied
following washing in phosphate-buffered saline.
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Figure 2 Disorganised,
detached retina of the left eye
showing marked hyaline
thickening and luminal
narrowing of retinal vessels
(arrowheads) with
intramural inflammatory
infiltration. H and E x 140.
Table I Primary monoclonal antibodies
Antibody Source Specificity
T3 Dako* Pan T lymphocytes
T4 Dako CD4+ T lymphocytes
T8 Dako CD8+ T lymphocytes
L 26 Dako B lymphocytes
IL2R Dako Interleukin 2 receptor
MAC 3 Dako Monocytes/macrophages
HLA DR Dako HLA DR antigen expressio
k High Wycombe, UK
Slides were then developed in amino ethyl
carbazole to give a red final reaction product and
counterstained in haematoxylin.
CONTROLS
Sections of each level examined were stained
immunohistochemically as above with the
omission of the primary monoclonal antibody to
provide negative controls. Frozen sections from
a normal eye were stained with each monoclonal
antibody to demonstrate the distribution of each
cell type in uninflamed ocular tissue. Known
positive tissues (inflammatory eyelid or orbital
lesions) were stained simultaneously using each
primary monoclonal antibody to verify the
effectiveness of the staining procedure.
Results
Pathological examination of the brain revealed
widespread cerebral oedema with gyral flattening
but no evidence of coning. Histologically, there
was no active cerebral vasculitis.
The pathological appearances were similar in
the right and left eyes. There was amild lympho¬
cytic infiltrate of the iris and ciliary body; this
extended into the choroid where there were
scattered lymphocytes in all sections exanimeu.
The retinas showing loss of ganglion cells and
photoreceptors. The retinal vessels were paten
but showed marked hyaline thickening of thei
walls (Fig 2). Therewere infiltrating lymphocyte
within this hyaline tissues. The retinas wer
focally detached with underlying patches o
subretinal fluid. In the right eye the optic nerv
head was oedematous and there was a lympho
cytic perivasculitis of the central retinal vessel
extending into the nerve. The left optic nerv
headwas not oedematous but had a perivasculitis
Both optic nerves had moderate loss of neura
tissue.
Positive immunohistochemical staining for ""
lymphocytes was seen in cells in the retinal vesse
walls and surrounding the optic nerve heai
vessels (Fig 3). These cells also stained positive!
with the CD4 monoclonal antibody; however th
small number of cells present precluded count
of T cell subset ratios. The perivascular T cell
also stained positively with the IL2 recepto
monoclonal antibody. Lymphocytes in the iris
ciliary body, and choroid were also positive fo
the T lymphocytemonoclonal antibody althoug
they were generally IL2 receptor negative. N
CD8+ T lymphocytes or B lymphocytes wer
found. A few cells in the hyalinised vessel wall
were positive for the macrophage primary anti
body. No neutrophils were identified in th
vasculitic lesions.
A small number of stromal cells of fibroblasti
morphology in the optic nerve head and retin:
vascular endothelial ceiis wereHLA DR positive
There were also numerous HLA DR positiv
cells in the retinal pigment epithelium.
Figure 3 Optic nerve head
ofleft eye showing CD3
positive T lymphocytes
(arrowheads) around
hyalinised vessel. CD3 (pan-




There was minimal background staining i
sectionswhere the primary antibodywas omittec
In the normal eye there were very occasional cell
in the choroid which were positive for the
lymphocyte and CD4 monoclonal antibodies
There were also small numbers of cells in th
choroid which were HLA DR positive. All othe
antibodies were negative.
Discussion
The ocular inflammation in Behcet's disease i
characterised by a severe occlusive vasculitis
Most of the eyes examined pathologically fror
patients with Behcet's disease have been remove
because of secondary complications and reflec
the end stage pathology of the condition.910 Th
eyes we have studied were obtained postmorter
and were not removed because of complicatin
pathology. This tissue therefore, althoug
subject to modification by immunosuppressfv
therapy, gives a better picture of the ongoin
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immunopathology of the condition. A peri¬
vascular lymphocytic infiltrate and marked
thickening of the vascular walls was seen in the
retinal and optic nerve vessels of both eyes and
the lymphocytes in and around the vessel walls
were identified as T cells. The perivascular
lymphocytes in "ocular sarcoidosis" and pars
planitis12 have also been identified as T cells.
A proportion of the T cells found in the
perivascular infiltrates and within the vessel
walls stained positively with CD4 and IL2
receptor monoclonal antibodies. The IL2
receptor expression of these cells is remarkable
since the patient was heavily immunosuppressed
at the time of death and demonstrates the
difficulty in treating adequately the severe
vasculitis seen in Behcet's disease.
The role of T lymphocytes in the tissue
pathology of Bef^et's disease has been demon¬
strated in immunohistopathological studies of
tissues from other affected sites.5"8 The identifi¬
cation of T cells as the predominant cell type in
the ongoing vascular lesions in the eye supports
the view that cell-mediated immune mechanisms
are responsible for the tissue damage seen in this
condition. The absence of B lymphocytes and
neutrophils is evidence that humoral immune
mechanisms do not play amajor role in the ocular
immunopathology.
The expression of the MHC class II antigen
HLA DR by retinal pigment epithelial cells and
vascular endothelial cells has been described in
other forms of intraocular inflammatory
disease.11-14 Aberrant expression of MHC class II
antigens has been demonstrated on endogenous
tissue cells in conditions thought to be of auto¬
immune aetiology,1516 and it has been suggested
that these cells may play a role in antigen
presentation to infiltrating CD4+ T lympho¬
cytes17 such as those demonstrated in this study.
Successful immunotherapy of intraocular
disease will depend on targeting specific cellular
components involved in the pathogenesis of the
tissue destruction. The demonstration in this
study activated CD4+ T cells in the vasculitic
lesions in ocular Behcet's disease suggests that
future treatment directed at the down-regulation
of the effects ofCD4+ T cells would be beneficial
in controlling the severe ocular inflammation.
The work was supported by Wellcome Trust Grant No 030412
11.4R.
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SUMMARY
Experimental autoimmune uveorclinitis (EAU) is a well-characterized model of immune-mediated
intraocular inflammation. The intraocular infiltrate in EAU consists predominantly of T lympho¬
cytes. The in vivo production of interferon-gamma (IFN-y) by these T cells was investigated
immunohistochemically and by in situ hybridization using a cDNA probe to rat IFN-y ntRNA.
Positive localization of IFN-y rnRNA began simultaneously with disease onset and increased as the
inflammatory tissue destruction progressed. The positive signal was seen on cells in the retina, uveal
tract and extraocular region where collections of inflammatory cells contained many T lymphocytes.
Numerous cells in these locations also stained positively immunohistochemically for IFN-y. These
results indicate that the in vivo production of IFN-y within the eye could play a role in the immune
regulation of intraocular inflammatory disease.
INTRODUCTION
>nic posterior uveitis and retinal vasculitis are ocular
mmatory conditions which often result in significant visual
despite treatment. The aetiology of these diseases is largely
town but autoimmune mechanisms involving ocular anti-
have been implicated in their pathogenesis. Experimental
immune uvcoretinitis (EAU) is an animal model ofautoim-
e intraocular inflammation1 induced by systemic immuni-
n with a purified retinal antigen in adjuvant. In the rat
el of EAU there is a mixed infiltrate of polymorphonuclear
tcytes and lymphocytes to the anterior and posterior
ents of the eye with CD41 T lymphocytes predominating in
lestructive retinal lesions.2
iAU can be adoptively transferred by activated, ocular
:en-specific CD4+ T-cell lines2 demonstrating that these
ated T cells are capable of initiating the disease process. The
ominant cell infiltrating the retina in the inflammatory
e is also the CD41" T cell implicating this cell in the
uctive inflammatory process.
lurinc CD4+ T cells have been divided into two groups
i on their lymphokine secretion pattern in vitro.4 Thl cells
uce interleukin-2 (1L-2), interferon-gamma (IFN-y) and
hotoxin and are thought to act as primary effector cells,
tells produce IL-4,1L-5 and IL-6 and act as helper cells, for
iple providing specific B-cell help. Human T-cell clones do
necessarily follow this pattern.5 The OX22 monoclonal
iody has been used in the rat to characterize CD4f T cells as
: (OX22 high) and memory (OX22 low)/' This division
nrrespondence: Dr D. G. Charteris, The Institute of Ophthalmo-
17 25 Cayton St., London ECIV 9AT, U.K.
appears to have functional significance related to cytokine
production, the OX22 high cells producing greater amounts of
1L-2 and IFN-y and the OX22 low cells producing more I L-4/"8
Rat uveitogenic T-cell lines have been demonstrated to produce
IL-2, I L-4 and IFN-y when activated in vitro9 but the in vivo
production of lymphokines in EAU by infiltrating activated T
cells is not known.
IFN-y is a lymphokine produced by activated T lymphocytes
and natural killer (NK) cells which has multiple actions in
immune response regulation.10 In addition to its roles in major
histocompatibility complex (MHC) class II induction and
cellular differentiation and activation it has recently been
demonstrated to play an important role in the development of
effector cell function in cytolytic T lymphocytes."12 In addition
IFN-y has been shown to induce macrophage activation.13
IFN-y is therefore likely to have a key role in the autoimmune
inflammatory process.
The aim of this study was to determine if IFN-y was
produced in vivo by the infiltrating T lymphocytes in the Lewis
rat model of EAU. IFN-y protein was localized immunohisto-
chemically using a rat IFN-y-specific monoclonal antibody and
a cDNA probe was used to detect IFN-y mRNA.
MATERIALS AND METHODS
Animals
Female Lewis rats [bred under specific pathogen-free (SPF)
conditions, St Thomas's Hospital Medical School, London,
U.K.], 100-150 g weight, 6-8 weeks old were used for all
experiments.
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Induction of uveitis
Rats were immunized in a hind footpad with 50 pg of purified
bovine S-antigen 14 in a 1:1 emulsion in complete Freund's
adjuvant (Sigma, Poole, Dorset, U.K.) supplemented with
Mycobacterium tuberculosis organisms (Sigma) to a final con¬
centration of 1 -5 mg/ml. Animals were also given 5 x 109 heat-
inactivated Bordetella pertussis organisms (Wellcome Labora¬
tories, Beckenham, Kent, U.K.) in 150 /d phosphate-buffered
saline (PBS) intrapcritoneally. A total of 17 eyes from individual
animals were studied. Two eyes from Days 10, 11, 12, 13, and 21,
and three eyes from Days 14 and 17 after disease induction, as
well as control eyes from a non-immunized animal were
removed, embedded in OCT (Shandon, Runcorn, U.K.) and
snap frozen in acetone and dry ice. Specimens were stored at
— 70J.
Probe preparation
A cDNA probe to rat IFN-y mRNa in the pPC3 plasmid vector
was kindly supplied by Dr Ton Kos, TNO, Rijswijk, The
Netherlands. The probe consisted of a 528-base pair (bp)
fragment comprising two identical repeats of a 264-bp sequence
corresponding to the last 21 residues of exon 2, all of exon 3 and
the first 60 residues ofexon 4 as deduced from the rat IFN-y gene
structure.15 The plasmid was amplified in HB 101 Escherichia
coli and the cDNA probe was extracted, purified and labelled
with ,5S-dCTP alpha (Amersham International. Amersham,
Bucks, U.K.) using the random primer technique (Boehringer
Mannheim. Lewes, U.K.) and adjusted to 2 x 105 c.p.m./ml in
hybridization buffer [600 mM sodium chloride, 50 mM sodium
phosphate pH 7 0, 5 m EDTA, 0 02% Ficoll, 0 02% bovine
serum albumin. 0-02% polyvinylpyrolidene, 0-1% salmon testis
DNA and 50% deionized formamide (all chemicals supplied by
Sigma)].
In situ hybridization
Whole-eye sections of 12 pm thickness were cut on a cryostat
and mounted on specially prepared gelatin (300 bloom swine,
Sigma) coated slides. Sections were fixed for 5 min in 4%
glutaraldehyde in 0-1 m Sorensens phosphate buffer pH 7-2 with
20% ethylene glycol, rinsed twice in hybridization buffer and
soaked in hybridization buffer for 1 hr, rinsed in ethanol and
dried. The 15S-labelled probe in hybridization buffer was heated
to 90 for 10 min, cooled and 100 p\ applied to each slide under a
parafilm (Sigma) coverslip. Sections were left to hybridize in a
humidified chamber at room temperature for 72 hr. Post-
hybridization, slides were immersed in 2 x SSC until the cover-
slips dislodged, rinsed in 2 x SSC and washed at 40 for 30min in
1 x SSC. Slides were then rinsed briefly in distilled water, in 70%
ethanol for 5 min, in 95% ethanol for 5 min and allowed to dry.
A utoradiography
The slides were dipped in K5 (Ilford, Mobberley, U.K.)
photographic emulsion diluted 1:1 in 0-5% glycerol and left to
expose at 4 for 21-24 days over silica gel. Slides were then
developed for 3-5 min in D19 (Kodak, Hemel Hempstead, U.K.)
developer, fixed in Unifix (Kodak), washed in distilled water and
counterstained with haematoxylin.
Controls
The control studies outlined below were carried out simulta¬
neously with the in situ hybridization.
Figure 1. Cells showing positive hybridization signal in the outer l
(arrow) and choroid (arrowhead) at the early stage of inflamm;
Retina (R), choroid (C), vitreous (V). Haematoxylin counterstain >
RNAase. Sections from each eye were fixed for 5 m
glutaraldehyde buffer, washed once in 2 x SSC with 5% T'
and three times in 2 x SSC. One hundred microlitres of RN.
A (Boehringer Mannheim) 1 mg/ml in 2 x SSC was applit
each slide under a parafilm coverslip and incubated at 37:
hr, slides were then washed in 2 x SSC and hybridization ca
out as above.
P53 probe. To determine the specificity of the IFN-y p
hybridization, each section was also hybridized with a
labelled probe to the p53 oncogene which was considered i
irrelevant to the EAU disease process.
Non-immunized animal. Eyes from normal, non-immur
Lewis rats were studied both by in situ hybridization for II
mRNA and by immunohistochemistry.
Monoclonal antibodies
For immunohistochemistry primary monoclonal antibodi
rat IFN-y (Holland Biotechnology, Leiden. The Netherla:
pan T cells (OX 19, Serotec, Oxford, U.K.), IL-2 rece
(OX39, Serotec) and MHC class II expression (OX6, Sen
were utilized.
Immunohistochemistry
Sections of 6 pm thickness were cut from each eye and mou
on 3Amino Propyl Triethoxysilane (APES) (Sigma) cc
slides. Slides were fixed in acetone for 7 min and endoge
peroxide activity blocked with 3% hydrogen peroxide in
methanol. Sections were stained by a standard avidin-bf
complex method (Vector, Peterborough, U.K.) using e
immunoglobulin adsorbed biotinylated secondary antil




Animals developed histological evidence of disease on Da
post-induction. The histological changes were characteric c
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e 2. Positive cells (arrows) adjacent to a patch of retinal oedema in
disease. Haematoxylin counterstain x485.
J.1 There was a marked mixed leucocyte infiltrate of the
rior and posterior segments of the eyes with patches of
al oedema progressing to total retinal destruction in which
thocytes were the predominant infiltrating cell.
ilization of IFN-y mRNA
tive hybridization signals, observed as collections of dark
is in the photographic emulsion, were seen over cells from
12 post-immunization onwards. In the early stages of the
tse process positive cells were seen in the outer retina and
oid (Fig. 1) and related to patches of retinal destruction and
ma (Fig. 2). As the retinal destructive process progressed
:asing numbers of positive cells were seen in these regions
. 3a) as well as in accumulations of inflammatory cells in the
ry body and the anterior extraocular region. Later in the
tse when there was marked retinal destruction, positive cells
: found predominantly in the choroid.
unohistocheniical localization of IFN-y
IFN-y monoclonal antibody gave positive membrane
ling of cells from Day 12 post-induction onwards. Mono-
ear cells in the extraocular tissues, anterior chamber, ciliary
/, choroid, retina (Fig. 4), vitreal cavity and subretinal fluid
towed positive staining. The staining intensity increased as
nflammatory process progressed.
liar immunohistochcmistry
9 (pan T cell) positive cells were found in inflammatory
rates throughout the extraocular tissues, anterior chamber,
ry body, choroid and retina, including the areas of IFN-y
4A localization (not shown). Cells in these regions also
red positive staining with the OX39 antibody for IL-2
ttor expression. MHC class II expression was found on cells
i Day 10 post-induction onwards; this increased markedly
e disease progressed and was seen both on organ-resident
infiltrating cells (not shown).
Controls
The eyes from non-immunized animals showed no localization
of IFN-y mRNA or evidence of infiltrating inflammatory cells.
Pre-treatment with RNAase abolished all localizing hybridiza¬
tion signal (Fig. 3b) and hybridization with the p53 oncogene
probe gave only a vague background signal in the inflamed
tissue without any cellular localization (not shown).
DISCUSSION
We have demonstrated the presence of IFN-y mRNA localized
to cells in areas of T-lymphocyte infiltration in the rat model of
experimental autoimmune uveoretinitis. Furthermore we have
shown that IFN-y is present throughout these eyes using a
monoclonal antibody specific for rat IFN-y. These results
correlate with the immunohistochemical finding of IFN-y
related to areas of activated T-ccll infiltration in human
posterior uveitis.16 IFN-y mRNA was found in two areas within
the eyes of rats with EAU, the retina and the uveal tract (choroid
and ciliary body) and also in extraocular inflammatory cell
infiltrates. No IFN-y mRNA was found in cells in the anterior
chamber or vitreous cavity although many T lymphocytes were
present in these sites. This would imply that IFN-y production
takes place in the retina, choroid or ciliary body where
activation of the T lymphocytes may take place or in the
extraocular region where cells are trafficking to and from the
eye. It follows that once T cells arc in the anterior chamber or
vitreous cavities they no longer produce IFN-y.
Greater numbers of T cells had strong immunohistochemi¬
cal staining for IFN-y than had a positive signal for IFN-y
mRNA. It is likely that this is due to the transient expression of
mRNA for this cytokine by T cells8 compared to a longer time
period when cytokine protein can be demonstrated on cells,
either localized to cytokine receptors or on cells no longer
expressing cytokine mRNA.
It has recently been demonstrated that systemically adminis¬
tered IFN-y down-regulates the immune response in the mouse
model of EAU.17 The demonstration that there is increased
mRNA expression for IFN-y in the later stages of the intaocular
destructive process is evidence that its local production could
play a role in the immune regulation of this disease in vivo.
IFN-y is known to induce or up-regulate MHC class II
antigen expression on a variety ofcell types.1" It has been shown
that IFN-y can induce MHC class II expression in vitro in rat,
guinea-pig18 and human19 retinal pigment epithelial (RPE) cells,
a layer of cells lying between retina and choroid forming part of
the blood-retinal barrier. RPE cells are known to express MHC
class II antigens in vivo in human posterior uveitis20 and in
EAU21 and it has been proposed that such aberrant expression
of class II may be important in the development of autoimmu¬
nity.22 Local production of IFN-y provides a mechanism
whereby aberrant expression of class II antigens on organ
resident cells can occur in uveitis.
Intraocular injection of recombinant IFN-y into the vitreous
cavity of rat eyes has been demonstrated to induce in vivo MHC
class II expression on organ-resident cells in the uveal tract and
cornea and also on extraocular conjunctival epithelial cells.
Subretinal injection of recombinant IFN-y produces in vivo class
II expression on RPE cells in rats.21 These changes were shown
to be associated with an infiltrate of both neutrophil polymor¬
phonuclear leucocytes and monocytes to the iris and inner
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Figure 3. (a) Numerous positive cells (arrowheads to examples) within disorganized retina (R) and choroid (C) in advanced
inflammation. Haematoxylin counterstain x 300. (b) Retina from adjacent section to (a) pre-treated with RNAase. No localizing
hybridization signal. Haematoxylin counterstain x 300.
Figure 4. Immunohistochemical localization of cells staining positively for IFN-y within the retina (R) and choroid (C) at a stage of
advanced destruction (arrowheads to examples). Sclera (S). Haematoxylin counterstain x 300.
retinal layers suggesting that local IFN-y plays an important
role in the induction of autoimmune inflammatory eye disease.
This finding is contrary to the aforementioned down-regulation
ofmurine EAU by systemic IFN-y17 and the exact role oflocally
produced IFN-y in EAU requires further elucidation.
The investigation of patterns of cytokine production has
given information on the roles of T-cell subsets in the mouse,4
rat6-7-8-4 and in humans.5-7-25 The murine subgroups Th 1 and Th2
do not appear to be consistent in rats and humans. IFN-y is
produced predominantly by the OX22 high subgroup of rat
CD4 ' T cells which are thought to represent naive cells prior to
antigen contact.7-24 This finding is in conflict with human CD4+
T cells where CD45RO (memory) T cells produce IFN-y. It has
been proposed that a further subset of human CD4 1 T ceils may
exist and that rat and human CD4 ' T cells may therefore have
similar patterns of lymphokine secretion.7 Analysis of rat CD4+
T cells for IFN-y mRNA has shown that there is a greater
frequency of positive cells in the OX22 low group although the
level of secreted IFN-y protein is higher from OX22 high cells.8
This may be due to post transcriptional regulation of translation
of IFN-y mRNA or regulation of secretion of IFN-y protein
since continued stimulation of OX22 low T cells results in a
down-regulation of expression of IFN-y mRNA. The II
mRNA expressing cells found in EAU may be from eithei
OX22 high or low groups and further analysis of the
infiltrating the retina in EAU by flow cytometry woul<
necessary to determine their exact phenotype.
Although the identity of the effector cells in the destrui
retinal lesions in EAU is not known, T lymphocytes
macrophages have been shown to be present in large numbc
these lesions as the disease progresses.1 IFN-y is capabl
producing development of cytotoxic T-lymphocyte precui
into cytotoxic effector cells'U2 and also has the potenti;
activate macrophages,13 its in situ production at the site
retinal destruction in EAU would potentially enable both t
cell types to act as effector cells. The further investigation o
pattern ofcytokine production in these destructive foci will
us to understand the roles of these cells in the disease proc
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SUMMARY
Experimental autoimmune uveoretinitis (EAU) is a well-characterized model of immune-mediated
intraocular inflammation. The intraocular infiltrate in EAU consists predominantly of T lympho¬
cytes. The in vivo production of interleukin-2 (IL-2), lymphotoxin and IL-4 by these T cells was
investigated by in situ hybridization using cDNA probes to lymphokine mRNA. Localization of
lymphokine mRNA was found simultaneous with disease onset in areas ofT-celi infiltration. Positive
signal was seen over cells in the uveal tract, retina and extraocular region. Less than 10% of the
population of T cells defined immunohistochemically had positive localization of mRNA for these
lymphokines. The number of positive cells was similar for each of the three probes and increased as
the disease progressed. The findings suggest that these lymphokines are produced in vivo in immune-
mediated intraocular inflammation and may play a role in the immunopathology seen in these
conditions.
INTRODUCTION
srimcntal autoimmune uveoretinitis (EAU)1 is a model of
ian ocular inflammatory disease, a range of conditions
:h can result in significant visual loss despite treatment. The
tlogy of human intraocular inflammation is unknown but
limmune mechanisms involving ocular antigens have been
icatcd in its pathogenesis. EAU can be induced in various
ral species by systemic immunization with a retinal antigen
ijuvant. In the Lewis rat model of EAU. immunization is
iwcd 10-12 days later by a mixed infiltrate of polymorpho-
ear leucocytes and lymphocytes to the anterior and pos-
>r segments of the eye, with CD4 + T lymphocytes predomi-
ig in the destructive. retinal lesions.2 It has been
onstrated that activated, retinal antigen-specific CD4 ' T
are capable of adoptively transferring EAU to non-
unized animals.3 CD4+ T lymphocytes are therefore impli-
d in both the initiation of the disease process and the
ructive retinal pathology.
ylurine CD4+ T cells have been divided into two types based
heir pattern of lymphokinc secretion4 and this has been
elated with their function. Thl cells secrete interleukin-2
2), interferon-}* (IFN-y) and lymphotoxin and arc thought
inction as effector cells, whereas Th2 cells produce IL-4, IL-
d IL-6 and are considered to be helper cells, for example
iding specific B-cell help. Both cell types produce IL-3,
ulocyte-macrophage colony-stimulating factor (GM-CSF)
tumour necrosis factor-a (TNF-oc). Rat CD4 1 T cells do not
orrespondence: Dr D. G. Charteris, Manchester Royal Eye
)ital, Oxford Road, Manchester M13 9WH, U.K.
appear to follow this stable pattern of lymphokine secretion and
have been sublyped according to their binding of the OX22
monoclonal antibody. Naive CD4 4 T cells (OX22 high) have a
high binding affinity for this antibody and produce IL-2 and
IFN-y, following antigen contact these cells become OX22 low
and produce IL-4.5 7
Rat uveitogenic T-cell lines have been shown to produce IL-
2, IL-4 and IFN-y when activated in vitro.* We have previously
demonstrated that there is in vivo expression of IFN-y mRNA
and the presence of IFN-y protein in areas of T-lymphocyte
infiltrate in the destructive tissue pathology throughout the
time-course of EAU.9 In this study we have extended these
investigations to the lymphokines IL-2, lymphotoxin and IL-4
with the aim of further characterizing the in vivo pattern of
lymphokine production in the destructive lesions seen in EAU.
We have identified infiltrating cells immunohistochemically and




Female Lewis rats [bred under specific pathogen-free (SPF)
conditions; St Thomas' Hospital Medical School, London,
U.K.], 100-150 g weight, 6-8 weeks old were used for experi¬
ments and as controls.
Induction of uveitis
Rats were immunized in a hind footpad with 50 pg of purified
bovine S-antigcn10 in a 1:1 emulsion in complete Freund's
adjuvant (CFA) (Sigma, Poole, U.K.) supplemented with
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Mycobacterium tuberculosis organisms (Sigma) to a final con¬
centration of 2-5 mg/ml. Animals were also given 5 x 10' heat-
inactivated Bordetella pertussis organisms (Wellcome Labora¬
tories, Beckenham, U.K.) in 150 p\ phosphate-buffered saline
(PBS) intraperitoneally. A total of 24 immunized and four
control (non-immunized) eyes from individual animals was
studied. Two animals were studied on days 10 and 11 post-
immunization, and four animals were studied on days 12, 13,14,
17 and 21 post-immunization. Eyes were rapidly removed,
embedded in OCT (Shandon, Runcorn, U.K.) and snap frozen
in acetone and dry ice. Specimens were stored at —70°.
Probe preparation
Three cDNA probes were used for the in situ hybridization. The
rat IL-2 probe was a full-length 740 base pair (bp) fragment
corresponding to rat IL-2 mRNA" and the rat IL-4 probe
consisted of the first 406 bp of the specific rat IL-4 gene
structure.7 Both these were probes kindly supplied by Dr A.
McKnight (MRC Cellular Immunology Unit, Oxford, U.K.)
The lymphotoxin probe was a 1 -42 kbp coding sequence derived
from the murine lymphotoxin gene12 (kindly given by Dr N.
Ruddle, Yale University Medical School, New Haven, CT). The
probe-containing plasmids were amplified in HB 101 Escheri¬
chia coli and the cDNA probes were extracted, purified and
labelled with 35S dCTP alpha (Amersham International, Amer-
sham, U.K.) using the random primer technique (Boeringer
Mannheim, Lewes, U.K.) and adjusted to 2 x 105 c.p.m./ml in
hybridization buffer [600 mM sodium chloride, 50 mM sodium
phosphate pH 7 0, 5 mM EDTA, 0-02% Ficoll, 0 02% bovine
serum albumin (BSA), 0-02% polyvinylpyrolidene, 0-1% sal¬
mon testis DNA and 50% deionized formamide (all chemicals
supplied by Sigma)].
In situ hybridization
Whole eye sections of 12 pm thickness were cut on a cryostat and
mounted on specially prepared gelatin (300 bloom swine,
Sigma) coated slides. Sections were fixed for 5 min in 4%
glutaraldehyde in 01 M Sorensens phosphate buffer pH 7-2 with
20% ethylene glycol, rinsed twice in hybridization buffer and
soaked in hybridization buffer for 1 hr, rinsed in ethanol and
dried. The 35S-labelled probe in hybridization buffer was heated
to 90° for 10 min, cooled and 100 pi applied to each slide under a
parafilm (Sigma) coverslip. Sections were left to hybridize in a
humidified chamber at room temperature for 72 hr. Post-
hybridization, slides were immersed in 2 x SSC until the cover-
slips dislodged, rinsed in 2 x SSC and washed at 40° for 30 min in
1 x SSC. Slides were then rinsed briefly in distilled water, in 70%
ethanol for 5 min, in 95% ethanol for 5 min and allowed to dry.
Control sections from each eye were fixed for 5 min in
glutaraldehyde buffer, washed once in 2 x SSC with 5% Tween
and three times in 2 x SSC. One hundred microlitres of RNAase
A (Boehringer Mannheim) I mg/ml in 2 x SSC was applied to
each slide under a parafilm coverslip and incubated at 37° for 1
hr, slides were then washed in 2 x SSC and simultaneous
hybridization with each probe carried out as above.
To determine the specificity of the lymphokine probe
hybridization, each section was also hybridized with a 35S-
labelled probe to the P53 oncogene which was considered to be
irrelevant to the EAU disease process.
Autoradiography
The slides were dipped in K5 (Ilford, Mobberlcy, I
photographic emulsion diluted 1:1 in 0-5% glycerol and k
expose at 4° for 21-24 days over silica gel. Slides were
developed for 3-5 min in D19 (Kodak, Hemel Hempstead, L
developer, fixed in Unifix (Kodak), washed in distilled watei
counterstained with haematoxylin.
To compare the number of cells producing each lymphc
the mean number of positive cells at each stage of the di;
process was estimated for each probe.
Monoclonal antibodies
For immunohistochemistry primary monoclonal antibodii
pan rat T cells (OX19; Serotex, Oxford, U.K.), IL-2 rece
(OX39, Serotec) and (MHC) class II expression (OX6; Sen
were utilized.
Immunohistochemistry
Sections of 6 pm thickness were cut from each eye and mou
on 3-amino propyl triethoxysilane (Sigma) coated slides. S
were fixed in acetone for 7 min and endogenous pero
activity blocked with 3% hydrogen peroxide in 50% methr
Sections were stained by a standard avidin-biotin com
method (Vector, Peterborough, U.K.) using a rat immi
globulin adsorbed biotinylated secondary antibody (Vec




Animals developed histological evidence of disease on da
post-induction. The histological changes were character
EAU in rats immunized with S antigen1 and it is well descr
that this does not occur in animals immunized with (
alone.13-15 There was a marked mixed leucocyte infiltrate ol
anterior and posterior segments of the eyes with patche
retinal oedema progressing to a total retinal destructio:
which lymphocytes were the predominant infiltrating cell.
Localization of IL-2 mRNA
Positive signal for IL-2 mRNA, observed as collections of <
grains in the photographic emulsion, was found over cells f
day 12 post-immunization onwards. In the early phase of
disease there was an accumulation of positive cells around
areas of retinal oedema and destruction (Fig. 1). These pos
cells were localized to the inner retina despite the focal neci
of the photoreceptors. At the early disease stage there were
minimal numbers of positive cells in the choroid and vitreou
the eyes with established and advanced disease there \
numerous positive cells in the retina and vitreous, and mark
increased numbers of positive cells scattered throughout
ciliary body and choroid. No positive signal was seen on eel
the anterior chamber. Numerous positive cells were seen in
extraocular inflammatory infiltrates in both anterior and
terior extraocular regions at all stages of the disease proce
Localization of lymphotoxin mRNA
Positive hybridization signal from the lymphotoxin probe
generally less strong than the other probes utilized. In the e












. 4.-' •>?* *
Wt'




^ 'vhH* . - •' .





I. (a) Detached retina in early (day 12 post-immunization) EAU.
in inner retina have positive hybridization signal to IL-2 probe
vheads to examples) around a focus of outer retinal oedema and
iction (arrow). Haematoxylin counterstain x 120. (b) Adjacent
n to (a) pre-treated with RNAase. No localization of IL-2 mRNA.
atoxylin counterstain x 120.
: of the disease positive cells were most numerous in the
ocular inflammatory cell infiltrates but a few scattered
,ve cells were also found in the choroid and very occasional
ve cells in the retina at this stage (Fig. 2). Numbers of
ve cells increased as the disease progressed and were
inent in the choroidal infiltrate in the later phase of the
se. In general very few lymphotoxin positive cells were
1 in the retina. No positive cells were found in the anterior
ber.
ization of IL-4 mRNA
idizations with the IL-4 probe revealed positive cells from
2 post-immunization onwards. These were seen in the
red retina (mainly the inner retina, related to patches of
.1 necrosis and destruction), choroid and extraocular
ates in the early phase of the disease. In the established and
ages of the disease (Fig. 3) there was a marked increase in
umbers of positive cells found in the ciliary body and
iid. Small numbers of cells in the retina and subretinal fluid
rositive in the later stages of the disease process. Again, no
ve signal was seen on any of the numerous inflammatory
n the anterior chamber.
Figure 2. (a) Foci oflocalization of lymphotoxin mRNA (arrowheads to
examples) in outer retina (R) and choroid (C) day 14 post-immuniza¬
tion. S = sclera. Haematoxylin counterstain x 120. (b) Adjacent section
to (a) pretreated with RNAase. No localizing signal. Haematoxylin
counterstain x 120.
Overall results of in situ hybridization
Positive cells for each probe were found simultaneous with the
onset of disease on day 12 post-immunization, increased in
numbers during the established phase of the disease and
remained constant during the recovery phase. A similar number
of cells were positive for each of the three probes at all stages of
the disease. On the frozen sections examined immunohisto-
chemically it was not possible to make accurate cell counts of the
T-cell numbers because of the difficulty in defining individual
cells with positive immunohistochemical stain in areas of
marked accumulation of infiltrating mononuclear cells. It was
estimated that 5-10% of the T-cell population had positive
localizing signal for each probe.
No autoradiographic signal suggestive of localization of
lymphokine mRNA was found using any of the probes in any of
the four non-immunized animals studied.
Analysis of sections pretreated with RNAase at a concentra¬
tion of 1 mg/ml for 1 hr showed that this abolished all localizing
signal on the sections of all the positive eyes for each probe (Figs
2b, 3b). Sections hybridized with the P53 probe revealed a
generalized background signal over areas of inflamed tissue
without any focal cellular localization (not shown).
Immunohistochemistry
OX 19 (pan T cell) positive cells were found in inflammatory
infiltrates throughout the extraocular tissues, anterior chamber,
ciliary body, choroid and retina, including the areas of lympho¬
kine mRNA localization (not shown). Cells in these regions also
390 D. G. Charteris & S. L. Lightman
(a) '
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Figure 3. (a) Localizing foci of IL-4 mRNA localization in retina and
choroid (C) (arrowheads) in advanced (day 21 post-immunization)
EAU. Haematoxylin counterstain x 180. (b) Adjacent section to (a)
pretreated with RNAase. No localizing signal with IL-4 probe.
Haematoxylin counterstain x 180.
N 'Ktj
Figure 4. IL-2 receptor (OX39) positive T lymphocytes (arrowheads)
infiltrating the ciliary body in advanced (day 17) disease. Haematoxylin
counterstain x 150.
had positive staining with the OX39 antibody for IL-2 receptor
expression (Fig. 4). MHC class II expression was found on cells
from day 10 post-induction onwards, this increased markedly as
the disease progressed and was seen both on organ-resident and
infiltrating cells.
The presence ofmRNA for the lymphokines IL-2, lymphot
and IL-4 was demonstrated in the areas of T-lymphc
infiltrate in actively inflamed eyes in EAU. We have previc
demonstrated that IFN-y mRNA and protein are present
similar distribution.9 At present no specific monoclonal ;
bodies are available for the immunohistochemical detectic
rat IL-2, lymphotoxin and IL-4 protein but the other inves
tions have shown that levels of IL-2, IL-2 receptor and IF
protein16 and bioactive IL-2 and IL-417 reflects the level of 1
respective cellular mRNA.
The presence of these four cytokines has implications
regard to the subsets of CD4+ T cells (the predomii
infiltrating cell type in EAU) present in the rat model used. I
CD4+ T cells conform to the pattern of subsets found in mu
CD4+ T-cell clones, that is the Thl and Th2 types,4 the
follows that both subsets are present in the T-cell infiltrafi
this model. Alternatively it is possible that the T cells presen
of the ThO subset which are thought to be a product of an a
or short-term stimulation and produce IFN-y, IL-2 and IL
There is evidence, however, that rat CD4+ T cells do not fit i
the stable pattern of lymphokine secretion seen in murine CI
T-cell clones. Rat CD4+ T cells have been subtyped accordin
their binding of the OX22 monoclonal antibody, naive CD4
cells (OX22 high) produce IL-2 and IFN-y and follov
antigen contact cells become OX22 low and produce IL-
According to this scheme both naive and memory CD4+ T t
would be present in the infiltrates found in EAU. This wc
seem logical since any section of an actively inflamed eye wc
be likely to contain a mixture ofT cells involved in the dyna
process of trafficking to the eye followed by antigen contact
subsequent effector or helper function. It is also possible t
additional subgroups of rat CD4f T cells exist and the posil
may be considerably more complex. Analysis of the cytol
secretion by individual T cells from the inflammatory infiltr;
would be necessary to investigate further the exact nature of
T cells present. Additionally non-ocular antigen-specific T c
may be involved in the destructive process following chet
attraction produced by activated ocular antigen-specific T ci
The IL-2 and IL-4 producing cells were notably distribt
in relation to foci of retinal oedema and destruction suggesl
that a stimulus to produce these lymphokines is present in
area and their subsequent release may contribute to the fc
destructive lesions seen in the early stages of EAU. Anti
contact is one potential stimulus; however, it is notable t
these cells were distributed almost entirely within the in
retina in contrast to the outer retinal distribution of S antif
The stimulus for production of these lymphokines may thi
fore be another antigen or inflammatory mediator.
IL-2 is a lymphokine which is produced by helper T c
following activation by antigenic or mitogenic stimulation;
required for the subsequent proliferation ofT lymphocytes ;
therefore plays a key role in the initiation of an imm
response.19 IL-2 mRNA has been demonstrated at the site:
tissue pathology in autoimmune disease such as rheumat
arthritis.20 IL-2 protein has been demonstrated in human e
with posterior uveitis21 and an increase in circulating 1
receptor positive22 T lymphocytes has been demonstratec
patients with active uveitis. The demonstration of IL-2 mR
and IL-2 receptor positive lymphocytes in EAU is furt
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■nee that this mediator is central to the immunopathology
traocular inflammatory disease.
.ymphotoxin is produced by both CD4+ and CD8+ T
ihocytes and is thought to play a key role in T-lymphocyte
.oxicity.23 Secretion of IFN-y along with lymphotoxin
ars to promote CD4+, class II-restricted T-cell cytotox-
24IL-2 has also been demonstrated to produce differentia-
of cytotoxic T lymphocytes.25-26 The in vivo expression of
<1A specific for these lymphokines at the site of tissue
ology in EAU is evidence that the tissue destruction may be
meed by effector T lymphocytes.
"-cell cytotoxicity can be mediated by several mcchan-
24,27 29 anj reiatjvely low numbers of cells in the retinal
ology producing lymphotoxin would suggest that cytotoxic
tanisms other than those involving lymphotoxin may be
lved.30 The widespread cellular expression ofMHC class II
>ens in the eye in EAU would provide suitable target cells
:ytotoxic CD4 1 T cells which may subsequently produce
; extensive damage through 'innocent bystander' killing.24
L-4 produces B-lymphocyte activation, MHC class II
ession and immunoglobulin (IgGl and IgE) production. It
so involved in T-lymphocyte activation and growth.31
ough few B cells are present in the intraocular pathology in
J, in vivo IL-4 production would facilitate antigen presen-
n by those B cells present to the infiltrating antigen-specific
nphocytes.
L-4 has been shown to increase the cytotoxic capacity and
C class II expression of macrophages.31 IFN-y also has the
ntial to activate macrophages32 and the in vivo production
ese two lymphokines could therefore promote an effector
unction in the numerous macrophages present at the sites of
e pathology in EAU.
t has been demonstrated thatmRNA formultiple cytokines
esent in affected joints in rheumatoid arthritis,33 a disease
ght to have an autoimmune aetiology. Our results indicate
this may also be the case in intraocular inflammatory
,se and the relative contribution ofeach individual cytokine
e tissue pathology will require further study.
"argeting the lymphokines involved in the pathogensis of
une-mediated pathology may limit the subsequent tissue
uction. Several such approaches are currently under inves-
ion, for example the use of monoclonal antibodies to a
cine or its receptor,34 the administration of soluble cytokine
ttors35 to interfere with the cytokine-receptor interaction or
se of specific cytokine antagonists.36 Further investigation
e cytokine mechanisms involved in EAU will be useful in
evelopment ofmore specific therapies for human intraocu-
lflammatory disease.
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